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Abstract 
Bacteria encounter a plethora of environmental stresses and have evolved different mechanisms 
to recognize and respond to various harmful conditions. Understanding and elucidating common 
themes as well as unique aspects of the molecular mechanisms underlying stress adaptation is 
important and can provide valuable strategies for applications. This study focuses on stress 
responses in three different bacteria, namely, Acidothermus cellulolyticus, Mycobacterium 
smegmatis and Escherichia coli. The thermophilic and acidophilic organism A. cellulolyticus was 
used as a model system to understand the effects of lignin phenolic acids on cellulolytic bacteria. 
Lignin phenolic acids pose a significant challenge to microbial deconstruction of lignocellulosic 
biomass for the commercial production of renewable products. Analysis of total proteins profiles 
of A. cellulolyticus revealed the enhanced expression of a predicted thiosulfate sulfurtransferase 
(TST) protein (Acel_0059) during exposure to phenolic acids. Expression of genes involved in 
sulfur assimilation into cysteine was also upregulated in the presence of phenolic acids. 
Heterologous expression of the Acel_0059 gene in E. coli alleviated growth inhibition of 
inhibitory phenolic acids. Analyses of the whole transcriptome of A. cellulolyticus revealed that 
exposure to these inhibitory lignin components induced the expression of genes coding for 
membrane proteins, efflux and transport proteins, oxidative stress response proteins, redox-
sensors, TST, and sulfur assimilation pathway enzymes. Deletion of the Acel_0059 counterpart 
gene (MSMEG_5879) in a surrogate host M. smegmatis increased the sensitivity of the organism 
to a variety of stressors. The deletion of TST gene affected cysteine biosynthesis from inorganic 
sulfate under hypoxic conditions in M. smegmatis. In another study, E. coli was used as a model 
to assess the biological effects of oxidized graphene (OG), a carbon nanomaterial. Growth 
analysis revealed that the addition of OG inhibited the growth of E. coli. Analyses of the whole 
transcriptome of E. coli showed that the cytotoxicity of OG in E. coli could be attributed to 
oxidative stress, membrane stress and DNA damage. Overall the above studies provided new 
insights into the shared (eg. sulfur metabolism, oxidative stress adaptation) as well as unique (eg. 
TST, membrane proteins) aspects of bacterial responses to diverse stresses. 
 
Acknowledgements 
I would like to thank the University of Arkansas, Cell and Molecular Biology Program and the 
Department of Biological Sciences for providing me the opportunity to be a part of this great 
institution. Special thanks to my advisor Dr. Ravi Barabote for his mentorship, guidance and 
training. I would like to thank my committee members Drs. Daniel Lessner, Mack Ivey, Ralph 
Henry and Suresh Thallapuranam for their expert advice and allowing me to use the instruments 
in their lab. The work contained in the dissertation was made possible through Dr. Barabote’s 
research funding provided by the Arkansas Biosciences Institute (ABI), the Arkansas Research 
Alliance (ARA), the U.S. Food and Drug Administration, and the University of Arkansas. I was 
supported on research assistantship through Dr. Barabote’s research funding, including grants 
and funds from ABI, ARA, the U.S. Food and Drug Administration, Cell and Molecular Biology 
Program and University of Arkansas. I would like to thank Department of Biological Sciences, 
Cell and Molecular Biology Program, Graduate School and University of Arkansas (Barabote 
RIF) for teaching assistantship and travel support. I thank Dr. Suresh Thallapuranam and Dr. 
Srinivas Jayanthi for assistance with HPLC. My heartiest thanks to Dr. Ines Pinto for her 
mentorship and guidance. Thanks to Dr. Jeffery Lewis and his lab family for their help and 
support. I am thankful to former and current lab members for their help, love and support. 
Special thanks to my family for their continuous and uparalleled love and encouragement. 
 



















2.9 Supplementary tables..……………………………………...………………………………..43 




Whole transcriptome analyses of Acidothermus cellulolyticus 11B exposed to lignin and lignin 
phenolic acids…………………………………………………………………………………….59 
3.1 Introduction………………………………………………………..…………………………59 









Generation and phenotypic analysis of knockout mutant of a thiosulfate sulfurtransferase gene in 
Mycobacterium smegmatis…………………………..………………………………………….126 
4.1 Introduction………………………..………………………………………………………..126 





4.7 Supplementary figures………………..…………………………………………………….164 
4.8 References………………………….……………………………………………………….165 
Chapter 5 
Physiological and transcriptomic analyses of the bioactivity of oxidized graphene in Escherichia 
coli……………………………………………………………………………………………....171 
5.1 Introduction………………………..………………………………………………………..171 















List of unpublished manuscripts 
Chapter 2 is from 
Rampal S, Angel A, Barabote RD. Inhibitory phenolic acids affect the expression of thiosulfate 









Bacteria are among the first life forms to have existed on earth, and have consequently had 
exposure to changing environmental conditions [1]. Bacterial genomes are highly adaptable and 
have evolved unique strategies to sense and respond to harmful changes in their environment, 
and these strategies are collectively refered to as stress response [2, 3]. Molecular understanding 
of stress responses across bacteria aids in identifying shared and unique aspects of how different 
bacteria deal with hostile environmental conditions. We looked at the response of three bacteria 
viz. Acidothermus cellulolyticus, Mycobacterium smegmatis and Escherichia coli to different 
stresses. A. cellulolyticus is a thermophilic, acidophilic and cellulolytic bacteria which is used for 
the commercial hydrolysis of cellulose into glucose [4]. It is a promising candidate for the 
conversion of lignocellulosic biomass into biofuels and numerous value added chemicals. M. 
smegmatis is a fast-growing, non-pathogenic bacteria that shares many similarities with other 
pathogenic mycobacteria. It has been widely used as a model system for understanding 
mycobacterial physiology and development of drug targets for pathogenic mycobacteria. E. coli 
is a Gram-negative, facultative anaerobe that is most studied and widely used model bacterium. 
It is extensively used as a host organism for expression of recombinant proteins, and plays an 
important role in biological engineering and industrial microbiology [40].  
 
1.2 Overview of chapters 
The research described Chapter 2 was aimed at understanding the response of Acidothermus 
cellulolyticus 11B towards inhibitory lignin phenolic acids. A. cellulolyticus 11B is a 
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thermophilic, acidophilic, Gram-positive, bacterium belonging to the high G+C Actinobacteria 
group. It encodes genes for multiple plant cell wall degrading enzymes and is a promising 
candidate for the bioconversion of lignocellulosic biomass into biofuels and other valuable 
products [4-6]. Lignocellulosic biomass is often pretreated to breakdown and separate the 
recalcitrant lignin from cellulose and hemicellulose components. The latter yield simple sugars 
that can be converted into biofuels. The pretreatment of lignocellulosic biomass releases lignin 
derived phenolic acids as free acids into the hydrolysate [7]. These phenolic acids are inhibitory 
to the growth of many microorganisms, including A. cellulolyticus [8-11]. Understanding and 
reducing the toxicity of lignin and its related phenolics is important towards improving the 
efficiency of microbial bioconversion of lignocellulose [12]. 
 
Global gene expression profiling is a useful tool towards understanding the molecular 
mechanisms of toxicity and the mechanisms by which organisms adapt to toxic environments 
[13]. Chapter 3 discusses the genome-wide gene expression analysis of A. cellulolyticus in 
response to lignin and its related phenolic acids. We observed that genes providing protection 
against oxidative stress and membrane damage were induced in response to the compounds 
tested. The information obtained about the genes involved in response to these inhibitory 
compounds, could be used to engineer microbial strains with enhanced tolerance to toxic 
lignocellulosic hydrolysate. One such candidate is the Acel_0059 gene that codes for a putative 
thiosulfate sulfurtransferase (TST) enzyme. Analysis of the total protein profiles of A. 
cellulolyticus grown in the presence of phenolic acids revealed that the expression of TST was 
upregulated in the presence of phenolic acids (Chapter 2). The phenolic acids also upregulated 
the expression of genes involved in the assimilation of sulfate into cysteine. Our studies reveal 
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the importance of TST during survival under phenolic acid inhibition and its plausible role in the 
sulfur metabolism. TSTs are enzymes that catalyze the transfer of sulfur from thiosulfate to 
cyanide in vitro and therefore were initially proposed to be involved in cyanide detoxification 
[14, 15]. However, several studies suggest that TSTs play important roles in various cellular 
functions including the assembly of iron-sulfur clusters, cysteine biosynthesis, maintenance of 
sulfane sulfur pools, etc. [16-19]. However, the precise biological function of TST is yet to be 
understood. 
 
It is important to study whether the role of TST during survival under stress is unique to A. 
cellulolyticus or shared by other bacteria. The closest sequence homolog of A. cellulolyticus TST 
in the UniProt/Swissprot database was found to be MSMEG_5789 protein (a putative TST) 
belonging to Mycobacterium smegmatis mc2 155. M. smegmatis mc2 155 (basonym for 
Mycolicibacterium smegmatis mc2 155), like A. cellulolyticus, is a Gram-positive, rod shaped, 
high G+C Actinobacteria belonging to the order Actinomycetales. M. smegmatis is a fast-
growing, non-pathogenic bacterium that shares the distinct cell wall structure and a number of 
homologous genes including those for stress adaptation with other mycobacterial species [20, 
21]. It has thus been widely used as a surrogate host for genetic analysis of various pathogenic 
mycobacteria such as M. tuberculosis, M. avium, and M. paratuberculosis [22-24]. Antibacterial 
drugs aimed at targeting genes involved in stress response have been proposed as a possible 
solution for combating drug resistance in pathogenic bacteria [25]. Chapter 4 discusses the 
generation and phenotypic analysis of TST. Data from this chapter revealed the importance of 
TST during survival under stress in M. smegmatis. Our studies revealed that the deletion of TST 
coding gene, MSMEG_5789, in M. smegmatis increased its sensitivity to a variety of stressors.  
 
 4 
Chapter 5 discusses the cytotoxic effects of oxidized graphene (nanomaterial) on Escherichia 
coli. E. coli is a Gram-negative, facultative anaerobe that is widely used as a model bacterium in 
understanding bacterial physiology as well as a key tool in molecular biology [26]. Graphene is 
the thinnest material known on earth that consists of a single layer of carbon atoms arranged in a 
hexagonal honeycomb lattice structure [27, 28]. It exhibits a number of exceptional properties 
including excellent mechanical strength, high thermal and electrical conductivity, impermeability 
to gases, high optical transmittance etc. [29, 30]. Owing to these properties graphene-family 
nanomaterials have attracted interest in applications such as nanoelectronics, super-capacitors, 
electrochemical sensors and biosensors, drug delivery etc. [31-33]. It is therefore important to 
evaluate the bioactivity and potential hazards of graphene on living organisms and environment, 
to implement their use without disturbing the ecological balance [34]. There have been 
contradictory results on the toxicity of graphene, which could be attributed to the differences in 
size, solubility, surface chemistry etc. of the graphene tested [35, 36]. Graphene is often 
chemically functionalized in order to tune its inertness, solubility and processability, a crucial 
step for its end applications, resulting in variations in surface properties [37-39]. However, 
chemical functionalization is thought to also impart bioactivity to inert graphene, rendering it 
potentially toxic to living organisms. To evaluate and understand the bioactivity of oxidized 
graphene, we studied the effect of pristine graphene (PG) and oxidized graphene (OG) on the 
growth of E. coli. The OG tested in our study, was obtained by treating pristine graphene with 
concentrated sulfuric acid and nitric acid, to increase its hydrophilicity [36]. OG was found to be 
inhibitory to the growth of E. coli. The genome-wide gene expression profiles of E. coli upon 
exposure to OG or PG were also studied. Exposure of E. coli to OG resulted in enhanced 
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expression of genes encoding for stress response proteins, membrane proteins, transporters, and 
proteins involved in sulfur metabolism. 
 
Chapter 6 provides a summary of the results obtained from the studies discussed in Chapter 2-5. 
Our studies reveal a link between phenolic acid stress and TST in A. cellulolyticus. The 
importance of TST in M. smegmatis during survival upon exposure to a variety of stressors is 
elucidated. We discuss the appositeness of sulfur assimilation into cysteine during survival under 
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Acidothermus cellulolyticus strain 11B is an efficient cellulose-degrading bacterium that is of 
high value in the production of biofuels from lignocellulose. However, antimicrobial phenolic 
acids found in lignocellulose inhibit the growth of the organism. To understand the cellular 
targets affected by this inhibition, we analyzed total proteins from bacteria grown in the presence 
of phenolic acids, namely 4-hydroxybenzoic acid (HA), p-coumaric acid (CA), syringic acid 
(SA), trans-ferulic acid (FA), and vanillic acid (VA). Expression of an approximately 30 kDa 
protein was found to be upregulated in the presence of phenolic acids. Mass spectrometry 
revealed the upregulated protein to be Acel_0059, a predicted thiosulfate sulfurtransferase 
(TST). Expression of the Acel_0059 gene as well as genes predicted to be involved in sulfur 
assimilation and cysteine biosynthesis (cysN, cysD, cysC, cysH, and cysM) were also upregulated 
in the presence of phenolic acids. Supplementation of L-cysteine in the growth media containing 
HA alleviated the upregulation of Acel_0059 while concurrently lowering the growth inhibition. 
The Acel_0059 gene was cloned in Escherichia coli and the heterologous protein was partially 
purified. Partially purified Acel_0059 protein showed rhodanese activity in vitro between 55°C 
and 80°C. Expression of Acel_0059 in E. coli increased bacterial survival upon exposure to 
inhibitory concentration of HA. These data suggest that Acel_0059 may be important for 





Phenolic acids at sufficient concentrations are toxic to most organisms. However, the cellular 
targets that are impacted by phenolic acids are not fully understood. Our study provided new 
insights into genes affected by phenolic acids in A. cellulolyticus. In addition, it revealed a novel 
link between growth inhibition by phenolic acids and thiosulfate sulfurtransferase (TST, a.k.a. 
rhodanese). TST is a highly conserved enzyme that is found ubiquitously in Bacteria, Archaea, 
and mitochondria of Eukaryotes. Although the rhodanese enzyme was discovered and 
characterized in vitro more than eight decades ago, the true biological functions of rhodaneses 
remain enigmatic till date. Our findings indicate a role for A. cellulolyticus TST in response to 
growth inhibition by phenolic acids and suggest a plausible role for it in sulfur metabolism. The 
data expand the realm of our understanding on the biological roles of rhodaneses. 
 
2.3 Introduction 
Acidothermus cellulolyticus strain 11B, a thermophilic Gram-positive bacterium belonging to 
high G+C Actinobacteria, is one of the most efficient cellulose-degrading organisms that is 
capable of degrading crystalline cellulose [1]. The genome of this organism has been completely 
sequenced and analyzed [2]. Owing to its ability to produce biotechnologically important 
hyperthemostable enzymes, A. cellulolyticus is of very high interest in the bioconversion of 
lignocellulose to biofuels and value-added chemicals [1-3]. While we had previously reported 
that phenolic acids found in lignocellulose are inhibitory to the organism [4], the cellular targets 
affected by the phenolic acids were unknown. Identification of these molecular targets could 
provide novel strategies to mitigate the inhibitory effects of phenolic acids and enhance A. 
cellulolyticus for applications in cellulosic biofuels production [5]. 
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Phenolic acids constitute one of the most numerous and ubiquitously distributed group of plant 
secondary metabolites. Phenolic acids are toxic to most organisms, including bacteria, fungi, 
plants, and animals. They have been shown to inhibit the growth of cellulolytic and non-
cellulolytic bacteria and fungi [6-11]. Phenolic acids are also known to be allelopathic to plants 
as they cause defects in germination, growth, survival, and reproduction [12-15]. Phenolic acids 
also have the ability to inhibit the growth of cancer cells and induce apoptosis in animal cell 
cultures [16-18]. The precise molecular effects of phenolic acids on cellular physiology are not 
fully understood. Most phenolic acids act as antioxidants at low (nanomolar to micromolar) 
concentrations and are beneficial to life, while at higher (millimolar) concentrations they act as 
prooxidants and are toxic [19, 20]. Inhibitory effects of phenolic acids are generally thought to 
be exerted through the disruption of integrity and function of cell membranes [21]. 
 
Cellular and genetic responses of organisms to inhibitory phenolic acids are diverse. We have 
previously shown that phenolic acids induce the expression of efflux pumps in the Gram-
negative bacterial plant pathogen Erwinia chrysanthemi [22-23]. In the opportunistic human 
pathogen Serratia marcescens phenolic acids affect expression of enzymes involved in fatty acid 
biosynthesis [24]. In the fungus Fusarium, phenolic acids inhibit the expression of mycotoxin 
biosynthesis genes causing decreased toxin production [25]. Recently, phenolic acids were found 
to induce stress pathways associated with programmed cell death in the fungal maize pathogen 
Cochliobolus heterostrophus [26]. Few microorganisms have the ability to detoxify or degrade, 
but not utilize phenolic acids as sole carbon source. For example, in certain Gram-positive 
bacteria, such as Bacillus subtilis, Lactobacillus plantarum, and Pediococcus pentosaceus, 
phenolic acids are known to induce the expression of phenolic acid decarboxylases, which are 
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involved in detoxification of phenolic acids [27, 28]. While a few other bacteria have the ability 
to utilize phenolic acids as sole carbon source as they produce enzymes that can catalyze the 
aromatic ring cleavage via the ortho pathway [29]. However, A. cellulolyticus 11B can neither 
utilize phenolic acids as a sole carbon source nor does its genome encode homologs of enzymes 
known to be involved in detoxification and metabolism of phenolic acids. 
 
In the present study, we studied the total protein profiles of A. cellulolyticus grown in the 
presence of phenolic acids and found that the expression of Acel_0059 was upregulated in the 
presence of phenolic acids. We confirmed this upregulation by studying the expression of the 
Acel_0059 gene. We also found that phenolic acids upregulated the expression of genes involved 
in assimilation of sulfate into cysteine. We found that supplementation of cysteine relieved both 
growth inhibition and the upregulation of Acel_0059 in the presence of phenolic acids. We 
cloned the Acel_0059 gene in Escherichia coli and overexpressed and partially purified the 
protein. The partially purified Acel_0059 protein showed TST activity in vitro. E. coli cells 
expressing the Acel_0059 gene showed increased survival in the presence of phenolic acids at 
inhibitory concentrations. We discuss the relevance of Acel_0059 upregulation in response to 
growth inhibition by phenolic acids and its plausible role in bacterial survival and sulfur 
metabolism in A. cellulolyticus. 
 
2.4 Materials and methods 
2.4.1 Bacteria and growth conditions. All bacteria and plasmids used in this study are listed in 
Table 1. A. cellulolyticus was grown in LPBM (low phosphate basal salts medium) as described 
previously [3]. LPBM contained per liter 1 g NH4Cl; 0.1 g Na2HPO4.7H2O; 1 g KH2PO4; 0.2 g 
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MgSO4.7H2O; 0.2 g CaCl2.2H2O; 0.5 g yeast extract; 5 g D-cellobiose. Phenolic acids were 
prepared as 1 M stocks in dimethyl sulfoxide (DMSO), filter sterilized, and were added to the 
sterilized growth medium at 1 mM final concentration. To media without any phenolic acids 
(controls) equivalent amount of DMSO was added to account for any solvent effects. To study 
the effect of sulfur supplementation in media, filter-sterilized solution of sulfur-containing amino 
acids (L-cysteine or L-methionine), sodium thiosulfate, L-glutathione were added at 0.5 mM 
final concentration or as indicated in the experiment, while MgSO4 was supplemented at 5X 
higher concentration than in regular LPBM. The final pH of the all media was adjusted to 5.5 by 
the addition of sterile 10% phosphoric acid or 10N NaOH. E. coli was grown in Luria-Bertani 
(LB) medium containing appropriate selective antibiotics at 37°C as described previously [3]. 
Bacterial growth was measured using optical density at 600 nm. 
 
2.4.2 RNA extraction. Total RNA was extracted from mid-exponential phase A. cellulolyticus 
cultures using RNeasy Plant Mini kit (Qiagen). For the control, RNA was extracted from 100 ml 
culture at 20 h (OD600 0.6), and for the phenolic acid treatments, RNA was extracted from 200 
ml culture at 37 h (OD600 0.3). The total RNA was treated with two rounds of RNase-Free DNase 
(Qiagen) to eliminate any contaminating genomic DNA. The quality of RNA was analyzed using 
agarose (0.8%) gel electrophoresis. Complete elimination of genomic DNA from RNA samples 
was confirmed using HotStartTaq Plus DNA Polymerase (Qiagen) using primers specific for the 
Acel_0005 (gyrB) gene and Acel_0305 (rpsJ) gene. RNA was quantified using Qubit RNA HS 




2.4.3 Quantitative Reverse Transcriptase PCR (qRT-PCR). The relative expression level of 
genes of interest was quantified using QuantiFast SYBR Green RT-PCR kit (Qiagen) and 
BioRad CFX96 Real-Time System. Gene-specific primers were designed using OligoPerfectTM 
Designer (ThermoFisher Scientific). The specificity of primers was verified using genomic DNA 
as template in a PCR reaction. All primers that were used in this study are listed in Table S3. 10 
ng of total RNA was used as template in 25 µl reaction volume with 1 µM of each primer. The 
reaction mix was incubated at 50°C for 10 minutes for RT reaction, followed by denaturation at 
95°C for 5 minutes and 35 cycles of PCR (10 seconds at 95°C and 30 seconds at 60°C). PCR 
products were run on 0.8% agarose gel in Tris-Borate-EDTA buffer (pH 8) to verify the 
amplification of a single PCR product of expected size. Acel_0305 (rpsJ that encodes the 30S 
ribosomal protein S10) was used as the internal normalizer gene. Relative gene expression was 
calculated using the 2-∆∆CT method as described previously [22]. Briefly, transcript abundance for 
each gene was first normalized to that of Acel_0305 and then fold expression was calculated 
relative to the expression of the gene in the control treatment. 
 
2.4.4 Extraction and analysis of total proteins from A. cellulolyticus. Total proteins were 
extracted from mid-exponential phase cultures of A. cellulolyticus. For the control, proteins were 
extracted from 25 ml culture at 20 h (OD600 0.6), and for the phenolic acid treatments, proteins 
were extracted from 50 ml culture at 37 h (OD600 0.3) or at indicated times in the experiment. 
Cells were harvested by centrifugation at 10,000 g for 10 min at room temperature and re-
suspended in sterile deionized water. Cells were lysed using a Branson Ultrasonic sonicator 
(10% amplitude, 2 seconds pulse ON, 5 seconds pulse OFF, for a total of 90 seconds). Sonicated 
samples were centrifuged at 10,000 g for 10 min 4°C to remove any cells and debris. Protein 
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concentration in the lysate was measured using the Qubit Protein Assay kit (Life Technologies). 
Proteins (30 µg) were separated on nUView 4-20% Tris-Glycine precast gels (NuSep) and 
visualized using Biosafe Coomassie Brilliant Blue G-250 (BioRad).  
 
2.4.5 Identification of Acel_0059. Protein bands of interest were excised and sent to the UAMS 
Proteomics Core Facility for analysis using tandem mass spectrometry. Tandem mass spectra 
were analyzed using Mascot (Matrix Science, London, UK; version 2.4.1). Mascot was set up to 
search the A. cellulolyticus predicted proteome (2157 proteins) in UniProtKB. Mascot was 
searched with a fragment ion mass tolerance of 0.50 Da and a parent ion tolerance of 2.0 PPM. 
Carbamidomethyl of cysteine was specified in Mascot as a fixed modification. Oxidation of 
methionine and acetyl of the N-terminus were specified in Mascot as variable modifications. 
Scaffold (version Scaffold_4.5.0, Proteome Software Inc., Portland, OR) was used to validate 
MS/MS based peptide and protein identifications. Peptide identifications were accepted if they 
could be established at greater than 99.9% probability by the Scaffold Local FDR algorithm. 
Protein identifications were accepted if they could be established at greater than 99.9% 
probability and contained at least 5 identified peptides. Protein probabilities were assigned by the 
Protein Prophet algorithm [61]. Proteins that contained similar peptides and could not be 
differentiated based on MS/MS analysis alone were grouped to satisfy the principles of 
parsimony. Proteins having a minimum of 10 normalized total spectra were identified. 
Acel_0059 was identified based on the normalized total spectra. 
 
2.4.6 Cloning of Acel_0059. The Acel_0059 gene was cloned in E. coli using pET expression 
system. Full-length sequence (840 bp) of the gene was amplified from A. cellulolyticus genomic 
 
 16 
DNA using primers containing NcoI and XhoI restriction sites (see Table S3). PCR product was 
purified and was restriction digested and ligated into pET-28a(+) expression vector (Novagen) 
that had been predigested with the same restriction enzymes. The ligation mixture was 
electroporated into subcloning efficiency electrocompetent E. coli DH5α cells (ThermoFisher 
Scientific) using BioRad GenePulser using the manufacturer’s preset protocol. Transformants 
were selected on kanamycin (50 µg/ml). Recombinant plasmid (pAc59) was isolated from E. coli 
DH5α cells using QIAprep Spin Miniprep kit (Qiagen) and the presence of the Acel_0059 gene 
insert was confirmed using restriction digestion as well as PCR. The insert was sequenced to 
ensure correctness of the gene sequence and lack of any mutations. 
 
2.4.7 Partial purification of Acel_0059. For partial purification of the Acel_0059 protein, the 
pAc59 plasmid was electroporated into E. coli Rosetta™(DE3)pLacI competent cells (Novagen). 
Transformed cells were selected on chloramphenicol (17 µg/ml) and kanamycin (25 µg/ml). E. 
coli cells carrying pAc59 (ECRDL59) were grown in LB broth containing the above antibiotics. 
For production of the Acel_0059 protein, cells were grown to OD600 between 0.3-0.5 and the 
Acel_0059 gene was induced for 4 hours using 1 mM Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) with vigorous shaking at 300 rpm. For uninduced control, parallel cultures were grown 
without the addition of IPTG. Cells were centrifuged at 15,000 g for 15 minutes at room 
temperature. Cell pellets were re-suspended in 1/10th culture volume of lysis buffer (50 mM Tris-
Cl pH 8, 5% glycerol, 50 mM sodium chloride, 10 mg/ml lysozyme) and mixed by vortexing. 
Lysis was carried out by incubating the cell suspension at 37°C for 20 minutes, followed by a 
cold shock at -20°C for 30 seconds, and immediate transfer to 37°C for 1 minute. To eliminate 
any contaminating genomic DNA, the protein samples were treated with DNase (Qiagen) at 
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37°C for 30 minutes. Cell debris was removed using centrifugation at 15,000 g for 15 minutes at 
room temperature and the clear protein solution was obtained. The thermostable Acel_0059 
protein was partially purified by denaturing and precipitating the host proteins at 55°C for 1 
hour; precipitated host proteins were removed by centrifugation as done above. The protein 
preparation was passed through centrifugal filters with 9 kDa membrane (Pierce) to concentrate 
the Acel_0059 protein. Protein concentration was determined using Qubit Protein Assay kit (Life 
Technologies). The partially purified protein was stored at -20°C in 50 mM Tris-Cl pH 8 
containing 50% glycerol. 
 
2.4.8 Rhodanese activity and Zymogram analysis of partially purified Acel_0059 protein. 
Rhodanese activity and substrate preference of the Acel_0059 protein was determined using 
either thiosulfate or mercaptopyruvate as sulfur donors and potassium cyanide as the sulfur 
acceptor as described previously [62]. Briefly, rhodanese activity was determined by measuring 
SCN formation as the red Fe(SCN)3 complex from cyanide and thiosulfate. The reaction mixture 
(1 mL) contained 100 mM Tris-Acetate pH 9.0, 10 mM KCN, and 1 mg of partially purified 
Acel_0059. Reaction was initiated by addition of 10 mM of either Na2S2O3 or 3-
mercaptopyruvate. After incubation at 50°C for 15 min the reaction was stopped by addition of 
200 µL acidic iron reagent (per liter composition: 50 g of FeCl3, 200 ml of 65% HNO3). After 
centrifugation at 13,000 g for 3 min the absorption was read at 460 nm. For control, thiocyanate 
formation was determined in the absence of Acel_0059 protein in the reaction mixture. Amounts 
of product formation were quantified using a standard curve done with NaSCN. The Vmax and Km 
values of the enzyme were measured as follows: the reaction mixture (1 ml) containing 100 mM 
Tris-Acetate (pH 8.5), 10 mM KCN, and 0.5 mg of partially purified Acel_0059 was 
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supplemented with different substrate concentrations (Na2S2O3, 0-50 mM). The reaction was 
carried out by incubation at 55°C for 3 min and the reaction was stopped by the addition of 
200 µL acidic iron reagent. After centrifugation at 13,000 g for 3 min the absorption was read at 
460 nm. The concentration of product obtained was quantified using a standard curve of  
NaSCN. The data obtained was used to generate Lineweaver Burk plot, and the Lineweaver Burk 
equation was used to calculate Vmax and Km values. For Zymogram analysis, activity was assayed 
in non-denaturing polyacrylamide gels using thiosulfate and potassium cyanide as substrates as 
described previously [63]. Briefly, 50 µg of partially purified protein from uninduced and 
induced cultures of ECRDL59 was separated on Blue Native Polyacrylamide gel (BN-PAGE, 
ThermoFisher Scientific). After electrophoresis, gels were either stained with Bio-Safe 
Coomassie (BioRad) or used for zymogram assay. For zymograms, gels or gel lanes were 
incubated at 70°C for 50 minutes in 5 volumes of reaction mixture containing 100 mM Tris-
acetate buffer pH 8.5, 200 mM sodium thiosulfate, 200 mM potassium cyanide and 300 mM 
calcium chloride. Gels were washed with distilled water and 10% glacial acetic acid. A white 
insoluble band resulting from the formation of CaSO3 precipitate in the zymogram indicates TST 
activity. To evaluate the temperature optima for enzyme activity, gels were incubated different 
temperatures as indicated in the experiment. 
 
2.4.9 Survival assay and Agar diffusion assay. For survival assay, E. coli cells carrying the 
pAc59 plasmid (ECRDL59) and control cells (ECRDL28) containing the pET28a vector were 
grown in LB with chloramphenicol (17 µg/ml) and kanamycin (25 µg/ml). IPTG was used at 0.1 
mM (one-tenth of the concentration that was used for protein overexpression) to allow for 
induction of gene expression without the cessation of growth. Cells were grown at 37°C for 9 
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hours to obtain an optical density of 0.6. Cultures were diluted to a density of 106 cells/ml and 
were treated with 15 mM HA for 30 minutes. Colony forming units after dilution plating were 
used to calculate the total number of surviving cells before and after HA treatment. For agar 
diffusion assay, ECRDL59 and ECRDL28 cultures were grown in LB with chloramphenicol (17 
µg/ml) and kanamycin (25 µg/ml) and IPTG at 0.1 mM concentration. Cells were grown at 37°C 
for 9 hours to obtain an OD600 of 0.6. 100µl of 107 cells/ml were plated on LB agar plates 
containing the same concentrations of antibiotics and IPTG as mentioned above. 50 µl of 0.5 M 
phenolic acids (equimolar mixture of HA, VA, CA, FA, SA, adjusted to pH 7) was added to 
sterile discs (Sigma). Air dried discs were placed in the center of the agar plates and incubated at 
37°C for 18-20 hours. Distance from the edge of the disc to edge of the zone was measured. 
Mean values from biological replications were used for statistical analysis. To analyze the effect 
of Acel_0059 on the growth in the presence of PA, overnight grown ECRDL59 and ECRDL28 
were inoculated (105 cells/ml final concentration) in LB with chloramphenicol (17 µg/ml) and 
kanamycin (25 µg/ml) in either the absence or presence of 20 mM PA. Cells were grown at 37°C 
and 300 rpm for 25 hours and growth was monitored using optical density 600 nm. 
 
2.5 Results 
2.5.1 Expression of an approx. 30 kDa band containing the Acel_0059 protein was 
enhanced in the presence of phenolic acids. Plant phenolic acids, namely 4-hydroxybenzoic 
acid (HA), vanillic acid (VA), trans-ferulic acid (FA), p-coumaric acid (CA), and syringic acid 
(SA) inhibited the growth of A. cellulolyticus at 1 mM concentration (Fig. 1). To identify the 
proteins whose expression was affected during the inhibition, total protein profiles of the bacteria 
grown in the absence or presence of phenolic acids were analyzed using Coomassie-stained 
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sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Analysis of the SDS-
PAGE gel revealed that intensity of a protein around 30 kDa was prominently elevated in 
cultures grown in the presence of phenolic acids (Fig. 2A). Gel slices containing the 30 kDa band 
were excised from all lanes and the proteins in each slice were analyzed using tandem mass 
spectrometry (LC-MS/MS). Mass spectrometry identified ten proteins with molecular weights 
between 30-32 kDa (Table S1). Of these, the Acel_0059 protein (GenBank accession 
ABK51835.1) with a predicted mass of 31.7 kDa had the highest normalized total spectra 
(between 53 and 110). Other proteins had substantially fewer number of normalized total spectra 
(between 10 and 28). Also, compared to the control sample, only Acel_0059 showed 
substantially higher number of normalized total spectra in samples corresponding to phenolic 
acids. Specifically, compared to the control lane, HA and VA lanes had approx 2-fold more 
normalized total spectra for the Acel_0059 protein, while CA and FA lanes had approx 1.4-fold 
more normalized total spectra (Fig. 2B). Normalized total spectra in the SA lane was comparable 
to that of the control. However, it should be noted that gel excision is variable and therefore 
normalized total spectra may not be reflective of actual protein abundances. For most of the 
downstream analyses, HA was selected as a representative phenolic acid. To further understand 
the expression pattern of Acel_0059 during growth, total proteins profiles were analyzed at 
regular intervals for 37 hours. The data indicated that the expression of Acel_0059 protein 
steadily increased during growth in the presence of HA, while there was no visible upregulation 
of the expression of Acel_0059 protein in the control (Fig. 2C). To rule out any effects of the 
acidic properties of phenolic acids on Acel_0059 upregulation, total proteins were analyzed from 
cultures grown in control medium (without phenolic acids) that was adjusted to different initial 
pH. Acidic pH did not result in upregulation of Acel_0059 expression (Fig. S1).  
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2.5.2 Expression of Acel_0059 gene was upregulated in the presence of phenolic acids. To 
confirm the genetic upregulation of Acel_0059 protein in the presence of phenolic acids, 
expression of the Acel_0059 gene was analyzed in the presence of phenolic acids. For this, the 
transcript abundance of Acel_0059 was analyzed using quantitative reverse transcriptase PCR 
(qRT-PCR). The data confirmed that the transcript abundance of Acel_0059 was increased in the 
presence of HA and VA by approx 16-fold and 8-fold, respectively (Fig. 4A). The higher 
transcript abundance of Acel_0059 in HA and VA validated the higher protein amounts seen in 
the SDS-PAGE gels and the mass spectrometry data discussed above. The relative transcript 
abundance of Acel_0059 was higher than that of housekeeping genes rpsJ and gyrB (Fig. 4B). 
The rpsJ (Acel_0305) gene encodes the small subunit ribosomal protein S10P that is required for 
ribosome assembly, while the gyrB (Acel_0005) gene encodes the DNA gyrase subunit B that is 
required for DNA replication. The relatively high expression of Acel_0059 gene corroborated 
with the prominence of the Acel_0059 protein in SDS-PAGE gels. To check if Acel_0059 was 
possibly upregulated for the metabolism and detoxification of phenolic acids, the concentration 
of HA was measured in culture supernatants at regular intervals during growth. The 
concentration of HA showed no decline during growth (Fig. S2), which suggested that the 
upregulation of Acel_0059 had a different purpose. Based on the genomic annotation of 
Acel_0059 as a putative thiosulfate sulfurtransferase (TST), we hypothesized that it may play a 
role in sulfur metabolism or homeostasis.  
 
2.5.3 Bioinformatic analysis of sulfur assimilation genes in A. cellulolyticus. To identify the 
putative sulfur assimilation pathway in A. cellulolyticus, amino acid sequences of known proteins 
involved in key sulfur assimilation pathways were obtained from the MetaCyc and KEGG 
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databases [30, 31], and were used to identify the corresponding homologs in A. cellulolyticus. 
Five genes that encoded homologs of enzymes involved in the assimilatory sulfate reduction 
pathway were found in single copy in the A. cellulolyticus genome (GenBank accession 
NC_008578) (Table S2). These included sulfate adenylyltransferase subunit 1 (CysN, 
Acel_1617), sulfate adenylyltransferase subunit 2 (CysD, Acel_1618), adenylylsulfate kinase 
(CysC, Acel_1619), phosphoadenylyl-sulfate reductase (CysH, Acel_2054), and sulfite reductase 
(CysI, Acel_2055). In addition, the A. cellulolyticus genome encodes homologs of the 
mycobacterial CysM/CysO/mec+ pathway for cysteine synthesis [32, Table S2]. The 
mycobacterial CysM protein (Rv1336) encodes an O-phosphoserine sulfhydrylase that was 
shown to function along with a small sulfur-carrier protein CysO (Rv1335) and a CysO-cysteine 
peptidase protein mec+ (Rv1334) proteins in cysteine synthesis in vitro [32]. More recently, the 
adenylyltransferase/sulfurtransferase protein MoeZ (Rv3206c) was shown to transfer sulfur from 
an unknown source to CysO [33]. The A. cellulolyticus genome encodes a homolog of MoeZ 
(Acel_1777). Surprisingly, the A. cellulolyticus genome did not contain identifiable homologs of 
the O-acetylserine-dependant cysteine synthase (CysK1, Rv2334) and the serine 
acetyltransferase (CysE, Rv2335) that is required for the synthesis of O-acetylserine [34, 35]. 
Further, the A. cellulolyticus genome also did not encode CysK2 (Rv0848), a second O-
phosphoserine-dependent cysteine synthase [36]. Thus, these data suggested that A. cellulolyticus 
likely encodes a single pathway for cysteine synthesis that involves the CysM (Acel_1687), 
CysO (Acel_1688), mec+ (Acel_1689), and MoeZ (Acel_1777) proteins [32]. All four proteins 
appear to be encoded in a single copy in the genome. The predicted pathway for assimilatory 
sulfate reduction pathway and cysteine synthesis in A. cellulolyticus, along with the 
corresponding homologs, is provided in Figure 3. 
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2.5.4 Expression of genes for assimilatory sulfate reduction was upregulated in the presence 
of phenolic acids. To study the expression of the assimilatory sulfate reduction genes, relative 
transcript abundance of five genes was quantitated using quantitative real-time RT-PCR (Fig. 
4A). Expression of all genes was significantly increased in the presence of HA and VA. 
Depending on the gene, transcript abundance was enhanced between 5- and 31-fold in the 
presence of HA, and between 6- and 29-fold in the presence of VA. No significant differences 
were observed in the presence of CA, while only three genes each were significantly upregulated 
in the presence of SA or FA. The cysH gene showed the highest relative increase in transcript 
abundance in the presence of HA and VA, approx 31- and 29-fold, respectively. The cysC gene 
showed approx 23- and 13-fold increase in relative transcript abundance in the presence of HA 
and VA, respectively. Both cysN and cysD showed approx 13-fold increase in relative transcript 
abundance in the presence of HA and VA. The cysM gene showed approx 5- and 6-fold increase 
in relative transcript abundance in the presence of HA and VA, respectively. Taken together, the 
upregulation of the assimilatory sulfate reduction pathway and cysteine synthesis genes 
suggested that there may be an increased need for cysteine synthesis from sulfate during 
exposure to phenolic acids. Increased cysteine biosynthesis may be important for increasing thiol 
pools (antioxidants) in the cells for mitigating the oxidative effects of the phenolic acids [37]. 
 
2.5.5 Supplementation of cysteine in the growth medium relieved the inhibition by HA. We 
studied the effect of L-cysteine supplementation in the media on the growth inhibition by HA. 
Under normal growth (i.e., in the absence of phenolic acids), addition of L-cysteine had no 
significant effect on the growth of bacterial culture (Fig. 5A). However, in the presence of HA, 
addition of L-cysteine in the media significantly increased the growth of A. cellulolyticus (Fig. 
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5B). On the contrary, addition of L-methionine (the other sulfur-containing amino acid) 
decreased the growth of A. cellulolyticus significantly in the presence of HA. Supplementation of 
HA-containing media with 5X the normal concentration of inorganic sulfate also lowered the 
growth of A. cellulolyticus, albeit to a lesser extent than L-methionine. In the absence of HA, L-
methionine did not significantly affect growth while 5X sulfate enhanced the growth of A. 
cellulolyticus. Elevated sensitivity to HA in the presence of L-methionine or 5X sulfate hints at a 
complex regulation of sulfur assimilation in the organism. Additionally, we evaluated the effects 
of the addition of thiosulfate and glutathione, a small molecular weight thiol, on the growth of 
bacteria in the presence of HA. It should be noted that A. cellulolyticus does not produce 
glutathione, but is instead predicted to produce mycothiol. However, due to the ease of 
availability we used glutathione as a low molecular weight redox agent. In the presence of HA, 
while the addition of glutathione resulted in growth similar to regular medium, thiosulfate 
addition substantially enhanced the growth (Fig. 5B). In the absence of HA, both glutathione and 
thiosulfate enhanced growth during the exponential phase (Fig. 5A). Overall, the data suggested 
that cysteine is important for A. cellulolyticus to mitigate the inhibitory effects of phenolic acids, 
which is consistent with the known role of cysteine in combating stress [37]. 
 
2.5.6 Cysteine supplementation alleviated the upregulation of Acel_0059 in the presence of 
HA. We hypothesized that if Acel_0059 was upregulated for increased cysteine synthesis during 
phenolic inhibition then supplementation of L-cysteine in the growth medium would relieve the 
upregulation of Acel_0059 in the presence of phenolic acids. To evaluate this, we studied the 
expression of the Acel_0059 protein in A. cellulolyticus grown in media supplemented with 0, 
0.25, or 0.5 mM L-cysteine. The data showed that supplementation of L-cysteine in the growth 
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medium substantially alleviated the upregulation of Acel_0059 in the presence of HA (Fig. 6). 
Furthermore, in the presence of HA, there was an inverse correlation between the amount of L-
cysteine added to the growth medium and the relative amount of the Acel_0059 protein. Thus, 
addition of 0.5 mM L-cysteine to HA-containing medium resulted in lesser upregulation of 
Acel_0059 protein than the addition of 0.25 mM L-cysteine. These data suggested that 
Acel_0059 has a role in cysteine biosynthesis in A. cellulolyticus. 
 
2.5.7 Acel_0059 encodes a functional enzyme that shows TST activity in vitro. In the 
GenBank database, the Acel_0059 gene was annotated as TST. We confirmed this annotation 
using BLAST search against the nr and swissprot databases and bioinformatics analyses. 
Acel_0059 has a predicted length of 279 amino acids and a predicted molecular mass of 31.68 
kDa. The protein has no secretion signals and the subcellular localization is predicted to be 
cytoplasmic based on the pSORTb database v3.0 [38]. Based on BLAST search against all 
functionally studied TSTs, the closest homolog of Acel_0059 was CysA from S. erythraea 
(accession P16385.1). Acel_0059 shared 75% sequence identity with the S. erythraea CysA, and 
31% sequence identity with the human mitochondrial rhodanese (accession Q16762.4). Similar 
to the functionally characterized TSTs, Acel_0059 is a tandem rhodanese-domain protein with a 
catalytically inactive N-terminal domain and a catalytically active C-terminal domain that 
contains the active site cysteine at position 233 (Cys233). Also, the amino acid motif CRIGER 
that is next to the active site cysteine matches with the consensus motif CRxGx[R/T] for TSTs 
[39, 40]. To know whether Acel_0059 encodes a functional TST enzyme, the Acel_0059 gene 
was cloned and overexpressed in E. coli. The overexpressed Acel_0059 protein was partially 
purified (Fig. 7A). To demonstrate the rhodanese activity of the Acel_0059 protein, we used 
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zymogram analysis. A single white band corresponding to the Acel_0059 protein was obtained in 
the zymogram (Fig. S3). Partially purified proteins from un-induced E. coli cells did not show 
the band confirming that the rhodanese activity was specific to Acel_0059 and was not due to 
host proteins. A linear increase in the intensity of the white band was observed with increasing 
amounts of Acel_0059 protein (Fig. 7B, panel 1). Zymogram analysis at different reaction 
temperatures showed that the partially purified Acel_0059 was active in vitro at 55°C, 70°C, and 
80°C but showed no activity at 25°C and 37°C (Fig. 7B, panel 2). These data demonstrated that 
Acel_0059 encoded a thermostable TST enzyme. In addition, the Acel_0059 protein was used to 
determine enzyme activity using either thiosulfate or mercaptopyruvate as the sulfur donor 
substrates. With thiosulfate as the sulfur donor, the reaction yielded approx. four times more 
product than with mercaptopyruvate as the sulfur donor (Fig. 7C). Thus, as expected for TSTs, 
the Acel_0059 enzyme showed substrate preference for thiosulfate over mercaptopyruvate in 
vitro. The dependence of enzyme activity of Acel_0059 on sodium thiosulfate concentration was 
measured. The activity was found to plateau above 10 mM sodium thiosulfate (Fig. 7D). The Km 
and Vmax of Acel_0059 for sodium thiosulfate was 4.71±1.06 mM and 13.204±1.26 nmoles/min 
(Fig. 7E). 
 
2.5.8 Acel_0059 enhanced the survival of cells exposed to inhibitory concentration of HA. 
Tools for the genetic manipulation of A. cellulolyticus are lacking currently. Therefore, we used 
E. coli as a heterologous host to further study the role of Acel_0059 in bacterial survival upon 
exposure to phenolic acids. For this, we evaluated the ability of E. coli expressing the Acel_0059 
gene to survive in the presence of inhibitory concentrations of HA. It was experimentally 
determined that much higher concentration of HA was required to inhibit E. coli (15 mM) 
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compared to A. cellulolyticus (1 mM) because E. coli is a Gram-negative bacterium with an outer 
membrane that offers enhanced protection against antimicrobial compounds [41]. Differences in 
inhibitory concentrations could partly be due to the differences in the media used for the two 
organisms. Despite the differences, we observed substantial protection by Acel_0059 against HA 
in E. coli. To quantitate the effect of short exposure to HA on cell survival, 1.50±0.24 x 105 cells 
of parent E. coli cells (ECRDL28) and 2.56±0.58 x 105 E. coli cells expressing the Acel_0059 
gene (ECRDL59) were exposed to 15 mM HA for 30 minutes. While approx 18% of the parent 
E. coli cells (0.27±0.04 x 105 cells) survived after 30 minutes of exposure to HA, approx 62% of 
the E. coli cells that expressed Acel_0059 (1.59±0.65 x 105 cells) survived upon exposure to HA. 
Additionally, we studied the growth of ECRDL28 and ECRDL59 cells in the presence of an 
equimolar mixture if five phenolic acids (PA; Fig. 8A). The data show that while ECRDL28 and 
ECRDL59 cells grew comparably in the absence of 20 mM PA, ECRDL59 grew significantly 
better than ECRDL28 in the presence of PA. In addition, ECRDL59 produced smaller zone of 
inhibition (p < 0.05) on agar plates carrying discs containing 0.5 M PA, compared to ECRDL28 
(Fig. 8B). The sizes of the zone of inhibition were 8.75±0.25 mm and 7.25±0.48 mm for 
ECRDL28 and ECRDL59, respectively. 
 
2.6 Discussion 
The present study on the molecular effects of phenolic acids in A. cellulolyticus revealed novel 
information on the expression, activity, and the role of Acel_0059. There were no prior 
experimental data on Acel_0059. Our study revealed that Acel_0059 is a functional enzyme with 
rhodanese activity that is expressed in relatively high abundance in A. cellulolyticus and is 
upregulated during bacterial growth in the presence of inhibitory phenolic acids. TSTs a.k.a. 
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rhodaneses (E.C. 2.8.1.1) are an important family of proteins that are ubiquitous across Bacteria, 
Archaea, and Eukarya [39]. Rhodanese was first discovered from rabbit liver more than eight 
decades ago [42]. Ubiquity of rhodanese domain proteins in nature signifies an important role for 
these proteins. Previous reviews have discussed the significance of rhodaneses in the normal 
growth and health of humans, animals, plants, and microbes [39, 40]. Based largely on in vitro 
data, rhodaneses have been proposed to function in cyanide detoxification. While in vitro 
rhodaneses carry out transsulfuration of cyanide to thiocyanate using thiosulfate as the sulfur 
donor, their precise in vivo function remains elusive. Proposed physiological roles of TSTs 
include cyanide detoxification, regeneration of iron–sulfur clusters in Fe-S proteins, and 
maintenance of the intracellular sulfane pool [43-45]. While most studies have focused on the 
enzymatic functions of rhodaneses, less is known about their expression and regulation. Our data 
showing a higher level of expression of the Acel_0059 gene compared to housekeeping genes 
(rpsJ and gyrB) (Fig. 4B) suggest an important metabolic function for TST. This idea is 
bolstered by the transcriptome data on M. smegmatis published by Li et al [46]. Our analysis of 
the data published by Li et al revealed that the orthologous TST gene (MSMEG_5789) in M. 
smegmatis is among the top 1% of highly expressed genes under normal growth. Thus, the data 
suggest that TSTs may have an important cellular function. It should be noted that the A. 
cellulolyticus genome encodes a paralog of Acel_0059, which is Acel_1417. While Acel_1417 is 
annotated as a TST, it shows homology to mercaptopyruvate sulfurtransferase (MST) from other 
bacteria. This protein was not detected in our mass spectrometry data. It is possible that it is 
either not expressed under the conditions used in the present study or is expressed at very low 
levels. In this regard, the transcriptome data on M. smegmatis published by Li et al [46] also 
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indicate that the expression level of its MST ortholog (MSMEG_3238) is at least 12-fold lower 
than that of its TST ortholog (MSMEG_5789). 
 
Upregulation of Acel_0059 in response to growth inhibition by phenolic acids is a new finding. 
In particular, we found that expression of Acel_0059 protein and its gene was elevated in the 
presence of inhibitory concentration of HA and VA. While several studies have reported on the 
inhibitory effects of plant phenolic acids on microbes, the involvement of rhodanese homologs in 
cellular response to stress induced by phenolic acid has not emerged previously. With regards to 
the effects of antimicrobial plant chemicals on bacterial TST expression, we found only one 
report where plant extracts of Radix Ranuncoli Ternati (a Chinese herb) significantly affected 
(although downregulated) the expression of the TST (cysA2) in M. tuberculosis [47]. Significant 
upregulation of rhodanese homologs has been reported in human and animal pathogenic bacteria 
that experience oxidative stress in the host environment [48, 49]. For example, in clinical isolates 
of M. tuberculosis, the TST homolog Rv0815c (cysA2) was found to be upregulated during 
intracellular growth in macrophages [48]. While in M. avium subspecies paratuberculosis the 
TST homolog SseA was found to be upregulated during natural infection in sheep [49]. 
Oxidative stress induced during growth on phenanthrene was reported to significantly induce 
sulfurtransferase activity in environmental strains of Rhodococcus aetherovorans, R. opacus and 
M. smegmatis [50]. However, the physiological significance of TST upregulation in the above 
studies was not investigated. In the present study, upregulation of Acel_0059 may point to its 
plausible role in mitigating the inhibitory effects of phenolic acids. Phenolic acids are known to 
disrupt membranes causing loss of cellular integrity, which exposes cellular contents to oxidizing 
environments that can oxidize thiols and damage labile Fe-S clusters in critical metabolic 
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enzymes [14, 51]. Rhodaneses have been shown to function both as an antioxidant for reducing 
oxidized thiols and in the restoration of iron–sulfur centers in Fe–S proteins [52, 53]. It is 
possible that Acel_0059 plays a role in these functions during phenolic acid inhibition in A. 
cellulolyticus. 
 
There is very limited in vivo data on the functions of bacterial TST homologs and much less is 
known about the role of TST in sulfur metabolism and cysteine synthesis. In the cyanogenic 
Pseudomonas aeruginosa, studies on rhodanese function have primarily focused on its role in 
cyanide detoxification [54]. In Saccharopolyspora erythraea, mutation in the rhodanese 
encoding gene (cysA) was found to result in cysteine auxotrophy [55]. In Streptomyces 
clavuligerus, the rhodanese enzyme RhlA was proposed to be involved in the formation of the 
cysteine precursor for the synthesis of the antibiotic holomycin [56]. In Azotobacter vinelandii, 
deletion of the rhodanese RhdA was found to increase sensitivity to oxidative growth conditions 
and the enzyme was proposed to play a role in maintaining redox homeostasis and in the 
regeneration of glutathione [53, 57]. Our data suggest that the A. cellulolyticus Acel_0059 has a 
role in assimilation of sulfur towards cysteine biosynthesis. Firstly, the Acel_0059 gene and 
sulfur assimilation genes were simultaneously upregulated in the presence of phenolic acids. And 
secondly, supplementation of cysteine in HA-containing medium alleviated the upregulation of 
Acel_0059. Supplementation of both cysteine and thiosulfate was able to relieve growth 
inhibition of A. cellulolyticus in the presence of HA. These data suggest that thiosulfate and 
cysteine are important for mitigating the inhibitory effects of phenolic acids. Cysteine plays an 
important role in defense against oxidative stress as well as in the regeneration of oxidized Fe-S 
clusters and low molecular weight thiol antioxidants. Cysteine auxotrophs are known to be 
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sensitive to oxidative stress [37]. The S. erythraea cysA mutant, a cysteine auxotroph, could only 
utilize thiosulfate among inorganic sulfur sources for growth [55]. The genome of the S. 
erythraea strain that was used in the above published study on the cysA mutant has not been 
sequenced. Also, additional reports on cysteine synthesis in this strain are lacking. Therefore, it 
is unknown if cysteine synthesis in this strain is solely dependent on the CysM-CysO-mec+ 
pathway. Although TSTs use thiosulfate as a substrate in vitro, their role in the generation of 
thiosulfate has been proposed [39, 40]. We hypothesize that Acel_0059 may play a role in 
generating thiosulfate that may be required for cysteine biosynthesis (Fig. 4). 
 
Thiosulfate has been shown to serve as a sulfur source for cysteine synthesis. In vitro, rat liver 
mitochondrial lysate was demonstrated to incorporate the sulfane sulfur from thiosulfate into 
cysteine without intermediate formation of free sulfide ions [58]. The E. coli cysteine synthase 
has been shown to use thiosulfate as the substrate along with O-acetylserine [59]. However, the 
A. cellulolyticus genome lacks the cysE gene that is required for the synthesis of O-acetylserine. 
Moreover, the single cysteine synthase (Acel_1687) that is encoded in the A. cellulolyticus 
genome appear to be an orthologs of the M. tuberculosis CysM, an O-phosphoserine 
sulfhydrylase [32]. The M. tuberculosis CysM was shown in vitro to preferentially use a small 
CysO-thiocarboxylate protein as a sulfur donor, and sulfide to a much lower degree, for cysteine 
synthesis. The cysM gene occurs in an operon, where it clusters with a small sulfur carrier 
protein cysO (sulfur carrier protein) and a zinc-dependent hydrolase mec+ (CysO-cysteine 
peptidase). The CysM protein has much higher specificity for O-phosphoserine compared to O-
acetylserine as a substrate, and is upregulated under conditions of oxidative stress [60]. The 
sulfur source for the CysO-thiocarboxylate formation remains unknown, however. And it 
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remains to be seen if either thiosulfate or sulfide could serve as in vivo sulfur donors for CysO-
thiocarboxylate. Future in vivo data may provide additional insights that may help define the 





Table 1. Bacterial strains and plasmids. 
Material Description/genotype Source 
(A) Strains   
ACEL11B A. cellulolyticus strain 11B ATCC (#43068) 
ECDHA00 E. coli DH5α. Genotype: F- Φ80lacZΔM15 
Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk-, 
mk+) phoA supE44 thi-1 gyrA96 relA1 λ- 
ThermoFisher Scientific 
(#18265017) 
ECRDL00 E. coli Rosetta™(DE3)pLacI. Genotype: F– ompT 
hsdSB (rB– mB–) gal dcm (DE3) pLacIRARE 
(CamR) 
Novagen (#70920) 
ECRDL28 ECRDL00 carrying pET-28a(+) This study 




pET-28a(+) Expression vector Novagen (#69864) 
pAcTST pET-28a(+) carrying the Acel_0059 gene cloned in 









Figure 1. Effect of phenolic acids on the growth of A. cellulolyticus. Bacteria were grown either 
in the absence of phenolic acids (open circles) or in the presence of 1 mM of HA (black circles), 
VA (cross marks), CA (white squares), SA (black triangles), or FA (gray triangles). Growth was 
monitored using optical density at 600 nm. Data represent the mean values with standard error 






Figure 2. Expression of Acel_0059 is increased in the presence of phenolic acids. (A) SDS-
PAGE showing the enhanced expression of ~30 kDa protein band in the presence of phenolic 
acids. Total proteins (30 µg) isolated from bacteria grown in the absence (control, C) or presence 
of phenolic acids (HA, VA, CA, SA, or FA) were separated on nUView 4-20% Tris-Glycine 
precast gel (NuSep) and visualized using Biosafe Coomassie Brilliant Blue G-250 (BioRad). 
Lane M: molecular weight ladder showing the 25 and 37 kDa protein standards from the 
Precision Plus Protein Dual Color Standard (BioRad). The upregulated ~30 kDa protein band is 
indicated with an arrow. (B) Relative quantity of Acel_0059 protein from tandem mass 
spectrometry. The ~30kDa protein band seen in panel A was excised from each lane and 
subjected to tandem mass spectrometry. The graph shows the normalized total spectral counts for 
Acel_0059. (C) SDS-PAGE image of time course analysis of the Acel_0059 expression from 
bacteria grown in the absence or presence of HA. Bacterial cultures grown in the absence 
(control, C) or presence of HA were harvested at 0, 7, 14, 22, 30, 37 hours after inoculation. 
Total proteins (30 µg) were separated and visualized as described above. The Acel_0059 protein 
band is indicated with an arrow. 
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Figure 3. Putative sulfate assimilation pathway and proposed role of Acel_0059. Dashed lines 
represent possible steps in A. cellulolyticus. Details of the reactions catalyzed along with 
structures of the metabolites are available in the KEGG database [31]. APS: adenosine-5’-
phosphosulfate (or adenylylsulfate); PAPS: 3’-phosphoadenosine-5’-phosphosulfate (or 
phosphoadenylylsulfate); CysN (Acel_1617): sulfate adenylyltransferase subunit 1; CysD 
(Acel_1618): sulfate adenylyltransferase subunit 2; CysC (Acel_1619): adenylylsulfate kinase; 
CysH (Acel_2054): phosphoadenylylsulfate reductase; CysI (Acel_2055): sulfite reductase 
(ferredoxin); CysM (Acel_1687): O-phosphoserine sulfhydrylase (cysteine synthase), CysO 
(Acel_1688): sulfur carrier protein , mec+ (Acel_1689): CysO-cysteine peptidase, MoeZ 
(Acel_1777): adenylyltransferase/sulfurtransferase, MshA (Acel_0073): D-inositol 3-phosphate 
glycosyltransferase, MshB (Acel_1868): 1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-
glucopyranoside deacetylase, MshC (Acel_1172): L-cysteine:1D-myo-inositol-2-amino-2-


























Figure 4. Analysis of relative transcript abundance using quantitative reverse-transcriptase PCR. 
(A.) Effect of phenolic acids on the expression of the Acel_0059 gene as well as sulfur 
assimilation genes in A. cellulolyticus. Total RNA was isolated from bacteria grown in the 
absence (control) or presence of phenolic acids (HA, VA, CA, SA, or FA). Relative transcript 
abundance was quantified using qRT-PCR and normalized to the expression of a housekeeping 
gene, rpsJ (Acel_0305). Fold expression of the genes in the presence of phenolic acids relative to 
their expression in the control (black bars, normalized to 1) is shown. Data represent mean 
values with standard error from three biological replicates. ** indicates statistically significant (p 
< 0.05) differences compared to the control. (B.) Relative transcript abundance of different A. 
cellulolyticus genes. Transcript abundance was quantified using qRT-PCR and normalized to the 
expression of the housekeeping gene, rpsJ (Acel_0305). Data represent mean values across all 
experiments and replicates (n=18). Error bars represent standard error of the mean. *** indicates 




Figure 5. Effect of supplementation of different sulfur sources on the growth of A. cellulolyticus. 
(A) Growth in the absence of phenolic acids. (B) Growth in the presence of HA. All cultures 
were grown in either regular medium (black circles) or medium supplemented with 0.5 mM 
sodium thiosulfate (black squares), 0.5 mM L-cysteine (white squares), 0.5 mM L-methionine 
(gray triangles), 5-fold higher concentration of MgSO4 (gray diamonds), or 0.5 mM glutathione 
(white circles, dashed line). Growth was monitored using optical density at 600 nm. Data 




























































Figure 6. Effect of supplementation of L-cysteine in the growth medium on the expression of the 
Acel_0059 protein. Bacteria were grown in the absence (control, C) or presence of 1 mM HA in 
medium supplemented with L-cysteine (L-cys) at 0, 0.25, or 0.5 mM. Total proteins were 






Figure 7. Characterization of Acel_0059 activity. (A.) Overexpression and partial purification of 
Acel_0059 protein from E. coli. The Acel_0059 gene was cloned in pET28a expression vector 
and the overexpressed protein was partially purified (see methods for details). Lane M: Page 
Ruler Plus Prestained Protein Ladder (Thermo Scientific); Lane 1: total proteins (30 µg) from 
lysate of un-induced cells; Lane 2: total proteins (30 µg) from lysate of IPTG-induced cells 
showing the overexpressed Acel_0059 protein, Lane 3: partially purified Acel_0059 (30 µg). 
(B.) Zymogram analysis of TST activity of Acel_0059. Partially purified Acel_0059 was 
separated on native gel and incubated with reaction mixture at 70°C for 50 minutes to detect TST 
enzyme activity (see the methods section for details). A white band resulting from the formation 
of CaSO3 precipitate indicates TST activity. In panel 1, 0-100 µg of protein was separated in the 
different lanes as indicated. In panel 2, 50 µg of protein was separated in each lane; gel lanes 
were cut and incubated at the indicated temperatures for enzyme assay. (C.) Rhodanese activity 
of partially purified Acel_0059 protein. Rhodanese activity of the Acel_0059 protein was 
measured using either thiosulfate or 3-mercaptopyruvate as sulfur substrates (see Methods 
section for details). Enzyme activity was expressed as nanomoles of the product formed per 
milligram of protein per minute. (D.) Dependence of TST activity of Acel_0059 on sodium 
C.
E.
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thiosulfate concentration. Activity was calculated using a standard curve for sodium thiocyanate. 
Data represent mean values with standard error from biological replicates. (E.) Double-reciprocal 
plot for calculating the Km and Vmax values for Acel_0059 with sodium thiosulfate as substrate. 
The rate of TST activity (y-axis) was calculated at different substrate concentrations using a 












Figure 8. Effect of heterologous expression of Acel_0059 in E. coli. (A.) Effect of Acel_0059 on 
the growth of E. coli in the presence of PA. Bacteria were grown either in the absence (circles) or 
presence (squares) of 20 mM PA at 37°C and 300 rpm. ECRDL28: E. coli carrying the plasmid 
vector (white); ECDRL59: E. coli expressing the Acel_0059 from the plasmid (black). Data 
represent mean values with standard error from biological replicates. (B.) Agar diffusion assay. 
ECRDL28 and ECRDL59 cells were grown to OD600 0.6 and 107 cells/ml were spread 
separately on agar plates. Sterile filter discs containing 0.5 M PA were placed and plates were 
incubated at 37°C overnight. Degree of inhibition was noted by measuring the mean distance (in 
mm) from the edge of the disc to the edge of the clear zone. The distances were 8.75±0.25 mm 
and 7.25±0.48 mm for ECRDL28 and ECRDL59, respectively. Data represent mean values with 
standard error, from biological replicates. The difference in mean values were statistically 





























2.9 Supplementary tables 
Table S1. Normalized total spectra for proteins identified in tandem mass spectrometry analysis 
of the ~30 kDa band from SDS-PAGE gel shown in Figure 2A. 
# UniProtKB identifier Identified Proteins MW 
Normalized Total Spectra 
C HA VA CA SA FA 
1 A0LQX5_ACIC1 Sulfurtransferase 32 kDa 53 97 110 73 56 76 
2 A0LU59_ACIC1 Short-chain dehydrogenase/reductase SDR 30 kDa 25 18 20 19 25 27 
3 DAPA_ACIC1 4-hydroxy-tetrahydrodipicolinate synthase 32 kDa 23 25 17 23 26 21 
4 RL2_ACIC1 50S ribosomal protein L2 30 kDa 20 14 15 14 28 16 
5 A0LUY1_ACIC1 Exodeoxyribonuclease III 31 kDa 20 14 10 19 19 18 
6 EFTS_ACIC1 Elongation factor Ts 30 kDa 19 23 26 18 18 22 
7 A0LSN8_ACIC1 Thioredoxin domain protein 31 kDa 19 22 17 16 23 22 
8 A0LTE7_ACIC1 Uncharacterized protein 32 kDa 15 17 13 14 13 14 
9 A0LVR0_ACIC1 Uncharacterized protein 32 kDa 15 16 19 17 15 14 







Table S2. Bioinformatic analysis of the A. cellulolyticus genome for putative sulfur assimilation and cysteine biosynthesis genes. 





Closest sequence homolog in the Uniprot/Swissprot database using the 
NCBI blastp search (default parameters) 
tst Acel_0059,  64187-65026 (+) 
Thiosulfate sulfurtransferase 
(EC:2.8.1.1) 279 31.7 
A0R4C9.1 (Mycobacterium smegmatis str. MC2 155) E-value 1e-161, 
Identities 211/277(76%) 
1. Genes for assimilatory sulfate reduction 
cysN Acel_1617,  1820457-1821752 (-) 
Sulfate adenylyl-transferase 
subunit 1 (EC:2.7.7.4) 431 46.5 
P9WNM4.1 (Mycobacterium tuberculosis CDC1551) E-value 1e-156, 
Identities 233/419(56%)  
cysD Acel_1618,  1821756-1822742 (-) 
Sulfate adenylyl-transferase 
subunit 2 (EC:2.7.7.4) 328 37.3 
Q9X5U0.1 (Streptomyces lavendulae) E-value 1e-175, Identities 
243/303(80%) 
A4T8Q2.1 (Mycobacterium gilvum PYR-GCK) E-value 2e-149, 
Identities 206/295(70%) 
cysC Acel_1619,  1822739- 1823428 (-) 
Adenylyl-sulfate kinase 
(EC:2.7.1.25) 229 24.4 
Q2JUC0.1 (Synechococcus sp. JA-3-3Ab) E-value 9e-59, Identities 
91/173(53%) 
P9WNM4.1 (Mycobacterium tuberculosis CDC1551) E-value 2e-41, 
Identities 78/151(52%) 
cysH Acel_2054,  2328112-2328882 (-) 
Phosphoadenylylsulfate 
reductase (EC:1.8.4.8) 256 29.3 
Q9RFS6.1 (Burkholderia cepacia) E-value 8e-56, Identities 
91/215(42%) 
P65669.1 (Mycobacterium bovis AF2122/97) E-value 2e-39, Identities 
88/200(44%) 
cysI Acel_2055,  2328885-2330804 (-) 
Sulfite reductase (ferredoxin) 
(EC:1.8.7.1) 639 69.9 
Q73YC1.1 (Mycobacterium avium subsp. paratuberculosis K-10) E-
value 1e-80, Identities 187/539(35%) 
2. Genes for cysteine synthesis 
cysM Acel_1687,  1898789-1899736 (-) 
O-phosphoserine sulfhydrylase 
(cysteine synthase (EC:2.5.1.47) 315 33.9 
P63874.1 (Mycobacterium bovis AF2122/97) E-value 3e-156, Identities 
238/321(74%) 
cysO Acel_1688,  1899745- 1900017 (-) Sulfur carrier protein 90 9.7 
P9WP33.1 (Mycobacterium tuberculosis H37Rv) E-value 1e-31, 
Identities 53/93(57%) 
mec+ Acel_1689,  1900046- 1900486 (-) CysO-cysteine peptidase 148 16.6 
P9WHS1.1 (Mycobacterium tuberculosis H37Rv) E-value 2e-63, 
Identities 94/136(69%) 
moeZ Acel_1777, 2019943-2018753 (-) 
Adenylyltransferase/ 
sulfurtransferase 396 42.6 
P9WMN6.1 (Mycobacterium tuberculosis CDC1551) E-value 0.0, 
Identities 265/395(67%) 
cysE Not found Serine acetyltransferase - - NP_216851.1 (Mycobacterium tuberculosis H37Rv) was used for searching the A. cellulolyticus genome 
cysK1 Not found O-acetylserine sulfhydrylase - - YP_177868.1 (Mycobacterium tuberculosis H37Rv) was used for searching the A. cellulolyticus genome 
cysK2 Not found S-sulfocysteine synthase / cysteine synthase - - 
YP_177762.1 (Mycobacterium tuberculosis H37Rv) was used for 
searching the A. cellulolyticus genome 
serA Acel_0114,  117787- 118920 (-) 
Phosphoserine aminotransferase 
apoenzyme 377 40.7 





Table S2 (con’t) 





Closest sequence homolog in the Uniprot/Swissprot database using the 
NCBI blastp search (default parameters) 
serC Acel_0709,  775135- 776727 (+) 
D-3-phosphoglycerate 
dehydrogenase 530 55.7 
YP_886720.1 (Mycobacterium smegmatis str. MC2 155) Evalue 0.0, 
Identities 300/527(57%) 
3. Mycothiol biosynthesis genes  





P9WMY7.1 (Mycobacterium tuberculosis H37Rv) was used for 
searching the A. cellulolyticus genome, Evalue 3e-153, Identities 
241/420(57%) 
mshB Acel_1868, 2110571-2111449 (+) 
1D-myo-inositol 2-acetamido-2-
deoxy-alpha-D-glucopyranoside 
deacetylase (EC 3.5.1.103) 
292 31.2 P9WJN3.1 (Mycobacterium tuberculosis H37Rv) was used for searching the A. cellulolyticus genome, 8e-55, Identities 133/298(45%) 
mshC Acel_1172, 1301464-1302675 (+) 
L-cysteine:1D-myo-inositol 2-
amino-2-deoxy-alpha-D-
glucopyranoside ligase (EC 
6.3.1.13) 
403 43.9 
P9WJM9.1 (Mycobacterium tuberculosis H37Rv) was used for 
searching the A. cellulolyticus genome, Evalue 2e-142, Identities 
223/414(54%) 
mshD Acel_2026,  2299351-2300334 (+) 
Mycothiol acetyltransferase (EC 
2.3.1.189) 327 35.9 
P9WJM7.1 (Mycobacterium tuberculosis H37Rv) was used for 




Table S3. Primers used in the study. 
Locus_tag Experiment Forward and reverse primers Product length 
Acel_0059 Cloning 
1. AAACCATGGCCAGACAGCAGGTACTCGTC (underlined 
sequence is NcoI site) 
2. AAACTCGAGTCAGGACCCGCTCCCCAGCTC (underlined 
sequence is XhoI site) 
867 bp 
Acel_0059 RT-PCR 1. GCCGACAGCGAAGAATGT 2. CTGAAATCGACGCCTGCT 108 bp 
Acel_1617  RT-PCR 1. CTGGTCGTTCTGCTTGTTGA 2. ATCACGGTATGGTCGCTGAT 209 bp 
Acel_1618 RT-PCR 1. GAATTTGAGCGTCCTGTGCT 2. CGGCGTCAATGTAGTCTTGA 220 bp 
Acel_1619 RT-PCR 1. TAGTAGGCAGGATCGGGAGA 2. GGTTCCTCATAGGGGTCGTC 282 bp 
Acel_1687 RT-PCR 1. GGCTTTGTCCCTGAGCTGTA 2. CGGTGGAGAGGTATTTCCAG 238 bp 








2.10 Supplementary figures 
 
Figure S1. Effect of pH of culture medium on the expression of Acel_0059. A. cellulolyticus was 
grown in LPBM medium that had been adjusted to different pH (5.00, 5.25, 5.75, or 6.00). Cells 
were harvested at mid-exponential growth (OD 0.6) and total proteins were isolated. Total 
proteins (30 µg) were separated on nUView 4-20% Tris-Glycine precast gel (NuSep) and 
visualized using Biosafe Coomassie Brilliant Blue G-250 (BioRad). Lane M: Precision Plus 
Protein Dual Color Standard (BioRad). 
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Figure S2. Amount of HA in A. cellulolyticus culture supernatants. Cell free supernatants were 
isolated from cultures at 7, 14, 23, 30, 37, 48 and 56 hours during growth in the presence of 1 
mM HA (refer to Fig. 1 for bacterial growth). The amount of HA in the supernatants was 
analyzed using High Performance Liquid Chromatography (HPLC, Hitachi Model l–400) using a 
reverse-phase C-18 column and UV detector. A binary gradient of 2% aqueous acetic acid 
(solvent A) and methanol (solvent B) was used at a flow rate of 1 mL min−1 and oven 
temperature of 30°C. The following gradient of A in B (v/v) was used: 0–5 min = 100% A; 5–10 
min = gradient 100–90% A; 10–15 min = 90% A; 15–20 min = gradient 90–80% A; 20–25 min 
= 80% A; 25–40 min = gradient 80–40% A; 40–50 min = gradient 40–20% A. HA was detected 
at at 254 nm. A calibration curve was generated using a range (0.125-2.0 mM) of HA standards. 
HA concentration in the culture supernatants was calculated using the built-in software. Data 





Figure S3. Zymogram analysis of TST activity of Acel_0059. Partially purified proteins from 
uninduced (U) and induced (I) cultures of ECRDL59 were separated on native gels and either 
stained with Coomassie blue (panel A) or used for zymogram analysis (panel B). For zymogram 
analysis, gel was incubated with reaction mixture at 70°C for 50 minutes to detect TST enzyme 
activity (see methods for details). A white band resulting from the formation of CaSO3 
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Figure S4. Full gel image of the gel shown in figure 2A. 
 
  












Figure S5. Full gel image of the gel shown in figure 2C. 
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Acidothermus cellulolyticus 11B is a Gram-positive acidophilic, thermophilic and cellulolytic 
rod-shaped bacteria belonging to the class Actinobacteria, order Actinomycetales and suborder 
Frankineae. It is the only known species of the genus Acidothermus and family Acidothermaceae 
[1]. A. cellulolyticus 11B (ATCC 43068) was first isolated from acidic hot springs at 
Yellowstone National Park in a research program dedicated towards production of biofuels from 
cellulosic biomass [2]. The 2.44 Mb genome of A. cellulolyticus consists of 2,157 protein coding 
genes and has a high G+C content at ~66.9% [3]. A. cellulolyticus encodes for multiple plant cell 
wall-degrading enzymes and is an important candidate for the conversion of lignocellulosic 
biomass into biofuels.  
 
Cellulose is the most prevalent biopolymer on earth, that can be broken down into simple sugars 
which are further fermented to form ethanol. Ethanol that is obtained from cellulosic biomass has 
the ability to decrease the need for petroleum fuel [4]. Lignocellulosic biomass serves as a 
renewable and sustainable source of bioenergy; its effective and low cost enzymatic conversion 
to simple sugars is essential for production of biofuels [5]. However, most of the bacteria that 
can degrade cellulose are either not thermophilic or acidophilic or both [2]. Low pH and high 
temperature conditions are prevalent in ethanolic fermentations [6]. For this reason, A. 
cellulolyticus was isolated from acidic hot springs in an enrichment culture using specific 
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criteria: pH range: 3-6, temperature range: 50-60°C, and the ability to degrade cellulose [2]. The 
A. cellulolyticus genome encodes for 17 plant cell-wall-degrading enzymes, and 10 fungal cell-
wall degrading enzymes [3]. The hyperthermostable enzymes from this organism exhibit high 
specificity to their substrates and are of commercial interest in microbial lignocellulosic 
deconstruction [7-11]. Heterologous expression of its enzymes in hosts such as transgenic rice 
seeds, tobacco, maize, yeast etc., has been suggested to create bio-ethanol without addition of 
any exogenous enzymes in the process [12-16]. 
 
A major barrier to the production of biofuels from lignocellulosic biomass is biomass 
recalcitrance, the natural resistance of plant cell walls to microbial deconstruction [17]. 
Lignocellulose consists of three components: cellulose, hemicellulose and lignin. Lignin binds 
the cellulose and hemicellulose fractions together in a hydrophobic network, and therefore, 
hinders their accessibility to enzymatic hydrolysis. Therefore, a harsh physical pretreatment 
aimed at solubilizing and separating the cellulose, hemicellulose and lignin fractions is required 
for lignocellulose breakdown [18]. The pretreatment releases lignin-derived phenolic compounds 
into the hydrolysate [19]. Both complete lignin and lignin-derived phenolic compounds hamper 
enzyme hydrolysis and reduce sugar yields [19-21]. The lignin phenolic acids have been found to 
be much more toxic than other pretreatment inhibitors due to hydrophobicity associated 
membrane damage and irreversible inhibition of enzymes [22-25]. In A. cellulolyticus, the 
presence of phenolic monomers was shown to reduce growth and enzyme activity yield [26]. The 
ability to deconstruct plant biomass without the use of conventional pretreatment methods is an 




If A. cellulolyticus can survive in the presence of lignin, it could be used as a whole-cell 
biocatalyst for the production of biofuel from cellulosic biomass at high rate. Understanding and 
reducing the inhibition due to phenolics is important in improving the efficiency of 
bioconversion of lignocellulose [19]. Regulation of gene expression is an adaptive response 
which ensures that appropriate proteins are expressed in response to environmental stresses or 
changing metabolic conditions [28]. Transcriptional profiling is a useful tool that could be 
employed at understanding global molecular targets affected by a stress and the mechanisms by 
which organisms adapt to a particular stress [29, 30]. This technique has been used to understand 
the genomic response of ethanologenic strain Zymomonas mobilis ZM4 to the phenolic aldehyde 
inhibitors derived from lignocellulose pretreatment. The study identified several reductases and 
transporters as potential phenolic aldehydes-tolerant genes [31]. Similar studies aimed at 
understanding the molecular stress response mechanism in Z. mobilis, revealed the importance of 
simultaneous regulation of carbohydrate metabolism, DNA replication, recombination and 
repair, transcriptional regulation, and universal stress responses etc. in providing tolerance to 
pretreatment inhibitors [32-35]. 
 
Transcriptomic studies of Saccharomyces cerevisiae strains exhibiting improved tolerance to 
lignocellulose derived inhibitors, revealed 52 genes potentially associated with stress response to 
inhibitors. These included genes functioning in cell wall and membrane stability, fatty acid 
metabolism, cellular metabolism (alcohol and aldehyde dehydrogenases, glyceraldehyde-3-
phosphate dehydrogenase), several multidrug transporters, and oxidative and DNA stress 
response genes. [36]. Ferulic acid, a lignin derived phenolic acid, has been shown to induce the 
expression of the mar regulon efflux-system genes, and heat shock response genes in E. coli 
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[37]. DNA microarray analyses of the Clostridium beijerinckii NCIMB 8052, revealed the down-
regulation of two-component systems and strong upregulation of efflux systems, heat shock and 
redox reaction proteins in response to ferulic acid [38]. In this study, we discuss the genome-
wide gene expression induced by lignin and lignin-derived phenolic compounds in A. 
cellulolyticus. The information on the genes involved in providing tolerance to these inhibitory 
compounds could be used to develop strategies to enhance A. cellulolyticus survival in the 
presence of such inhibitors.  
 
3.2 Materials and methods 
3.2.1 Bacteria, media and growth conditions. A. cellulolyticus was grown in low phosphate 
basal salts medium (LPBM). The medium contained 1 g/L NH4C1; 0.1 g/L Na2HPO4.7H2O; 1 
g/L KH2PO4; 0.2 g/L MgSO4.7H2O; 0.2 g/L CaCl2.2H2O; 0.5 g/L yeast extract; 5/L g D-
cellobiose [10]. The phenolic acid, 4-hydroxybenzoic acid (HA), was prepared as 1 M stock in 
dimethyl sulfoxide (DMSO), filter sterilized, and added to the sterilized growth medium at 1 mM 
final concentration. An equimolar mixture of five different phenolic acids (PA) i.e. 4-
hydroxybenzoic acid (HA), vanillic acid (VA), coumaric acid (CA), syringic acid (SA) and 
ferulic acid (FA) was prepared at 0.5 M stock in DMSO, filter sterilized, and added to the 
sterilized growth medium at 0.5 mM final concentration. Lignin was added to the media at 
0.01% (w/v), and sterilized along with media by autoclaving. The pH of all media was adjusted 
to 5.5 by the addition of either 10% phosphoric acid or 10 N NaOH. Growth was measured using 




3.2.2 RNA extraction and mRNA enrichment. Total RNA was extracted from A. cellulolyticus 
cultures using RNeasy Plant Mini kit (Qiagen). In case of phenolic acid treatments, 200 ml 
culture containing either HA or PA was grown for 37 hours. In case of control, 100 ml culture 
was grown for 20 hours. Cells were harvested by centrifugation at 15,000 g for 15 minutes. For 
lignin treatment, 200 ml culture containing lignin was grown for 37 hours. The lignin was 
separated from cell culture by allowing the culture to stand for 10 minutes followed by 
centrifugation of supernatant at 100 g for 2 minutes. Approximately, 150 ml lignin-free culture 
was centrifuged at 15,000 g for 15 minutes to harvest cells. The cell pellets were immediately 
frozen and ground to powder using liquid nitrogen, and RNA was isolated using manufacturer’s 
instructions. The isolation included two rounds of on-column treatments with RNase-Free DNase 
(Qiagen) to remove any remaining genomic DNA. RNA was quantified using Qubit RNA HS 
Assay Kit and Qubit 2.0 Fluorometer (Life Technologies).   
 
The total RNA was further processed for mRNA enrichment using MICROBExpress kit 
(Ambion, Life Technologies) according to manufacturer’s protocol. Briefly, 3.4 µg of total RNA 
was treated with a binding buffer. Oligonucleotides present in the buffer hybridized to 
homologous regions in rRNAs. The rRNA-bound oligonucleotides were then bound to magnetic 
beads and the complex was captured on a magnetic stand. The supernatant (~350 µl) containing 
enriched mRNA was aspirated and further purified using the Agencourt RNAClean XP system 
(Beckman Coulter). 40 µl of purified enriched mRNA obtained was quantified using Qubit RNA 
HS Assay Kit and Qubit 2.0 Fluorometer (Life Technologies). The depletion of rRNA was 
verified using 2100 Bioanalyzer (Agilent) and Agilent RNA ScreenTape system (Agilent 
Technologies). The RNA was stored at -80° until use.  
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3.2.3 cDNA library preparation. The template library was prepared from mRNA using the 
TruSeq Stranded mRNA LT Sample Preparation kit (Illumina) following the TruSeq Stranded 
mRNA Sample Preparation Guide (Illumina). Approximately 100 ng of purified mRNA was 
denatured, fragmented and primed using random hexamers (Illumina) for cDNA synthesis by 
reverse transcriptase. The first strand cDNA was then synthesized from the primed mRNA using 
SuperScript II Reverse Transcriptase (ThermoFisher Scientific) and First Strand Synthesis Act D 
mix (Illumina). The mix contained random primers and Actinomycin D to specifically allow only 
RNA-dependent synthesis. The RNA template was removed and first strand cDNA was used as a 
template for second strand cDNA synthesis using DNA polymerase I and RNase H present in the 
Second Strand Master Mix (Illumina). The blunt ended double stranded cDNA obtained was 
purified using Agencourt AMPure XP beads (Beckman Coulter). The cDNA was adenylated at 
3’ ends and ligated with indexing adapters containing complementary ‘T’ nucleotide. For control 
samples, Adapter index 6 (AR006; GCCAAT) was used, and for treatment samples (HA, PA or 
lignin), Adapter index 12 (AR012; CTTGTA) was used.  
 
The adapter ligated cDNA was purified using AMPure XP beads and selectively amplified 
through PCR using adapter specific primers present in PCR Primer Cocktail (Illumina). The PCR 
products were purified using AMPure XP beads and enriched DNA library was quantified using 
Qubit dsDNA BR Assay Kit and Qubit 2.0 Fluorometer (Life Technologies). The quality and the 
average library size for each sample were analyzed using 2100 Bioanalyzer (Agilent) and 




3.2.4 Denaturation, normalization, pooling of libraries and sequencing on the MiSeq. The 
libraries were prepared for sequencing according to the ‘Preparing Libraries for Sequencing on 
MiSeq Guide’ (Illumina). The concentration of libraries in nano molar (nM) were calculated 
using the following formula: 
!"#	%&'%(')*+),&'	('.) = %&'%(')*+),&'	('1 µ2⁄ )4660	(1 7&2⁄ ) × 	#9(*+1(	2,:*+*;	<,=(	(:>)? ×	10
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A 4 nM of treatment (HA, PA or lignin) DNA library was pooled with 4 nM of the 
simultaneously prepared respective control library. The pooled libraries were then denatured 
using 0.2 N NaOH. This resulted in dilution of the denatured libraries to a final concentration of 
20 pM DNA library in 1 mM NaOH. A PhiX control was used to balance for the low diversity 
libraries. The 10 nM PhiX library (Illumina) was diluted and denatured as described above, 
resulting in 20 pM PhiX library. The recommended PhiX control spike-in of 5% was prepared by 
addition of 30 µl 20 pM PhiX library to 570 µl 20 pM sample library. The MiSeq Reagent Kit 
v2, 250 cycles (Illumina) was used and the libraries were sequenced on the MiSeq platform 
(Carbonero lab).  
 
3.2.5 Sequence assembly and analysis. The sequencing results were output to BaseSpace 
(Illumina) and generated intermediate analysis files in the FASTQ format. The files containing 
base calls and quality values per read for each sample in the BaseCalls folder 
(Data/Intensities/BaseCalls) (Illumina) were then exported to a local computer. The FASTQ files 
for each sample including both reads 1 and 2 (reverse complemented) were uncompressed using 
7-zip (Copyright(C) 2018 Igor Pavlov) and further used for secondary analysis. The undetermined 
reads containing mostly PhiX reads and unindexed reads were not used for the downstream 
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analyses. The reads were mapped onto A. cellulolyticus 11B backbone using SeqMan NGen 
(DNAStar, Madison, WI, USA). The GenBank file containing reference genome for the 
complete sequence of A. cellulolyticus 11B (NC_08578.gbk) was obtained from NCBI FTP 
(ftp://ftp.ncbi.nlm.nih.gov/). Assembly was performed on a local computer by launching SeqMan 
NGen using Transcriptome/RNA-seq workflow. The mapping of sequence reads onto the 
reference genome was then performed using the default settings for haploid genome with few 
changes (merSkipQuery:2; maxGap: 25; minDepth: 5; pNotRef: 75). The data for control and 
treatment were run as separate assemblies.   
 
The RNA-seq assemblies generated were analyzed using ArrayStar (DNASTAR, Inc., Madison, 
USA). All assemblies generated using SeqMan NGen were combined at this step for analysis. 
The replicates were grouped together at this step. The ‘Mean’ was used as the averaging method 
for replicates. The processing was done using QSeq to quantify gene expression. The entire data 
set was normalized by assigning the number of reads per kilobase of template coding sequence 
per million mapped reads (RPKM). Gene expression levels were obtained based on log2 fold 
change values, and significant differences in expression were determined using the Student t-test 
(linear correlation) with threshold set at p £ 0.01, 0.05 or 0.10. Multiple testing correction for 
false discovery rate was based on Benjamini-Hochberg procedure in ArrayStar [39]. The heat 
map showing gene expression for all four experiments (control, HA, PA and lignin) was obtained 
using hierarchical clustering, Euclidean (distance metric) and centroid (fast) linkage method in 
ArrayStar. The scatter plots showing log2 expression levels of all genes compared to control 
were generated using ArrayStar. The genes whose expression was consistently up or 
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downregulated among different treatments at ³ 2-fold change and p £ 0.05 were used for further 
downstream analyses.  
 
3.2.6 Hierarchical clustering of genes. Hierarchical clustering of the gene expression data was 
performed using Gene Cluster 3.0 [40]. The gene expression data as fold change of HA, PA and 
lignin with respect to control was obtained from ArrayStar. The fold change values were log2 
transformed before clustering. The genes were centered on mean and normalized to represent 
relative gene expression by subtracting mean values for a gene from each treatment.  The genes 
were clustered with calculated weight at 0.4 cutoff, using centered Pearson correlation as the 
similarity metric, and centroid-linkage clustering method for clustering. The *.cdt file produced 
was visualized by Java Treeview to generate dendrogram and to obtain the list of genes that 
cluster together [41].  
 
3.3 Results 
3.3.1 Sequencing analysis and differentially expressed genes. The mRNA enrichment by 
rRNA depletion from total RNA samples is shown in Fig. S1. The average library size of cDNA 
libraries that were prepared from mRNA-enriched samples ranged between 236-280 bp (Fig. S2). 
Denatured, normalized and pooled libraries were sequenced using the Illumina MiSeq platform. 
The sequencing generated close to 50 million reads for most of the samples. The quality scores 
for the runs ranged around 90% and the percent reads identified ranged around 96%. The run 
information is provided in Table 1. The ArrayStar generated heat map displaying four 
experiments (control, HA, PA, lignin) clustered by similarities among their gene-expression 
profiles showed that the HA and PA were more similar to each other, while the expression 
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profile of lignin was more similar to control (Fig. S3).Scatter plots showing gene expression 
pattern in each treatment compared to control are shown in Fig. S4. The Cross R2 feature from 
ArrayStar was used to perform R2 statistical test for all pairwise combinations of experiments. 
The R2 value ranges between 0.0-1.0 and is a statistical measure of how close the data are to the 
fitted regression line, with the value of 1.0 indicating that the gene expression profile of the two 
treatments is same. The R2 values across the four experiments are presented in Table 2. With 
respect to control, the lignin-dependent gene expression profile was most similar (0.813), 
followed by HA (0.785) and PA (0.753). Among the three treatments, HA shared more similarity 
with PA (0.873) than with lignin (0.709). 
 
The number of significantly differentially expressed genes among each treatment with respect to 
control at ³ 2-fold change, ³ 4-fold change and ³ 8-fold change with p  £ 0.01, p £ 0.05 or p £ 
0.10 are shown in Table 3. The differentially expressed genes at ³2-fold change, p £ 0.05 were 
used for further analysis. These included 470 genes from HA treatment, 521 genes from PA 
treatment and 559 genes from lignin treatment (Table 4a). Of these, 225 genes, 168 genes and 
448 genes were upregulated in HA, PA and lignin, respectively (Table 4b); and 245 genes, 353 
genes and 111 genes were downregulated in HA, PA and lignin, respectively (Table 4c). Among 
the differentially expressed genes: 99 genes were common among all three treatments; 184 genes 
were common between HA and PA; 81 genes were common between PA and lignin; 45 genes 
were common between HA and lignin (Figure 1a). Among the upregulated genes: 38 genes were 
common among all three treatments; 53 genes were common between HA and PA; 39 genes 
were common between PA and lignin; 26 genes were common between HA and lignin (Figure 
1b). Among the downregulated genes: 43 genes were common among all three treatments; 142 
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genes were common between HA and PA; 39 genes were common between PA and lignin; 1 
gene was common between HA and lignin (Figure 1c). Most number of genes were upregulated 
in lignin followed by HA and then PA (Figure 1b). However, PA showed the most number of 
downregulated genes, followed by HA and then lignin (Figure 1c). The list of genes consistently 
up or downregulated among all the three treatments (HA, PA and lignin) are provided in Table 5 
and 6, respectively.  
 
3.3.2 Upregulated operons and pathways. All of the upregulated genes were analyzed to check 
if multiple genes present in the same putative operon were upregulated. Genes with ³ 2 fold 
change in a treatment compared to control with p £0.05 were selected for operon prediction. 
Putative operons were identified under the criterion where participating genes were located with 
£40 bp intergenic distance among genes, being transcribed in same direction. Most of the 
putative operons identified, contained genes with intergenic distance £15 bp. Table 7 shows the 
list of upregulated putative operons, in which at least two of the genes in a putative operon were 
upregulated in at least one of the treatments. Some of upregulated putative operons genes code 
for: thiosulfate sulfurtransferase and its regulators (Acel_0059-Acel_0060); sulfur assimilation 
pathway proteins (Acel_1616-Acel_1619; Acel_1685-Acel_1689; Acel_2053-Acel_2055); MarR 
family regulators and MFS transporters (Acel_0109-Acel_0110; Acel_0112-Acel_0114; 
Acel_0606-Acel_0607; Acel_1889-Acel_1890); thioredoxin thiol transporter and redox sensing 
proteins (Acel_0236-Acel_0239; Acel_0541-Acel_0542; Acel_0700-Acel_0703; Acel_1103-
Acel_1104; Acel_2053-Acel_2055); TetR regulators (Acel_1435-Acel_1437); glycoside 
hydrolases and sugar breakdown enzymes (Acel_0579-Acel-0582); sigma factors (Acel_0057-
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Acel_0058; Acel_0350-Acel_0351; Acel_0538-Acel_0539; Acel_1410-Acel_1412). Most of the 
genes present in these operons were upregulated by at least of the treatments. 
 
KEGG pathway annotations were used to assign pathways to upregulated genes. Of the 2157 
predicted protein coding genes and 53 RNA genes, only 832 genes were annotated with KEGG 
pathways. Out of the 647 total upregulated genes, only 229 genes were assigned pathway 
annotations. Based on these annotations it was observed that 62 pathways were upregulated (out 
of 109 annotated pathways) in at least one of the treatments. List of upregulated pathways 
containing at least three upregulated genes is provided in Table 8. Table 8 lists the number of 
genes upregulated and the total number of genes annotated for the upregulated pathways. 
However it should be noted that these results are not highly reliable. Since not all the genes in a 
particular pathway are annotated for A. cellulolyticus and only 229 genes out of 647 upregulated 
genes have been annotated, there could be bias introduced in the results due to lack of all genes 
being annotated for a pathway and some of the genes being assigned to multiple pathways. 
 
3.3.3 Hierarchical clustering of genes. Hierarchical clustering of genes based on fold change in 
expression in HA, PA and lignin treatments with respect to control was performed using either 
the gene expression data from all the genes (Fig. 2) or from gene expression data of significantly 
differentially expressed genes (³2-fold change, p £ 0.05) (Fig. 3). The clustering pattern was 
similar in both cases, wherein, the transcriptome response of HA and PA was more related than 
lignin. The clustering profile obtained after clustering of significantly differentially expressed 
genes (Fig. 3) was further analyzed to select gene clusters of interest. The fold upregulation in 
gene expression in a treatment compared to control was referred to as positive expression, and 
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the fold downregulation in gene expression in a treatment compared to control was referred to as 
negative expression. Eleven clusters of interest were selected (Fig. S5). Cluster 1 consisted of 25 
genes showing positive expression for PA, negative expression for HA and lignin. Some of the 
genes present in Cluster 1 are predicted to code for betaine-aldehyde dehydrogenase 
(Acel_1100), catecholic dioxygenase (Acel_1101), 5-carboxymethyl-2-hydroxymuconate 
isomerase (Acel_1102), ferredoxin (Acel_1103), FAD-dependent pyridine nucleotide-disulfide 
oxidoreductase (Acel_1104), DNA topoisomerase (Acel_1105), serine/threonine protein kinase 
(Acel_0931), L-glutamine synthetase (Acel_1096), acetoacetate decarboxylase (Acel_1097), 
AsnC family transcriptional regulator (Acel_1286), tellurium resistance protein TerC 
(Acel_0869), holliday junction resolvase RuvX (Acel_1329), glycoside hydrolase family protein 
(Acel_1701). The genes Acel_1100-Acel_1102, Acel_1103-Acel_1104 occur in an operon (Table 
7).  
 
Cluster 2 consisted of 27 genes showing positive expression for HA and PA, negative expression 
for lignin. Some of the genes present in Cluster 2 are predicted to code for glycosyl hydrolase 
family 5 (Acel_0135), thioredoxin family protein (Acel_0241), glycosyltransferase family 28 
protein (Acel_0478), N-acetylglucosamine-6-phosphate deacetylase (Acel_0557), Cupin 2, 
conserved barrel domain protein (Acel_0692), nicotinate-nucleotide-dimethylbenzimidazole 
phosphoribosyltransferase (Acel_0940), UDP-N-acetylmuramate--L-alanine ligase (Acel_1011), 
DNA-binding protein (Acel_1589), two-component sensor histidine kinase (Acel_1605), DNA-
binding response regulator (Acel_1606), DNA-binding response regulator (Acel_1765), amino 
acid permease (Acel_1853), ECF subfamily RNA polymerase sigma-24 factor (Acel_2057). The 
genes Acel_1605-Acel_1606 occur in an operon (Table 7). Cluster 3 (15 genes) and Cluster 4 (33 
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genes) consisted of genes showing positive expression for HA, negative expression for PA and 
lignin. Some of the genes present in Cluster 3 are predicted to code for nitrilase/cyanide 
hydratase and apolipoprotein N-acyltransferase (Acel_0030), phosphoketolase (Acel_0531), 
ABC transporter-like protein (Acel_0888), carboxymuconolactone decarboxylase (Acel_0891), 
TPP-dependent acetoin dehydrogenase complex (Acel_1047), ABC transporter (Acel_1131), 
WYL domain-containing protein (Acel_1201), membrane protein (Acel_1212), N-acetyl-gamma-
glutamyl-phosphate reductase (Acel_1263), MBL fold hydrolase (Acel_1997).  
 
Some of the genes present in Cluster 4 are predicted to code for phosphomethylpyrimidine 
synthase (Acel_0052), phospholipid carrier-dependent glycosyltransferase (Acel_0172), DNA-
binding response regulator (Acel_0365), acyl-CoA dehydrogenase (Acel_0405), TraR/DksA 
family transcriptional regulator (Acel_0537), nitrate/sulfonate/bicarbonate ABC transporter 
protein (Acel_0889), oxidoreductase (Acel_0896), 6-phosphogluconate dehydrogenase 
(Acel_0898), ABC transporter (Acel_0910), cell wall anchor domain-containing protein 
(Acel_0946), WYL domain-containing protein (Acel_1200), dolichol-phosphate 
mannosyltransferase (Acel_1211), transcriptional regulator (Acel_1346), heavy metal transport 
protein (Acel_1651), PadR family transcriptional regulator (Acel_2137), inositol-3-phosphate 
synthase (Acel_2138). Cluster 4 consisted of several ABC transporter coding genes.  
 
Cluster 5 consisted of 53 genes showing positive expression for HA and lignin, negative 
expression for PA. Some of the genes present in Cluster 5 are predicted to code for RNA 
polymerase sigma factor SigL (Acel_0057), D-inositol-3-phosphate glycosyltransferase 
(Acel_0073), MFS transporter (Acel_0458), (4Fe-4S)-binding protein (Acel_0499), RNA 
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polymerase subunit sigma-24 (Acel_0538), mycothiol system anti-sigma-R factor (Acel_0539), 
ABC transporter permease (Acel_0580), manganese transporter (Acel_0596), 2-oxoacid:acceptor 
oxidoreductase subunit gamma (Acel_0700), 2-ketoisovalerate ferredoxin oxidoreductase subunit 
alpha (Acel_0701), nitrate ABC transporter substrate-binding protein (Acel_0893), inner-
membrane translocator (Acel_0908), ABC transporter protein (Acel_0909), Fe-S cluster 
assembly protein SufB (Acel_1135), Fe-S cluster assembly protein SufD (Acel_1136), Fe-S 
cluster assembly scaffold protein NifU (Acel_1139), metal-sulfur cluster biosynthetic enzyme 
(Acel_1140), cysteine synthase (Acel_1687). The genes Acel_0538-Acel_0539, Acel_0700-
Acel_0701 occur in an operon (Table 7). Cluster 5 consisted of multiple genes coding for ABC 
transporters and Fe-S cluster containing proteins. 
 
Cluster 6 consisted of 28 genes showing positive expression for PA and lignin, negative 
expression for HA. Some of the genes present in Cluster 6 are predicted to code for 
phosphoribosyltransferase (Acel_0137), glycosyl transferase family protein (Acel_0460), FAD-
dependent oxidoreductase (Acel_0569), quinone oxidoreductase (Acel_0584), MFS transporter 
(Acel_0724), glutamine amidotransferase (Acel_1094), type II secretion system protein 
(Acel_1737), type II secretion system protein F (Acel_1738), dihydropteroate synthase 
(Acel_1839), hybrid sensor histidine kinase/response regulator (Acel_1873). 
 
The Cluster 7 (78 genes), Cluster 8 (17 genes), Cluster 9 (22 genes) and Cluster 10 (34 genes) 
consisted of genes showing positive expression for lignin, negative expression for HA and PA. 
Some of the genes present in Cluster 7 are predicted to code for chloride channel protein 
(Acel_0041), OsmC family protein (Acel_0042), phosphate ABC transporter permease subunit 
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PstC (Acel_0092), phosphate ABC transporter, permease protein PstA (Acel_0093), adenine 
glycosylase (Acel_0221), glutamate-1-semialdehyde 2,1-aminomutase (Acel_0231), anti-sigma 
factor (Acel_0351), diaminopimelate decarboxylase (Acel_0629), homoserine kinase 
(Acel_0632), pyruvate ferredoxin oxidoreductase (Acel_0702), 3-isopropylmalate dehydrogenase 
(Acel_0710), sugar ABC transporter (Acel_0719), flagellar biosynthesis protein FlgN 
(Acel_0833), flagellar FlbD family protein (Acel_0850), ferredoxin-NADP reductase 
(Acel_0866), mannitol dehydrogenase (Acel_0905), (Fe-S)-cluster assembly protein (Acel_1433), 
oxidoreductase (Acel_1454), MFS transporter (Acel_1922), hydroxyglutarate oxidase 
(Acel_1941), 4'-phosphopantetheinyl transferase (Acel_1943), trehalose-6-phosphate synthase 
(Acel_1953), DNA starvation/stationary phase protection protein (Acel_2007). The genes 
Acel_0092-Acel_0093 occur in an operon (Table 7). 
 
Some of the genes present in Cluster 8 are predicted to code for sulfate ABC transporter ATP-
binding protein (Acel_0192), delta-aminolevulinic acid dehydratase (Acel_0235), UDP-N-
acetylenolpyruvoylglucosamine reductase (Acel_0291), ABC transporter-like protein 
(Acel_0421), ATP synthase subunit gamma (Acel_0652), DNA polymerase III subunit delta 
(Acel_0775), alanine dehydrogenase (Acel_1288), NADH dehydrogenase (Acel_1902), 
thymidylate kinase (Acel_1971). Some of the genes present in Cluster 9 are predicted to code for 
phosphoserine aminotransferase (Acel_0114), DNA helicase PcrA (Acel_0375), cell envelope-
related transcriptional attenuator (Acel_0411), flagellar hook-associated protein FlgK 
(Acel_0832), ABC transporter (Acel_1050), dihydropyrimidine dehydrogenase subunit A 
(Acel_1079), WhiB family transcriptional regulator (Acel_1779), MarR family transcriptional 
regulator (Acel_1889), metal ABC transporter (Acel_2087). Some of the genes present in Cluster 
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10 are predicted to code for cell division protein FtsI (Acel_0020), cell division protein 
(Acel_0021), beta-N-acetylhexosaminidase (Acel_0072), MFS transporter (Acel_0113), short-
chain dehydrogenase/reductase SDR (Acel_0571), D-beta-D-heptose 1-phosphate 
adenosyltransferase (Acel_0720), DNA-binding protein (Acel_1194), ABC-2 type transporter 
(Acel_1368), polar amino acid ABC transporter permease (Acel_1640), malate dehydrogenase 
(Acel_1647), beta-glucosidase (Acel_1659), pyridine nucleotide-disulfide oxidoreductase 
(Acel_1745), MFS transporter (Acel_1747), ABC transporter ATP-binding protein (Acel_1769), 
MarR family transcriptional regulator (Acel_2084). No pattern of gene functions could be found 
among gene clusters showing positive expression specifically in lignin (Clusters 7-10). 
 
Cluster 11 consisted of 52 genes showing positive expression for HA and lignin, negative 
expression for lignin. Some of the genes present in Cluster 11 are predicted to code for 
magnesium transporter CorA (Acel_0053), deferrochelatase/peroxidase EfeB (Acel_0190), 
GNAT family N-acetyltransferase (Acel_0520), ABC transporter ATP-binding protein 
(Acel_0540), zinc permease (Acel_0605), ABC-2 type transporter (Acel_0745), ABC transporter 
(Acel_0746), ferredoxin (Acel_0803), riboflavin synthase subunit alpha (Acel_1273), peptide 
deformylase (Acel_1279), glycosyl hydrolase family 32 protein (Acel_1363), oxidoreductase 
FAD-binding subunit (Acel_1439), 30S ribosomal protein S15 (Acel_1509), ribosome-binding 
factor A (Acel_1513), two-component sensor histidine kinase (Acel_1594), peroxiredoxin 
(Acel_1608), xanthine dehydrogenase (Acel_1631), ferredoxin (Acel_1637), carbonic anhydrase 
(Acel_1672), glyceraldehyde 3-phosphate reductase (Acel_1715), nitrite reductase large subunit 
(Acel_1744), sugar ABC transporter substrate-binding protein (Acel_1806), thioredoxin domain-
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containing protein (Acel_1883), acetyltransferase (Acel_1935), NAD-dependent epimerase 
(Acel_1936), thioredoxin-disulfide reductase (Acel_2148).  
 
3.4 Discussion 
Plant phenolic acids bind the complex lignin polymer to the hemicellulose and cellulose in the 
plant cell wall [42]. These are benzene ring compounds with one or more hydroxyl groups, that 
play important role in plant development, structural integrity and protection against stress by 
killing microorganisms [43]. Enzymatic hydrolysis or industrial pre-treatments are employed to 
separate and degrade the cell wall. As a result, phenolic acids such as ferulic, p-coumaric, caffeic 
acids etc. are released as free acids [42, 44]. These are natural toxins that have been shown to 
inhibit growth and lead to specific stress responses in microorganisms [22, 45]. The amounts of 
phenolic compounds present in switchgrass, a lignocellulosic substrate, have been found to be 
higher than the threshold for growth inhibition in A. cellulolyticus [46]. Both lignin and lignin-
related phenolic acids are toxic to cell, however, the mechanism of toxicity could be different. It 
is important to understand how lignin and its phenolic acid derivatives affect the cell, in order to 
develop strategies to enhance adaptation or confer resistance against these compounds.  
 
We looked at the gene expression profiles of A. cellulolyticus upon exposure to sub-lethal 
concentrations of HA, PA and lignin. Lignin showed the most number of differentially expressed 
genes at ³2-fold change (p£0.05), followed by PA and then HA. This is correlated with the 
structural complexity of these compounds. However, the transcriptomic profiles of HA and PA 
were more related to each other than lignin (Fig. S3). The gene expression profile of lignin was 
more similar to control (Fig. S3). Our preliminary growth studies showed that HA and PA were 
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more toxic than lignin. Qin et al. observed that lignin-blocking agents such as calcium chloride 
and BSA had no effect the inhibition effect of phenolics, indicating that inhibition mechanism of 
phenolics on cell wall degrading enzymes is different from lignin [19]. The authors suggested 
that this could be due to the dispersity and multiple binding sites of phenolics than insoluble 
lignin.  
 
It has been shown that low molecular weight phenolic compounds are more inhibitory to the 
fermentation of lignocellulosic biomass [47]. Our studies showed that out of the five phenolic 
acids tested, HA with the lowest molecular weight was most toxic to A. cellulolyticus cultures 
(Chapter 1). Based on its abundance in lignocellulosic hydrolysate and inhibitory effect on 
fermentation, HA has previously been used as a model to study the influence of phenolic 
compounds on fermentation [48-50]. Therefore, it was chosen as a representative single phenolic 
acid tested. Our preliminary growth studies showed that combination of five different phenolic 
acids (PA) was more inhibitory than inhibition by each individual phenolic acids, suggesting a 
synergistic effect on toxicity. Similar observations were seen in E. coli, where the combination 
of fermentation inhibitors: acetic acid, aromatic aldehydes and alcohols, 2-furfural and furfuryl 
alcohol was shown to increase the inhibitory potential of these compounds [22-24].  
 
Understanding of the mechanism of inhibition might provide clues to the factors functioning in 
relieving the inhibition. The mechanism of cytotoxicity of phenolic acids and several other 
pretreatment byproducts, has been proposed to involve enzyme inhibition, intracellular pH 
imbalance, DNA damage, membrane disruption and interference with the function of 
intracellular hydrophobic targets [51, 52]. It has been reported that within the same phenol 
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functional group, the inhibition depends on the amount of methoxyl substituents and thus 
hydrophobicity, as the hydrophobic parts of proteins, enzymes, and membrane transport systems 
are possible targets for inhibitory action [53]. Phenolic compounds have been shown to partition 
into biological membranes and cause loss of membrane integrity, dissipation of proton/ion 
gradients and compromising the ability of cellular membranes to act as selective barriers [54]. 
Membrane disruption leads to release of proteins, RNAs, ATP, ions, out of the cytoplasm, 
consequently causing reduced ATP levels, diminished proton motive force and impaired protein 
function and nutrient transport [54]. A means to cope up with these phenolic acids could be the 
membrane proteins and membrane related efflux proteins that could act as a protective barrier 
against the influx of inhibitory compounds and/or their efflux through the plasma membrane 
[55]. Lignin upregulated genes coding for proteins that reside in membrane: membrane protein 
(Acel_0347), inner membrane translocator (Acel_0352), integral membrane protein (Acel_1955), 
membrane protein (Acel_2110). The homologs of Acel_0347 are predicted to be a putative drug 
exporter of the RND superfamily. The Acel_0352 is predicted to be a monosaccharide ABC 
transporter membrane protein. The homologs of Acel_1955 are predicted to be EamA 
drug/metabolite family transporter. The homologs of Acel_2110 are predicted to be homologs of 
DoxX family membrane proteins with an unknown function. An inner membrane translocator 
(Acel_1130) was upregulated in an operon along with ABC transporters (Acel_1129-Acel_1131) 
(Table 7). These genes are predicted to be involved in sugar transport.  
 
Efflux system of living cells is an efficient mechanism for detoxification of external toxic 
compounds and internal damaging intermediates [31]. We found a number of transporters 
upregulated in the presence of HA, PA and lignin. These included ATP-dependent transporters, 
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secondary transporters and few ion channels. A number of genes coding for proteins of ATP-
Binding Cassette (ABC) superfamily were upregulated: Acel_1360, Acel_0540 (Upregulated in 
HA and PA); Acel_0558, Acel_0577, Acel_0906, Acel_1119, Acel_1131, Acel_1132, Acel_1142, 
Acel_1281, Acel_1414 (Upregulated in HA); Acel_0093, Acel_0094, Acel_0192, Acel_0193, 
Acel_0352, Acel_0434, Acel_0578, Acel_0580, Acel_0597, Acel_0719, Acel_1050, Acel_1055, 
Acel_1368, Acel_1626, Acel_1769 (Upregulated in lignin). Among these, sulfate ABC 
transporter ATP-binding protein (Acel_0192), ABC-2 type transporter (Acel_0193), ABC 
transporter ATP-binding protein (Acel_1055), ABC transporter (Acel_1142), ABC-2 type 
transporter/ Transport permease protein (Acel_1368), ABC transporter related protein 
(Acel_1414) are multi-drug resistance ABC transporters. Multidrug resistance efflux pump 
assemblies have been shown to be involved in active efflux of xenobiotics, antibiotics, 
antiseptics, cationic dyes etc. has been shown to involve [56].  
 
The rest of the upregulated ABC transporter genes code for carbohydrate transporters 
(Acel_1360, Acel_0558, Acel_0577, Acel_1131, Acel_1132, Acel_0352, Acel_0434, Acel_0578, 
Acel_0580, Acel_0719, Acel_1050), amino acid/amide transporter (Acel_0906), 
oligopeptide/dipeptide transporter (Acel_1119), phosphate transporters (Acel_0093, Acel_0094), 
thiol reductant ABC exporter subunit (Acel_0597). Phenolic acids and other secondary 
metabolites from plants have been shown to inhibit ABC transporters and thereby reversing the 
resistance of microorganisms to antimicrobial agents [57]. We observed that several genes 
coding for ABC transporters being downregulated in the presence of HA, PA and lignin (Table 
6). Owing to their lipophilicity, plant phenolics have been predicted to act as substrates, resulting 
in competitive inhibition by direct binding or complex formation with ABC transporters [57]. 
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Membrane permeabilization and efflux pump inactivation have been proposed to contribute to 
antibacterial and anti-biofilm synergy of phenolic-rich maple syrup extract [58]. 
 
Cytoplasmic membrane acts as a selectively permeable barrier for small ions whose gradient 
between the intra- and extracellular environment functions in the regulation of cytoplasmic pH 
and generation of energy [59]. Vanillin, the aldehyde form of vanillic acid, has been shown to 
cause partial disruption of K+ gradients in E. coli MC1022 membranes, leading to loss of ion 
gradients [59]. A few ion channels were found to be induced: ammonia channel protein 
(Acel_1566), cation transporter (Acel_1221) were upregulated in lignin; potassium transporter 
(Acel_1398) was upregulated in HA; anion permease (Acel_1957) was upregulated in HA and 
PA. In addition to ion channels, bacterial cells have been shown to maintain intracellular pH by 
the activation of an amino acid decarboxylase coupled with an antiporter. Amino acid 
decarboxylases (lysine, arginine, glutamate, histidine) are greatly induced under acidic 
conditions and are hypothesized to play a role in pH homeostasis [60-63]. These pump in amino 
acids and pump out respective decarboxylated products which results in the expulsion of ions, 
e.g. 2H+ molecules per decarboxylated product in case of glutamate, leading to increase in 
intracellular pH [63]. Upregulation of aromatic acid decarboxylase (Acel_0257), acetoacetate 
decarboxylase (Acel_1097), diaminopimelate decarboxylase (Acel_0629), glycine decarboxylase 
(Acel_1222), carboxymuconolactone decarboxylase (Acel_0891) was observed. The upregulation 
of these decarboxylases could possibly be in response to the intracellular pH decrease in the 




Lignin-derived phenolic compounds have been shown to enhance the generation of reactive 
oxygen species such as hydrogen peroxide (H2O2), super oxides (O2-) and super hydroxyl (OH-) 
that interact with proteins, resulting in their denaturation, damaging other hydrophobic 
intracellular targets, DNA mutagenesis, and induction of programmed cell death [64]. We 
observed that a polyisoprenoid-binding protein (Acel_0530) was consistently upregulated in HA, 
PA and lignin. This protein interacts with isoprenoid quinones that play essential roles in 
respiratory electron transport and in controlling oxidative stress and gene regulation [65]. A 
quinone oxidoreductase (Acel_0584) was upregulated in PA and lignin (Cluster 6) and an 
NAD(P)H-quinone dehydrogenase (Acel_0394) was upregulated in lignin. An operon consisting 
of genes coding for NADH-quinone oxidoreductases (Acel_0726-Acel_0731) was upregulated in 
the presence of lignin (Table 7). Quinone oxidoreductases are considered as detoxification 
enzymes with the ability to deactivate reactive oxygen species by reducing xenobiotic quinones, 
azo compounds etc., and have been proposed to play broader antioxidant roles by acting as 
superoxide scavengers [66]. 
 
An operon (Acel_1103-Acel_1104) consisting of a ferredoxin (Acel_1103) and FAD-dependent 
pyridine nucleotide-disulfide oxidoreductase (Acel_1104) was upregulated (Table 7). The 
pyridine nucleotide-disulphide reductases use the isoalloxazine ring of FAD to shuttle reducing 
equivalents from NAD(P)H to disulfide bridge of cysteine residue which the eventually reduces 
the substrate [67]. Likewise, genes coding for redox-sensing transcriptional repressor Rex 
(Acel_0239) and a thioredoxin family protein (Acel_0241) were also upregulated. Acel_0241 was 
upregulated in HA and PA, however was downregulated in lignin (Cluster 2). A thiol reductase 
thioredoxin gene (Acel_0542) was upregulated by lignin, and the two upstream genes coding for 
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an ABC transporter and osmotically induced protein were upregulated in HA and lignin. The 
exposure to lignin also upregulated the expression of a thioredoxin-disulfide reductase gene 
(Acel_2148). The higher expression of these genes indicates that the compounds tested possibly 
induced oxidative stress in A. cellulolyticus. 
 
We looked at the expression of phenylacetic acid degradation genes. Phenylacetic acid is 
structurally similar to the phenolic compounds tested. An induction in the expression of these 
genes could indicate their possible role in metabolism of structurally similar phenolic acids in A. 
cellulolyticus. A. cellulolyticus contains several homologs of paa genes. A paaR, transcriptional 
regulator of phenylacetic acid degradation, TetR family was found to be upregulated in lignin. 
However, the upstream gene paaZ (Acel_1435) did not show any significant change. In the 
operon paaABCDE (Acel_1439-Acel_1443), pad (Acel_1440) and paaE (Acel_1439) were found 
to be upregulated, while there was no significant change in the expression of the other genes in 
the operon. The phenolic acid stress response regulator gene, padR (Acel_2137) was found to be 
upregulated in HA, but was downregulated in PA and lignin (Cluster 4). Phenylacetic acid 
degradation genes were therefore found not to be affected in the presence of phenolic acids. 
 
Sulfur metabolism plays an important role as cell’s anti-oxidative stress system [68]. We 
hypothesized that sulfur metabolism could be a key factor involved in A. cellulolyticus survival 
in the presence of lignin phenolic compounds. We observed that the genes involved in sulfur 
assimilation pathway dedicated towards the biosynthesis of cysteine were upregulated by the 
compounds tested. An operon (Acel_0059-Acel_0060) containing the thiosulfate 
sulfurtransferase gene (Acel_0059) was upregulated upon exposure to HA, PA. Thiosulfate 
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sulfurtransferase (TST), has been proposed to function in the metabolism of sulfur compounds 
and maintenance of redox balance, wherein its deletion was found to cause oxidative imbalance 
in cells and cysteine auxotrophy [69-72]. The expression of TST protein was highly induced in 
the presence of each of the five phenolic compounds tested (Chapter 2). Its over-expression 
enhanced the survival of E. coli in the presence of HA (Chapter 2). In case of Mycobacterium 
smegmatis, a knockout mutant of MSMEG_5789 (ortholog of Acel_0059) was more sensitive to 
stressors such as H2O2, formaldehyde etc., and oxygen limitation conditions compared to the 
wild type strain (see Chapter 4).  
 
The operon consisting of genes involved in the sulfur assimilation pathway (Acel_1616-
Acel_1619) was also upregulated in the presence of HA, PA and lignin (Table 7). The sulfate 
adenylyltransferases, CysND (Acel_1617, Acel_1618) convert inorganic sulfate into adenylyl 
sulfate, which is then converted into phosphoadenosine phosphosulfate by adenylyl-sulfate 
kinase, CysC (Acel_1619). The phosphoadenosine phosphosulfate is reduced to sulfite by 
phosphoadenosine phosphosulfate reductase, CysH (Acel_2054). The Acel_2054 is present in an 
operon, which was also upregulated (Acel_2053-Acel_2055) (Table 7). The RT-PCR results were 
consistent in the trend of upregulation of the expression these genes in the presence of different 
phenolic acids (discussed in Chapter 2). The ferredoxin nitrite/sulfite reductase, CysI 
(Acel_2055) reduces sulfite into sulfide, which is then incorporated into cysteine. The sulfite 
reductase and nitrite reductase are structurally similar in their architecture and often catalyze the 
reduction of both sulfite and nitrite [73, 74]. The genes coding for the expression of nitrite 




The operon cysHIJ was found to be upregulated in ethanologen E. coli during the fermentation of 
alkali-pretreated corn stover hydrolysate [75]. Miller et al. (2009) found that furfural, an 
inhibitor released during lignin breakdown, inhibits the growth of E. coli by inhibiting sulfur 
assimilation, resulting in the induction of many related genes, including the cysCND and cysHIJ 
[76]. The authors observed that expression of genes and regulators associated with the 
biosynthesis of cysteine and methionine (cysC, cysH, cysI, cysM, cysN, cysQ, metA, metB, metC, 
metL, sbp, tauA, tauB, tauC, and tauD) was increased by furfural and the supplementation of 
cysteine, methionine and thiosulfate increased furfural tolerance. Similar results were observed 
in our study, where, addition of cysteine and thiosulfate relieved phenolic acid stress (Chapter 2). 
However, we did not observe any effect with methionine and the stress response was specific to 
cysteine (see Chapter 2).  
 
Another proposed mechanism for relieving stress is by expression of MarR (multiple antibiotic 
resistance regulator) family transcriptional regulators. MarR homologs regulate the activity of 
genes involved in stress responses, oxidative stress, virulence, or degradation/export of harmful 
chemicals such as phenolic compounds, xenobiotics and antibiotics [77, 78]. MarR homolog is 
conventionally encoded together with a gene under its regulation and can act as both repressors 
and activators of gene expression [79]. Small phenolic compounds have been shown to act as 
ligands that bind to MarR homologs and induce the expression of degradation genes [80-82]. The 
genes coding for MarR regulators (Acel_0109, Acel_0606,Acel_1098, Acel_1889, Acel_1958, 
Acel_2060, Acel_2084) were found to be upregulated. A number of MarR homologs also control 
the multidrug efflux pumps in response to environmental stresses [83]. We found three genes 
coding for MarR regulators associated with MFS (major facilitator superfamily) transporters to 
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be upregulated: Acel_0109-Acel_0110, Acel_0606-Acel_0607, Acel_1889-Acel_1890. The 
MarR-MFS operon (Acel_1889-Acel_1890) belonging to the MFS Drug resistance transporter, 
EmrB/QacA subfamily, was however found to be downregulated in the presence of HA and PA 
and upregulated specifically in lignin. A MarR regulator not present in an operon (Acel_2060) 
was found to be upregulated in the presence of PA and lignin. MarR homologs have been shown 
to respond to oxidative stress by oxidation of specific cysteine residues [84].  
 
The knowledge obtained from this study helps in understanding the effect of phenolic acids in A. 
cellulolyticus and could serve in the development of more robust strains able to adapt better in 








Table 1. MiSeq run information of each control vs treatment library sequencing. The HA, PA, 
lignin represent treatment; numbers 1 and 2 represent the first and second replicate. Total Reads: 
the total number of reads; PF Reads: the total number of passing filter reads; % Reads Identified 
(PF): the total fraction of passing filter reads assigned to an index; Q-Score (%³Q30): the 
percentage of bases with a quality score of >30; CV: the coefficient of variation for the number 











HA1 46,004,805 26,185,652 92.76 81.35 0.2291 4.06 
HA2 47,144,181 40,888,045 97.63 94.31 0.3651 6.34 
PA1 50,657,331 39,405,958 98.02 92.70 0.3769 6.11 
PA2 45,869,195 39,366,594 97.38 94.26 0.2315 6.10 
Lignin1 49,566,083 37,792,898 97.59 42.92 0.0291 22.86 
Lignin2 85,306,904 72,306,692 98.00 94.75 0.1803 5.60 
 
 
Table 2. Cross-comparison R2 values of all pairings of four experiments i.e. control, HA, PA and 
lignin. The values were obtained from statistical analyses using Student’s t-test and Benjamini-
Hochberg procedure (false discovery rate) using ArrayStar. 
Experiment Control HA PA Lignin 
Control  0.785 0.753 0.813 
HA   0.873 0.709 












Table 3. Number of genes significantly differentially expressed. The number of differentially 
expressed genes (³ 2-fold, 4-fold or 8-fold change) was obtained for each treatment compared to 
control: HA (a), PA (b), lignin (c). The total number of significant genes were obtained using the 
Student’s t-test with threshold set at either p £ 0.01 (genes at 99% confidence), 0.05 (genes at 
95% confidence) or 0.10 (genes at 90% confidence). 
HA Total genes Genes at 2-fold 
change 
Genes at 4-fold 
change 
Genes at 8-fold 
change 
Genes at 99% confidence 691 376 118 50 
Genes at 95% confidence 1024 470 125 50 
Genes at 90% confidence 1187 506 127 50 
     
(a) 
PA Total genes Genes at 2-fold 
change 
Genes at 4-fold 
change 
Genes at 8-fold 
change 
Genes at 99% confidence 763 453 132 57 
Genes at 95% confidence 1104 521 137 58 
Genes at 90% confidence 1274 542 140 58 
(b) 
Lignin Total genes Genes at 2-fold 
change 
Genes at 4-fold 
change 
Genes at 8-fold 
change 
Genes at 99% confidence 674 407 96 34 
Genes at 95% confidence 1104 559 114 41 




Table 4. Number of differentially expressed genes at p £ 0.05 and ³ 2-fold change. Control was 
used as a baseline to calculate fold-change values for each set. (a): total number of differentially 
expressed genes; (b) number of upregulated genes; (c) number of downregulated genes. 
Treatment   (a) (b)  (c) 
HA  470 225 245 
PA 521 168 353 






Table 5. List of genes consistently upregulated genes in HA, PA and lignin treatments compared to control 
Locus tag NCBI gene name New locus tag NCBI 
product 
length 
















6.72 2.12 4.66 
Acel_0110 MFS transporter ACEL_RS00580 429 Major facilitator superfamily MFS_1 2.61 2.02 2.19 
Acel_0160 heat-shock protein Hsp20 ACEL_RS00845 147 Heat shock protein Hsp20 4.34 2.59 3.28 
Acel_0202 tRNA(Ile)-lysidine 
synthetase 
ACEL_RS01065 398 tRNA(Ile)-lysidine synthase (EC 6.3.4.19) 
(tRNA(Ile)-2-lysyl-cytidine synthase) 
(tRNA(Ile)-lysidine synthetase) 
2.20 3.73 2.69 
Acel_0336 tRNA pseudouridine(38-40) 
synthase TruA 
ACEL_RS01745 297 tRNA pseudouridine synthase A (EC 5.4.99.12) 
(tRNA pseudouridine(38-40) synthase) (tRNA 
pseudouridylate synthase I) (tRNA-uridine 
isomerase I) 
2.96 2.47 5.53 
Acel_0343 phosphoglucosamine 
mutase 
ACEL_RS01780 450 Phosphoglucosamine mutase (EC 5.4.2.10) 2.71 2.62 2.98 
Acel_0365 DNA-binding response 
regulator 
ACEL_RS01890 202 Two component transcriptional regulator, LuxR 
family 
3.27 2.15 2.19 
Acel_0529 EAL domain-containing 
protein 
ACEL_RS02725 378 Diguanylate phosphodiesterase 11.61 4.75 6.03 
Acel_0530 polyisoprenoid-binding 
protein 
ACEL_RS02730 186 YceI family protein 21.56 2.63 9.20 
Acel_0555 ATPase ACEL_RS11365 299 ATPase, BadF/BadG/BcrA/BcrD type 2.06 2.14 2.86 
Acel_0660 hypothetical protein ACEL_RS03400 340 Uncharacterized protein 2.80 2.85 3.22 
Acel_0704 hypothetical protein ACEL_RS03620 654 Uncharacterized protein 3.81 3.84 2.80 
Acel_0855 flagellar motor switch 
protein FliN 
ACEL_RS04425 123 Flagellar motor switch protein FliN 6.73 5.09 10.38 
Acel_0959 signal peptidase I ACEL_RS04950 244 Peptidase S26B, signal peptidase 2.79 3.32 6.60 
Acel_1012 cell division protein FtsZ ACEL_RS05210 460 Cell division protein FtsZ 2.87 2.17 2.61 
Acel_1013 hypothetical protein ACEL_RS05215 240 Uncharacterized protein 3.59 2.16 3.34 




Table 5 (con’t) 
Locus tag NCBI gene name New locus tag NCBI 
product 
2length 











ACEL_RS05670 290 5-carboxymethyl-2-hydroxymuconate delta-
isomerase (EC 5.3.3.10) 
2.14 21.04 2.50 
Acel_1289 primosomal protein N' ACEL_RS06635 699 Probable primosomal protein N' (EC 3.6.4.-) 
(ATP-dependent helicase PriA) 
2.81 2.53 2.74 
Acel_1324 hypothetical protein ACEL_RS06810 428 Uncharacterized protein 2.28 2.99 2.90 
Acel_1411 hypothetical protein ACEL_RS07270 149 Uncharacterized protein 2.12 2.66 2.61 
Acel_1424 hypothetical protein ACEL_RS07335 96 Uncharacterized protein 14.01 6.52 2.74 
Acel_1513 ribosome-binding factor A ACEL_RS07800 150 Ribosome-binding factor A 3.28 2.77 3.39 
Acel_1615 hypothetical protein ACEL_RS08325 221 Cobalamin (Vitamin B12) biosynthesis CbiX 
protein 
6.43 6.60 3.91 
Acel_1616 uroporphyrinogen-III C-
methyltransferase 
ACEL_RS08330 475 Uroporphyrinogen-III C-methyltransferase (EC 
2.1.1.107) 
3.97 3.48 2.65 
Acel_1625 hypothetical protein ACEL_RS08375 179 Uncharacterized protein 3.90 2.45 2.26 
Acel_1772 NrdH-redoxin ACEL_RS09160 89 Glutaredoxin-like protein 47.42 10.83 4.34 
Acel_1778 hypothetical protein ACEL_RS09190 324 Alpha/beta hydrolase fold protein 3.74 4.95 2.53 
Acel_1779 hypothetical protein ACEL_RS09195 243 Uncharacterized protein 4.48 2.81 2.23 
Acel_1789 chemotaxis response 
regulator protein-glutamate 
methylesterase 
ACEL_RS09250 379 Chemotaxis response regulator protein-
glutamate methylesterase (EC 3.1.1.61) 
2.16 2.09 2.59 
Acel_1823 type II secretory protein 
GspE 
ACEL_RS09425 571 Type II secretion system protein E 2.92 3.72 5.21 
Acel_1857 hypothetical protein ACEL_RS09590 418 GCN5-related N-acetyltransferase 3.20 6.10 3.19 
Acel_1948 pirin ACEL_RS10065 346 Pirin domain protein 10.97 2.11 8.11 
Acel_1959 MFS transporter ACEL_RS10120 484 Drug resistance transporter, EmrB/QacA 
subfamily 
9.32 6.48 2.14 
Acel_1966 helicase ACEL_RS10155 1162 Helicase domain protein 3.95 2.10 3.04 
Acel_1994 hypothetical protein ACEL_RS11725 150 Uncharacterized protein 2.24 3.30 3.01 
Acel_2053 hypothetical protein ACEL_RS10615 161 Uncharacterized protein 7.61 3.38 2.33 




Table 6. List of genes consistently downregulated genes in HA, PA and lignin treatments compared to control 















Acel_0049 ferric reductase ACEL_RS00265 453 Oxidoreductase FAD/NAD(P)-binding domain 
protein 
20.41 49.04 11.13 
Acel_0050 FMN-binding domain-
containing protein 
ACEL_RS00270 188 FMN-binding domain protein 25.70 65.97 8.90 
Acel_0091 phosphate ABC transporter 
substrate-binding protein 
PstS 
ACEL_RS00485 391 Phosphate-binding protein PstS 3.18 4.04 2.21 
Acel_0173 hypothetical protein ACEL_RS11275 357 Uncharacterized protein 5.85 10.10 9.28 
Acel_0233 hypothetical protein ACEL_RS01220 409 Uncharacterized protein 14.70 17.97 2.32 
Acel_0392 cold-shock protein ACEL_RS02025 68 Cold-shock DNA-binding protein family 3.92 3.46 2.84 
Acel_0411 cell envelope-related 
transcriptional attenuator 
ACEL_RS02125 520 Cell envelope-related transcriptional attenuator 18.99 22.01 2.66 
Acel_0440 hypothetical protein ACEL_RS02280 228 Uncharacterized protein 5.39 4.99 2.71 
Acel_0442 hypothetical protein ACEL_RS02300 509 Uncharacterized protein 9.31 8.42 3.97 
Acel_0443 hypothetical protein ACEL_RS02305 585 Uncharacterized protein 8.50 6.25 3.07 
Acel_0444 NAD-dependent 
dehydratase 
ACEL_RS02310 391 UDP-sulfoquinovose synthase (EC 3.13.1.1) 13.66 11.28 5.06 
Acel_0487 hypothetical protein ACEL_RS02520 160 Uncharacterized protein 4.01 5.18 2.40 
Acel_0488 undecaprenyl-diphosphatase ACEL_RS02525 219 Undecaprenyl-diphosphatase (EC 3.6.1.27) 5.17 4.99 2.54 
Acel_0611 hypothetical protein ACEL_RS03125 305 Phosphoesterase, PA-phosphatase related protein 4.79 4.84 3.32 
Acel_0893 nitrate ABC transporter 
substrate-binding protein 
ACEL_RS04620 305 ABC-type nitrate/sulfonate/bicarbonate transport 
systems periplasmic components-like protein 
2.58 5.42 3.26 
Acel_0895 hypothetical protein ACEL_RS11425 209 Carboxymuconolactone decarboxylase 2.32 14.04 9.00 
Acel_0904 hypothetical protein ACEL_RS04675 552 Uncharacterized protein 21.61 44.62 4.07 
Acel_1446 cysteine--tRNA ligase ACEL_RS07450 347 Cysteine--tRNA ligase (EC 6.1.1.16) 9.07 9.81 4.68 
Acel_1447 hypothetical protein ACEL_RS11520 190 Uncharacterized protein 123.69 144.16 43.24 
Acel_1448 two-component sensor 
histidine kinase 
ACEL_RS07460 524 Periplasmic sensor signal transduction histidine 
kinase 
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Acel_1449 DNA-binding response 
regulator 
ACEL_RS07465 246 Two component transcriptional regulator, winged 
helix family 
7.38 9.04 2.95 
Acel_1450 hypothetical protein ACEL_RS11525 628 Efflux transporter, RND family, MFP subunit 170.46 245.55 55.83 
Acel_1451 macrolide ABC transporter 
ATP-binding protein 
ACEL_RS07480 254 ABC transporter related protein 11.05 11.73 14.07 
Acel_1452 macrolide ABC transporter 
permease 
ACEL_RS07485 393 Uncharacterized protein 231.11 317.26 84.57 
Acel_1453 hypothetical protein ACEL_RS11530 214 Uncharacterized protein 86.13 93.07 10.56 
Acel_1456 hypothetical protein ACEL_RS07505 412 Uncharacterized protein 6.86 7.43 4.24 
Acel_1457 hypothetical protein ACEL_RS07510 653 Peptidoglycan-N-acetylmuramate O-
acetyltransferase 
4.67 4.79 3.66 
Acel_1592 IclR family transcriptional 
regulator 
ACEL_RS08190 238 Transcriptional regulator, IclR family 3.76 2.74 2.33 
Acel_1593 peptidase S1 and S6, 
chymotrypsin/Hap 
ACEL_RS08195 512 Peptidase S1 and S6, chymotrypsin/Hap 9.09 13.34 6.99 
Acel_1594 two-component sensor 
histidine kinase 
ACEL_RS08200 523 Periplasmic sensor signal transduction histidine 
kinase 
4.63 8.22 3.72 
Acel_1595 DNA-binding response 
regulator 
ACEL_RS08205 227 Two component transcriptional regulator, winged 
helix family 
2.60 6.15 3.09 
Acel_1659 beta-glucosidase ACEL_RS08560 897 Beta-glucosidase (EC 3.2.1.21) 76.85 68.59 4.62 
Acel_1671 acetyl-CoA carboxylase ACEL_RS08615 202 BioY protein 2.68 2.29 2.03 
Acel_1672 carbonic anhydrase ACEL_RS08620 179 Carbonic anhydrase (EC 4.2.1.1) (Carbonate 
dehydratase) 
4.96 8.19 4.63 
Acel_1715 glyceraldehyde 3-phosphate 
reductase 
ACEL_RS08845 341 Aldo/keto reductase 2.82 3.82 2.49 






homocysteine methyltransferase (EC 2.1.1.14) 
(Cobalamin-independent methionine synthase) 
(Methionine synthase, vitamin-B12 independent 
isozyme) 
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Acel_1737 type II secretion system 
protein 
ACEL_RS08950 311 Type II secretion system protein 9.83 2.94 2.28 
Acel_1738 type II secretion system 
protein F 
ACEL_RS08955 286 Type II secretion system protein 4.90 2.04 2.38 
Acel_1739 pilus assembly protein CpaF ACEL_RS08960 414 Type II secretion system protein E 8.07 3.32 3.49 
Acel_1740 hypothetical protein ACEL_RS08965 835 Diguanylate cyclase/phosphodiesterase 2.80 8.72 7.42 
Acel_1826 RNA polymerase sigma 
factor SigE 
ACEL_RS09440 235 RNA polymerase, sigma 29 subunit, SigE 3.36 5.42 7.79 




Table 7. List of upregulated operons where at least two of the genes were upregulated in at least one of the treatments. Genes with ³2 
fold change in a treatment compared to control with p £0.05 were selected for operon prediction. The listed putative operons contain 
genes with £40 bp intergenic distance being transcribed in same direction.  
Upregulated operon Genes upregulated Upregulated gene description Treatments that 
showed upregulation 
Acel_0030 - Acel_0033 Acel_0030 nitrilase/cyanide hydratase and apolipoprotein N-acyltransferase HA 
Acel_0031 dehydrogenase catalytic domain-containing protein HA 
Acel_0032 2-oxoisovalerate dehydrogenase subunit beta HA 
Acel_0033 pyruvate dehydrogenase (acetyl-transferring) E1 component subunit 
alpha 
HA 
Acel_0057 - Acel_0058 Acel_0057 RNA polymerase sigma factor SigL HA 
Acel_0058 hypothetical protein HA, PA 
Acel_0059 - Acel_0060 Acel_0059 sulfurtransferase HA 
Acel_0060 hypothetical protein HA, PA 
Acel_0061 - Acel_0062 Acel_0061 transcriptional repressor HA 
Acel_0062 folate-binding protein HA 
Acel_0079 - Acel_0081 Acel_0079 PIN/TRAM domain-containing protein PA, lignin 
Acel_0080 4-diphosphocytidyl-2C-methyl-D-erythritol synthase lignin 
Acel_0081 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase lignin 
Acel_0091 - Acel_0094 Acel_0092 phosphate ABC transporter permease subunit PstC lignin 
Acel_0093 phosphate ABC transporter, permease protein PstA lignin 
Acel_0095 - Acel_0096 Acel_0095 penicillin-binding protein lignin 
Acel_0096 GGDEF domain-containing protein lignin 
Acel_0109 - Acel_0110 Acel_0109 MarR family transcriptional regulator PA, lignin 
Acel_0110 MFS transporter HA, PA, lignin 
Acel_0112 - Acel_0114 Acel_0113 MFS transporter lignin 
Acel_0114 phosphoserine aminotransferase lignin 
Acel_0120 - Acel_0122 Acel_0121 hypothetical protein HA 




Table 7 (con’t) 
Upregulated operon Genes upregulated Upregulated gene description Treatments that 
showed upregulation 
Acel_0222 - Acel_0224 Acel_0222 chemotaxis response regulator protein-glutamate methylesterase PA, lignin 
Acel_0223 hypothetical protein PA, lignin 
Acel_0224 hypothetical protein HA, PA, lignin 
Acel_0232 - Acel_0235 Acel_0234 hypothetical protein lignin 
Acel_0235 delta-aminolevulinic acid dehydratase lignin 
Acel_0236 - Acel_0239 Acel_0237 hydroxymethylbilane synthase lignin 
Acel_0239 redox-sensing transcriptional repressor Rex HA, PA 
Acel_0305 - Acel_0315 Acel_0308 50S ribosomal protein L23 lignin 
Acel_0309 50S ribosomal protein L2 lignin 
Acel_0311 50S ribosomal protein L22 lignin 
Acel_0312 30S ribosomal protein S3 lignin 
Acel_0314 50S ribosomal protein L29 lignin 
Acel_0335 - Acel_0336 Acel_0335 50S ribosomal protein L17 HA, lignin 
Acel_0336 tRNA pseudouridine(38-40) synthase TruA HA, PA, lignin 
Acel_0350 - Acel_0351 Acel_0350 ECF subfamily RNA polymerase sigma-24 factor lignin 
Acel_0351 anti-sigma factor lignin 
Acel_0355 - Acel_0357 Acel_0355 alanine racemase lignin 
Acel_0356 DNA polymerase lignin 
Acel_0357 tRNA (adenosine(37)-N6)-threonylcarbamoyltransferase complex 
ATPase subunit type 1 TsaE 
PA, lignin 
Acel_0429 - Acel_0430 Acel_0429 hypothetical protein HA, PA 
Acel_0430 hypothetical protein HA, PA 
Acel_0453 - Acel_0454 Acel_0453 amidinotransferase HA, PA 
Acel_0454 ornithine--oxo-acid transaminase HA, PA 
Acel_0460 - Acel_0461 Acel_0460 glycosyl transferase family protein PA, lignin 




Table 7 (con’t) 
Upregulated operon Genes upregulated Upregulated gene description Treatments that 
showed upregulation 
Acel_0494 - Acel_0495 Acel_0494 hemerythrin HHE cation binding domain-containing protein lignin 
Acel_0495 hypothetical protein lignin 
Acel_0538 - Acel_0539 Acel_0538 RNA polymerase subunit sigma-24 HA, lignin 
Acel_0539 mycothiol system anti-sigma-R factor HA, lignin 
Acel_0541 - Acel_0542 Acel_0541 osmotically inducible protein OsmC HA, lignin 
Acel_0542 thiol reductase thioredoxin lignin 
Acel_0553 - Acel_0556 Acel_0555 ATPase HA, PA, lignin 
Acel_0556 glucosamine-6-phosphate deaminase HA 
Acel_0579 - Acel_0582 Acel_0580 ABC transporter permease HA, lignin 
Acel_0581 hypothetical protein HA 
Acel_0582 xylose isomerase HA 
Acel_0606 - Acel_0607 Acel_0606 MarR family transcriptional regulator lignin 
Acel_0607 MFS transporter HA, lignin 
Acel_0637 - Acel_0639 Acel_0637 hypothetical protein PA, lignin 
Acel_0638 UDP-N-acetylglucosamine 2-epimerase (non-hydrolyzing) HA, PA, lignin 
Acel_0639 HAD family hydrolase PA, lignin 
Acel_0651 - Acel_0654 Acel_0652 ATP synthase subunit gamma lignin 
Acel_0654 ATP synthase F1 subunit epsilon lignin 
Acel_0659 - Acel_0661 Acel_0659 ATPase HA, lignin 
Acel_0660 hypothetical protein HA, PA, lignin 
Acel_0661 hypothetical protein PA, lignin 
Acel_0700 - Acel_0703 Acel_0700 2-oxoacid:acceptor oxidoreductase subunit gamma HA, lignin 
Acel_0701 2-ketoisovalerate ferredoxin oxidoreductase subunit alpha HA 
Acel_0702 pyruvate ferredoxin oxidoreductase lignin 






Upregulated operon Genes upregulated Upregulated gene description Treatments that 
showed upregulation 
Acel_0709 - Acel_0710 Acel_0709 phosphoglycerate dehydrogenase lignin 
Acel_0710 3-isopropylmalate dehydrogenase lignin 
Acel_0716 - Acel_0719 Acel_0716 nucleoside/nucleotide kinase family protein lignin 
Acel_0719 sugar ABC transporter lignin 
Acel_0721 - Acel_0722 Acel_0721 hypothetical protein HA, lignin 
Acel_0722 carbohydrate kinase lignin 
Acel_0726 - Acel_0731 Acel_0726 NADH/ubiquinone/plastoquinone (complex I) lignin 
Acel_0727 NADH ubiquinone oxidoreductase lignin 
Acel_0728 NADH-quinone oxidoreductase subunit D lignin 
Acel_0729 NADH dehydrogenase lignin 
Acel_0730 hydrogenase lignin 
Acel_0731 NADH dehydrogenase subunit 1 lignin 
Acel_0734 - Acel_0735 Acel_0734 DNA mismatch repair protein MutS lignin 
Acel_0735 DNA mismatch repair protein MutS domain-containing protein HA, lignin 
Acel_0758 - Acel_0759 Acel_0758 GTPase ObgE lignin 
Acel_0759 glutamate 5-kinase lignin 
Acel_0773 - Acel_0775 Acel_0774 hypothetical protein lignin 
Acel_0775 DNA polymerase III subunit delta lignin 
Acel_0789 - Acel_0793 Acel_0792 hypothetical protein PA, lignin 
Acel_0793 GTPase Era lignin 
Acel_0820 - Acel_0821 Acel_0820 metallophosphoesterase lignin 
Acel_0821 SMC domain-containing protein lignin 
Acel_0830 - Acel_0833 Acel_0830 flagellar assembly protein FliW lignin 
Acel_0832 flagellar hook-associated protein FlgK lignin 





Table 7 (con’t) 
Upregulated operon Genes upregulated Upregulated gene description Treatments that 
showed upregulation 
Acel_0835 - Acel_0837 Acel_0835 flagellar hook-associated 2 domain-containing protein lignin 
Acel_0837 hypothetical protein lignin 
Acel_0838 - Acel_0839 Acel_0838 flagellar basal-body rod protein FlgB lignin 
Acel_0839 flagellar basal body rod protein FlgG lignin 
Acel_0840 - Acel_0848 Acel_0841 flagellar M-ring protein FliF lignin 
Acel_0843 flagellar biosynthesis/type III secretory pathway protein-like protein HA, PA, lignin 
Acel_0844 ATP synthase lignin 
Acel_0845 hypothetical protein lignin 
Acel_0846 lytic transglycosylase lignin 
Acel_0850 - Acel_0860 Acel_0850 flagellar FlbD family protein lignin 
Acel_0851 motility protein A lignin 
Acel_0852 OmpA/MotB domain-containing protein lignin 
Acel_0853 flagellar basal body-associated protein FliL lignin 
Acel_0854 hypothetical protein lignin 
Acel_0855 flagellar motor switch protein FliN HA, PA, lignin 
Acel_0857 flagellar biosynthetic protein FliP lignin 
Acel_0860 type III secretion exporter lignin 
Acel_0863 - Acel_0864 Acel_0863 hypothetical protein lignin 
Acel_0864 hypothetical protein lignin 
Acel_0871 - Acel_0873 Acel_0871 ribulokinase HA, lignin 
Acel_0872 L-ribulose-5-phosphate 4-epimerase HA, lignin 
Acel_0873 L-arabinose isomerase lignin 
Acel_0939 - Acel_0945 Acel_0940 nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase HA, PA 
Acel_0941 adenosylcobinamide kinase HA 





Table 7 (con’t) 
Upregulated operon Genes upregulated Upregulated gene description Treatments that 
showed upregulation  
Acel_0944 cobalt transport protein HA, PA 
Acel_1002 - Acel_1003 Acel_1002 ribosomal RNA small subunit methyltransferase H HA 
Acel_1003 hypothetical protein HA 
Acel_1040 - Acel_1043 Acel_1041 cupin HA 
Acel_1042 hypothetical protein HA 
Acel_1078 - Acel_1079 Acel_1078 glutamate synthase subunit alpha lignin 
Acel_1079 dihydropyrimidine dehydrogenase subunit A lignin 
Acel_1090 - Acel_1091 Acel_1090 hypothetical protein lignin 
Acel_1091 dephospho-CoA kinase lignin 
Acel_1092 - Acel_1094 Acel_1092 gamma-aminobutyraldehyde dehydrogenase PA, lignin 
Acel_1093 aspartate aminotransferase family protein PA, lignin 
Acel_1094 glutamine amidotransferase PA 
Acel_1100 - Acel_1102 Acel_1100 betaine-aldehyde dehydrogenase HA, PA 
Acel_1101 catecholic dioxygenase HA, PA 
Acel_1102 5-carboxymethyl-2-hydroxymuconate isomerase HA, PA, lignin 
Acel_1103 - Acel_1104 Acel_1103 ferredoxin PA 
Acel_1104 FAD-dependent pyridine nucleotide-disulfide oxidoreductase HA, PA, lignin 
Acel_1129 - Acel_1130 Acel_1129 ROK family protein HA 
Acel_1130 inner-membrane translocator HA 
Acel_1200 - Acel_1201 Acel_1200 WYL domain-containing protein HA 
Acel_1201 WYL domain-containing protein HA 
Acel_1221 - Acel_1222 Acel_1221 cation transporter lignin 
Acel_1222 glycine dehydrogenase (aminomethyl-transferring) lignin 
Acel_1255 - Acel_1262 Acel_1260 aspartate aminotransferase family protein lignin 





Table 7 (con’t) 
Upregulated operon Genes upregulated Upregulated gene description Treatments that 
showed upregulation 
Acel_1271 - Acel_1274 Acel_1273 riboflavin synthase subunit alpha HA, lignin 
Acel_1274 riboflavin biosynthesis protein RibD lignin 
Acel_1295 - Acel_1302 Acel_1296 dihydroorotate dehydrogenase lignin 
Acel_1299 carbamoyl-phosphate synthase small subunit HA 
Acel_1301 aspartate carbamoyltransferase HA 
Acel_1302 bifunctional pyr operon transcriptional regulator/uracil 
phosphoribosyltransferase 
HA 
Acel_1310 - Acel_1313 Acel_1312 hypothetical protein HA, lignin 
Acel_1313 pilus biosynthesis protein PilM lignin 
Acel_1327 - Acel_1336 Acel_1329 Holliday junction resolvase RuvX PA 
Acel_1334 aspartate--tRNA ligase lignin 
Acel_1335 histidine--tRNA ligase lignin 
Acel_1336 hydrolase HA, lignin 
Acel_1401 - Acel_1402 Acel_1401 hypothetical protein lignin 
Acel_1402 deoxyuridine 5'-triphosphate nucleotidohydrolase lignin 
Acel_1410 - Acel_1412 Acel_1410 ECF subfamily RNA polymerase sigma-24 factor lignin 
Acel_1411 hypothetical protein HA, PA, lignin 
Acel_1413 - Acel_1415 Acel_1413 hypothetical protein PA 
Acel_1414 hypothetical protein PA 
Acel_1423 - Acel_1424 Acel_1423 carboxymethylenebutenolidase HA, PA, lignin 
Acel_1424 hypothetical protein HA, PA, lignin 
Acel_1435 - Acel_1437 Acel_1436 TetR family transcriptional regulator lignin 
Acel_1437 DNA repair protein lignin 
Acel_1439 - Acel_1443 Acel_1439 oxidoreductase FAD-binding subunit HA, lignin 
Acel_1440 phenylacetate-CoA oxygenase subunit PaaJ HA, lignin 




Table 7 (con’t) 
Upregulated operon Genes upregulated Upregulated gene description Treatments that 
showed upregulation  
Acel_1481 GGDEF domain-containing protein lignin 
Acel_1505 - Acel_1508 Acel_1505 FAD-dependent oxidoreductase lignin 
Acel_1506 4-hydroxy-tetrahydrodipicolinate reductase lignin 
Acel_1507 peptidase M16 lignin 
Acel_1508 polyribonucleotide nucleotidyltransferase lignin 
Acel_1512 - Acel_1514 Acel_1512 tRNA pseudouridine(55) synthase TruB HA, PA, lignin 
Acel_1513 ribosome-binding factor A HA, PA, lignin 
Acel_1514 hypothetical protein HA, lignin 
Acel_1558 - Acel_1561 Acel_1558 tRNA (guanosine(37)-N1)-methyltransferase TrmD lignin 
Acel_1559 16S rRNA-processing protein RimM lignin 
Acel_1562 - Acel_1566 Acel_1562 hypothetical protein lignin 
Acel_1564 [protein-PII] uridylyltransferase PA, lignin 
Acel_1566 ammonia channel protein lignin 
Acel_1605 - Acel_1606 Acel_1605 two-component sensor histidine kinase HA, PA 
Acel_1606 DNA-binding response regulator HA, PA 
Acel_1616 - Acel_1619 Acel_1616 uroporphyrinogen-III C-methyltransferase HA, PA, lignin 
Acel_1617 sulfate adenylyltransferase HA, PA 
Acel_1618 sulfate adenylyltransferase subunit 2 HA, PA 
Acel_1619 adenylyl-sulfate kinase HA, PA 
Acel_1625 - Acel_1627 Acel_1625 hypothetical protein HA, PA, lignin 
Acel_1626 macrolide ABC transporter ATP-binding protein lignin 
Acel_1630 - Acel_1631 Acel_1630 hypothetical protein HA, lignin 
Acel_1631 xanthine dehydrogenase HA, lignin 
Acel_1633 - Acel_1639 Acel_1638 carbon monoxide dehydrogenase lignin 





Tabel 7 (con’t) 
Upregulated operon Genes upregulated Upregulated gene description Treatments that 
showed upregulation 
Acel_1685 - Acel_1689 Acel_1685 MBL fold metallo-hydrolase lignin 
Acel_1686 glutamate racemase lignin 
Acel_1687 cysteine synthase HA 
Acel_1688 molybdopterin synthase sulfur carrier subunit HA 
Acel_1705 - Acel_1707 Acel_1705 glutamine amidotransferase lignin 
Acel_1706 hypothetical protein lignin 
Acel_1718 - Acel_1719 Acel_1718 hypothetical protein HA 
Acel_1719 hypothetical protein PA, lignin 
Acel_1742 - Acel_1744 Acel_1742 uroporphyrinogen-III synthase lignin 
Acel_1744 nitrite reductase large subunit lignin 
Acel_1745 - Acel_1746 Acel_1745 pyridine nucleotide-disulfide oxidoreductase lignin 
Acel_1746 nitrite reductase lignin 
Acel_1889 - Acel_1890 Acel_1889 MarR family transcriptional regulator lignin 
Acel_1890 MFS transporter lignin 
Acel_1892 - Acel_1896 Acel_1892 magnesium chelatase lignin 
Acel_1893 VWA domain-containing protein lignin 
Acel_1894 hypothetical protein lignin 
Acel_1906 - Acel_1907 Acel_1906 exopolyphosphatase lignin 
Acel_1907 phosphatase lignin 
Acel_1966 - Acel_1967 Acel_1966 helicase HA, PA, lignin 
Acel_1967 hypothetical protein HA, PA, lignin 
Acel_1970 - Acel_1971 Acel_1970 DNA polymerase III subunit delta lignin 
Acel_1971 thymidylate kinase lignin 
Acel_1980 - Acel_1983 Acel_1980 type II secretion system protein lignin 





Table 7 (con’t) 
Upregulated operon Genes upregulated Upregulated gene description Treatments that 
showed upregulation  
Acel_1983 hypothetical protein lignin 
Acel_1989 - Acel_1992 Acel_1989 hypothetical protein lignin 
Acel_1990 alpha/beta hydrolase lignin 
Acel_1991 coenzyme A pyrophosphatase lignin 
Acel_2018 - Acel_2019 Acel_2018 tRNA-specific adenosine deaminase lignin 
Acel_2019 hypothetical protein lignin 
Acel_2053 - Acel_2055 Acel_2053 hypothetical protein HA, PA, lignin 
Acel_2054 phosphoadenosine phosphosulfate reductase HA, PA 
Acel_2055 ferredoxin--nitrite reductase HA, PA 
Acel_2094 - Acel_2095 Acel_2094 catalase HA 





















Table 8. List of KEGG annotated pathways/functions of upregulated genes. 
Metabolic pathway/function Number of 
annotated 




(fold change ≥2 
and p ≤0.05) 
Locus tag of the upregulated genes (treatment under which 
upregulated, H: HA, P: PA, L: Lignin) 
Aminoacyl-tRNA biosynthesis  70 19 Acel_1334 (L), Acel_1335 (L), Acel_R0002 (L), Acel_R0007 (L), 
Acel_R0010 (H), Acel_R0015 (L), Acel_R0017 (L), Acel_R0018 
(L), Acel_R0024 (L), Acel_R0039 (L), Acel_R0040 (L), 
Acel_R0042 (L), Acel_R0043 (PL), Acel_R0047 (L), Acel_R0054 
(L), Acel_R0059 (L), Acel_R0063 (HL), Acel_R0064 (L), 
Acel_R0066 (HL) 
ABC transporters  54 14 Acel_0092 (L), Acel_0093 (L), Acel_0434 (L), Acel_0558 (H), 
Acel_0577 (H), Acel_0578 (HL), Acel_0580 (HL), Acel_0597 (L), 
Acel_0719 (L), Acel_0944 (HP), Acel_1131 (H), Acel_1132 (H), 
Acel_1281 (H), Acel_1360 (HP) 
Ribosome  56 14 Acel_0297 (L), Acel_0298 (L), Acel_0308 (L), Acel_0309 (L), 
Acel_0311 (L), Acel_0312 (L), Acel_0314 (L), Acel_0319 (L), 
Acel_0322 (L), Acel_0335 (HL), Acel_2130 (H), Acel_R0034 (PL), 
Acel_R0035 (P), Acel_R0036 (P) 
Glycolysis / Gluconeogenesis  33 12 Acel_0031 (H), Acel_0032 (H), Acel_0033 (H), Acel_0138 (PL), 
Acel_0394 (L), Acel_0590 (H), Acel_0700 (HL), Acel_0701 (H), 
Acel_0702 (L), Acel_0721 (HL), Acel_1068 (HP), Acel_1611 (L) 
Purine metabolism  49 12 Acel_0299 (L), Acel_0300 (HL), Acel_0775 (L), Acel_0802 (L), 
Acel_1508 (L), Acel_1617 (HP), Acel_1618 (HP), Acel_1619 (HP), 
Acel_1906 (L), Acel_1910 (L), Acel_1970 (L), Acel_2129 (L) 
Flagellar assembly  27 11 Acel_0832 (L), Acel_0835 (L), Acel_0838 (L), Acel_0839 (L), 
Acel_0841 (L), Acel_0843 (HPL), Acel_0844 (L), Acel_0845 (L), 
Acel_0857 (L), Acel_0860 (L), Acel_0861 (L) 
Glycine, serine and threonine 
metabolism  
26 11 Acel_0100 (L), Acel_0114 (L), Acel_0632 (L), Acel_0686 (L), 
Acel_0709 (L), Acel_1092 (PL), Acel_1100 (HP), Acel_1222 (L), 
Acel_1285 (PL), Acel_1425 (HP), Acel_1846 (HL) 
Two-component system  47 10 Acel_0089 (PL), Acel_0222 (PL), Acel_0223 (PL), Acel_0834 (L), 
Acel_0851 (L), Acel_1564 (PL), Acel_1765 (HP), Acel_1789 
(HPL), Acel_1873 (PL), Acel_2032 (L) 
Porphyrin and chlorophyll 
metabolism  
18 8 Acel_0235 (L), Acel_0237 (L), Acel_0940 (HP), Acel_0941 (H), 




Table 8 (con’t) 
Metabolic pathway/function Number of 
annotated 




(fold change ≥2 
and p ≤0.05) 
Locus tag of the upregulated genes (treatment under which 
upregulated, H: HA, P: PA, L: Lignin) 
Alanine, aspartate and glutamate 
metabolism  
22 7 Acel_0556 (H), Acel_1078 (L), Acel_1079 (L), Acel_1093 (PL), 
Acel_1288 (L), Acel_1750 (H), Acel_1956 (L) 
Amino sugar and nucleotide sugar 
metabolism  
31 7 Acel_0291 (L), Acel_0343 (HPL), Acel_0557 (HP), Acel_0638 
(HPL), Acel_1460 (L), Acel_1947 (L), Acel_2033 (PL) 
Pyrimidine metabolism  32 7 Acel_1296 (L), Acel_1299 (H), Acel_1301 (H), Acel_1302 (H), 
Acel_1402 (L), Acel_1540 (L), Acel_1971 (L) 
Nitrogen metabolism  20 5 Acel_1744 (L), Acel_1745 (L), Acel_1746 (L), Acel_1747 (L), 
Acel_2055 (HP) 
Oxidative phosphorylation  38 5 Acel_0273 (L), Acel_0650 (L), Acel_0652 (L), Acel_0654 (L), 
Acel_1902 (L) 
Arginine biosynthesis  13 4 Acel_1096 (HP), Acel_1260 (L), Acel_1262 (L), Acel_1263 (H) 
Bacterial chemotaxis  18 4 Acel_0852 (L), Acel_0854 (L), Acel_0855 (HPL), Acel_1786 (H) 
Base excision repair  12 4 Acel_0118 (HP), Acel_0221 (HPL), Acel_0356 (L), Acel_1903 (P) 
Nucleotide excision repair  9 4 Acel_0375 (L), Acel_1771 (L), Acel_1775 (L), Acel_1913 (L) 
Starch and sucrose metabolism  26 4 Acel_0614 (P), Acel_0615 (P), Acel_1601 (L), Acel_1701 (P) 
Metabolic pathways  437 3 Acel_0220 (L), Acel_1211 (H), Acel_1484 (PL) 
Pentose and glucuronate 
interconversions  
11 3 Acel_0871 (HL), Acel_0872 (HL), Acel_0873 (L) 
Phenylalanine metabolism  13 3 Acel_1439 (HL), Acel_1440 (HL), Acel_1836 (PL) 
Terpenoid backbone biosynthesis  14 3 Acel_0080 (L), Acel_0081 (L), Acel_0181 (L) 
Thiamine metabolism  10 3 Acel_0989 (H), Acel_1583 (L), Acel_1584 (PL) 
Ubiquinone and other terpenoid-
quinone biosynthesis  









Figure 1. Venn diagrams showing unique and shared differentially expressed genes among the 
three treatments. Differential expression was calculated using threshold values at p £ 0.05 and ³ 
2-fold change. Control (no treatment) was used as a baseline to calculate fold-change values for 
each set. (a): total number of differentially expressed genes; (b) number of upregulated genes; (c) 
number of downregulated genes. Experiment IDs are as follows: A - HA x Control; B - PA x 


























































Figure 2. Dendrogram showing clustering tree and heat map generated using hierarchical 
clustering of genome wide gene expression data. Each row represents an individual gene (2213 
rows). The yellow color indicates positive expression (greater fold change compared to control); 
the blue color indicates negative expression (lesser fold change compared to control). The 






Figure 3. Dendrogram showing clustering tree and heat map generated using hierarchical 
clustering of gene expression data of only significantly differentially expressed genes (³2-fold 
change, p £ 0.05). Each row represents an individual gene (1042 rows). The yellow color 
indicates positive expression (greater fold change compared to control); the blue color indicates 
negative expression (lesser fold change compared to control). The missing genes are shown in 







3.7 Supplementary figures 
 
Figure S1. mRNA enrichment from total RNA. The images represent snapshots of RNA quality 
analyses before and after rRNA depletion. The x-axis represent size (nucleotides); the y-axis 
sample intensity [FU] or [FU](10^3). (a) total RNA from control sample; (b) rRNA depleted 
RNA from control sample; (c) total RNA from HA sample; (d) rRNA depleted RNA from HA 
sample; (e) total RNA from PA sample; (f) rRNA depleted RNA from PA sample; (g) total RNA 
from lignin sample; (h) rRNA depleted RNA from lignin sample. The images show one 






Figure S2. Assessment of DNA library quality and average library size. The x-axis represent 
size (bp); the y-axis sample intensity [FU]. (a) control DNA library (261 bp); (b) HA DNA 
library (238 bp); (c) PA DNA library (236 bp); (d) lignin DNA library (279 bp). The images 






Figure S3. Heat map displaying the expression levels of different genes across control, HA, PA 
and lignin treatments. Each row corresponds to one gene and each column represents a treatment 







Figure S4. The scatter plots of gene expression levels. Each gene (2213 genes total) is 
represented as an individual data point and is plotted on a log2 scale based on its expression in 
control and treatment. The x-axis represents control, the y-axis represents treatment: (a) HA, (b) 
PA and (c) lignin. The middle blue line is the identity line showing genes expressed at the same 
level in both control and treatment. The outer two blue lines show genes with at least 2-fold 
change in expression value in either control (green data points) or treatment (red data points). 
The increase in color intensity of a data point represent increase in expression level. The dashed 


















Figure S5. Gene clusters of interest. Dendrogram showing heat map of gene clusters generated 
using hierarchical clustering of gene expression data of differentially expressed genes. Each row 
represent an individual gene. The yellow color indicates positive expression; the blue color 
indicates negative expression. The missing genes are shown in white and genes with zero values 
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Mycobacterium smegmatis (basonym for Mycolicibacterium smegmatis) is an aerobic, fast 
growing, non-pathogenic, acid-fast Actinobacteria belonging to the family Mycobacteriaceae. It 
is a high G+C bacillus (67.4% G+C content) with the genome size of 6.9 Mb.  M. smegmatis mc2 
155 strain containing the efficient plasmid transformation (ept) mutation is one of the widely 
used strains of M. smegmatis for genetic manipulation. This strain has higher transformation 
efficiency compared to the wild-type strain ATCC 607 [1]. Etienne et al., (2005) used 
biochemical analysis to study the cell surface properties of the transformable strain mc2 155 and 
suggested that the variation in composition and structure of the cell envelope might be 
responsible for the enhanced transformation efficiency of the strain [2]. M. smegmatis shares the 
peculiar cell wall structure and a number of homologous genes including those involved in 
adaptation to stress in M. tuberculosis and other mycobacterial species [3, 4]. It has thus been 
widely used as a model organism and a surrogate host for genetic analysis of various pathogenic 
mycobacteria such as M. tuberculosis, M. avium, M. paratuberculosis [5-7].  
 
M. tuberculosis, the causative agent of tuberculosis (TB), is a facultative intracellular pathogen 
that resides within the macrophages of its host. Approximately one-third of the world’s 
population is thought to be infected with M. tuberculosis [8]. A vast number of research groups 




diverse and aim at growth inhibition by targeting various metabolic pathways such as cell wall 
biosynthesis especially mycolic acid biosynthesis, reductive sulfur assimilation pathway, 
mycothiol biosynthesis, amino acid and DNA synthesis etc. [9]. Many potential drug targets have 
been identified so far, however antibiotic resistance has become a huge concern. There have been 
increasing number of cases of multidrug-resistant TB (MDR-TB), which is caused by bacteria 
that are resistant to the most effective first line anti-TB drugs (isoniazid and rifampicin), and 
extensively drug-resistant TB (XDR-TB) including resistance to both first and second line TB 
drugs [10].  
 
It has been proposed that drug targets aiming at genes involved bacterial stress responses can be 
exploited to combat antibiotic tolerance and multidrug resistance in bacteria [11]. In 
Pseudomonas aeruginosa, the loss of a two-component regulator involved in membrane stress 
response, reduced the virulence of the bacteria as well as enhanced the action of aminoglycoside 
antibiotic tobramycin [12]. In our studies with the phenolic acid induced stress in Acidothermus 
cellulolyticus, we observed that a putative thiosulfate sulfurtransferase protein (Acel_0059) was 
highly upregulated when the bacteria was exposed to phenolic acids (see Chapter 2). We 
hypothesized that this protein might be an important candidate involved in the phenolic acid 
stress response in A. cellulolyticus possibly through the biosynthesis of cysteine. It is of interest 
to know whether the role of TST under stress is specific to A. cellulolyticus, or shared among 
different bacteria. Over the years, there have been numerous reports of TSTs (a.k.a. rhodaneses), 
especially under stress inducing conditions. Florczyk et al., (2001) suggested a possible role of 
TSTs in the assembly of iron-sulfur (Fe-S) clusters. Increased intracellular pools of Fe-S clusters 




showed these to function as thioredoxin oxidase in vitro suggesting that, their involvement in the 
detoxification of intra-mitochondrial reactive oxygen species in vivo [13]. These functions of 
TSTs have been proposed to be due to their ability to react with sulfur-containing anions such as 
thiosulfate and transfers them to thiophilic acceptor molecules [14]. TSTs can generate enzyme-
based persulfides (activated sulfur), which serve as the building blocks for sulfur containing 
compounds [15].  
 
We were interested in knowing whether the homolog of A. cellulolyticus TST (Acel_0059) could 
be involved in survival under stress and cysteine biosynthesis in mycobacteria. The M. 
tuberculosis genome encodes a total of four putative sulfurtransferases, namely CysA2 
(Rv0815c), CysA3 (Rv3117), SseA (Rv3283) and SseB (Rv2291). The presence of four different 
homologs suggest an important role for these proteins in mycobacteria [8]. Among the four 
genes, cysA2 (c909318-908485) and cysA3 (3483974-3484807) are 100% identical in their 
nucleotide sequence. We used NCBI blastx feature (https://blast.ncbi.nlm.nih.gov/) to analyze 
sequence similarity of the four sulfurtransferase homologs of M. tuberculosis H37Rv (Mtb) with 
M. smegmatis mc2 155 (M. smegmatis), A. cellulolyticus 11B (A. cellulolyticus) and E. coli K-12 
MG1655 (E. coli) strains (Table 1). The TST of A. cellulolyticus that was upregulated under 
phenolic acid stress i.e. Acel_0059 (ACEL_RS00315) showed 74% sequence identity with M. 
tuberculosis CysA2 (Rv0815c). M. smegmatis contains three different rhodanese domain 
containing proteins, namely, MSMEG_1809, MSMEG_3238 and MSMEG_5789. The protein of 
interest in M. smegmatis was MSMEG_5789, since it showed highest sequence identity with the 
M. tuberculosis CysA2 (Table 1). The MSMEG_5789 (chromosomal location: 5859664-




BLAST (blastp) using the Uniprot/Swissprot database revealed that the closest sequence 
homolog of A. cellulolyticus TST Acel_0059 was MSMEG_5789 from M. smegmatis mc2 155 
(see Chapter 2). The MSMEG_5789 is 277 amino acids in length with a molecular weight of 
30.98 kDa and contains two conserved rhodanese domains similar to Acel_0059.  
 
There are multiple reports showing the involvement of TST and other rhodanese domain 
containing proteins in mycobacteria under various conditions, however, the precise cellular 
function is yet to be known. In a study with clinical isolates of M. tuberculosis, Rv0815c was 
found to be upregulated in both sensitive and drug resistance isolates, suggesting its importance 
in intracellular survival of the pathogen [16]. The M. tuberculosis TST gene has been shown to 
be under the control of macrophage-induced promoters, suggesting its importance during 
survival in host macrophages [17]. The M. tuberculosis MoeZR protein involved in 
molybdopterin biosynthesis was predicted to contain a rhodanese-like domain at the C-terminus 
[18]. This protein was later on shown to play an additional role in cysteine synthesis in vitro, and 
it has been reported to be upregulated under oxidative stress conditions [19]. Cysteine is known 
to be important during survival under oxidative stress conditions due to its role in generation of 
redox mediators [20, 21]. Nakajima et al., (2008) demonstrated that rhodanese is induced by 
radiation exposure and proposed that its induction might be related to its anti-oxidative functions 
in cooperation with other anti-oxidative molecules such as glutathione and thioredoxin [22]. TST 
has been shown to participate in sulfane sulfur transport along with mercaptopyuvate 
sulfurtransferase and g-cystathionase in anaerobic L-cysteine metabolism, with reduced 





The difficulties in establishing the in vivo functions of these TSTs lie in the redundancy of 
rhodanese modules and rhodanese activities [24]. An exception to this was observed in 
Saccharopolyspora erythraea, where disruption of rhodanese-like gene resulted in cysteine 
auxotrophy [25]. Deletion of rhodanese-like protein (RhdA) in Azotobacter vinelandii produced 
an oxidative imbalance suggesting its role in anti-oxidative regulation of intracellular 
homeostasis [26]. In the present study, we aimed at generating an in-frame gene deletion mutant 
of MSMEG_5789 in M. smegmatis. The TST gene was replaced with hygromycin-resistance 
cassette in the knockout mutant. The mutant was then exposed to various stress conditions, and 
tested for cysteine dependence to understand the role of TST in M. smegmatis. 
 
4.2 Materials and Methods 
4.2.1 Bacteria, media and growth conditions. Mycobacterium smegmatis mc2 155(ATCC® 
700084TM) [1] was grown at 37°C with shaking at 150 rpm in Middlebrook 7H9 broth [27]. The 
Middlebrook 7H9 broth (Difco) was supplemented with 10% albumin-dextrose catalase (ADC) 
growth supplement (HIMEDIA), 0.2% (v/v) glycerol and 0.05% (v/v) Tween 80. For growth on 
solid medium, Middlebrook 7H10 (Difco) medium supplemented with 10% (ADC) and 0.5% 
glycerol was used. Antibiotics were added to the media as required: kanamycin (25 µg/ml) or 
hygromycin (150 µg/ml). Tryptic soy agar (Difco) was used for growth on solid medium for disk 
diffusion assays. Tryptic soy broth (Difco) was supplemented with Tween 80 (0.05%) when used 
for growth analysis. For analysis of growth in different sulfur sources, bacteria were grown in 
minimal M9 medium containing M9 salts (Difco) (1X), Tween 80 (0.05%), glycerol (0.5%), 
MgCl2 (1 mM), CaCl2 (0.1 mM) and a specific sulfur source. The following sulfur sources were 




µM). Escherichia coli was grown in Luria-Bertani medium [28] containing selective antibiotics, 
kanamycin or hygromycin (50 µg/ml) at 37ºC with shaking at 250 rpm. Growth was monitored 
using optical density at 600 nm (OD600).  
 
4.2.2 Plasmids. Plasmid pYUB28b was a gift from Ted Baker (Addgene plasmid # 37277). It is 
a 4921 bp shuttle vector between Mycobacteria and E. coli, that was used in this study to isolate 
hygromycin resistance cassette [29]. The plasmid was supplied in E. coli TOP10 strain. The cells 
containing pYUB28b were grown overnight in LB medium supplemented with hygromycin. 
Plasmid pYUB28b was isolated after overnight growth using QIAprep Spin Miniprep kit 
(Qiagen) and was quantified using Qubit dsDNA BR Assay kit and Qubit 2.0 Fluorometer (Life 
Technologies). Plasmid pJV53 was a gift from Graham Hatfull (Addgene plasmid # 26904). The 
plasmid contains the mycobacteriophage Che9c gp60 and gp61 recombinase genes fused to an 
inducible acetamidase promoter [30]. The expression of recombinases through acetamide 
induction in M. smegmatis was used for allelic exchange of MSMEG_5789 with hygromycin 
resistance gene. The plasmid pJV53 (8812 bp) was supplied in E. coli DH5a strain. The cells 
containing pJV53 were grown overnight in LB medium supplemented with kanamycin. Plasmid 
was isolated after overnight growth using QIAprep Spin Miniprep kit (Qiagen) and was 
quantified using Qubit dsDNA BR Assay kit and Qubit 2.0 Fluorometer (Life Technologies). 
 
4.2.3 DNA extraction. Genomic DNA from M. smegmatis was isolated using DNeasy Plant 
Mini kit (Qiagen). Briefly, 5ml overnight grown culture of M. smegmatis was harvested by 
centrifugation at 10,000 rpm for 15 minutes. The cell pellet was frozen in liquid nitrogen and cell 




DNA was further isolated in 200µl AE buffer including treatment with 4µl RNase stock solution 
(100 mg/ml) as per manufacturer’s instructions. DNA obtained was quantified using Qubit 
dsDNA BR Assay kit and Qubit 2.0 Fluorometer (Life Technologies).  
 
4.2.4 Polymerase chain reaction (PCR) conditions and primers. PCR amplifications were 
performed using Taq DNA Polymerase with Standard Taq Buffer (New England Biolabs). The 
standard 50µl PCR reaction consisted of Standard Taq reaction buffer (1X), dNTPs (200µM), 
forward and reverse primer (0.2 µM each), template DNA (1-10 ng) and Taq DNA Polymerase 
(2.5 units). In addition, dimethyl sulfoxide (DMSO) at 5% and betaine at 1M final concentration 
were added to the PCR mix. DMSO and betaine are widely used chemical agents that help in 
decreasing secondary structure formation and minimizing high Tm during PCR amplification of 
G+C-rich sequences [31]. Standard PCR amplifications were carried out as follows: initial 
denaturation at 95ºC (30 seconds), 30 cycles of denaturation (95ºC, 30 seconds), annealing (47-
68ºC, 30 seconds), extension (68ºC, 1 minute/kb), and final extension at 68ºC for 5 minutes. The 
sequences of primers used in the study are provided in Table 2. Sequences of genes of interest in 
M. smegmatis were obtained from NCBI [32]. Sequence of pYUB28b was obtained from 
Addgene. Primers were designed using OligoPerfect™ Designer (ThermoFisher Scientific). 
Primer properties including melting temperature, hairpins or dimers formation were analyzed 
using OligoAnalyzer® Tool (Integrated DNA Technologies).  
 
For Overlap PCR, primers were designed to contain 10-20 bp identity with the sequence of 
interest to be fused. Overlap PCR is a method in which two DNA sequences are fused together in 




real-time PCR (RT-PCR) was carried out using QuantiFast® SYBR® Green PCR kit (Qiagen) 
and BioRad CFX96 Real-Time System. The 25 µl reaction mix consisted of QuantiFast SYBR 
Green PCR Master Mix (1x), forward and reverse primer (0.3 µM each), and template DNA 
(variable). Real-time cycler conditions included a PCR initial activation step at 95°C for 5 
minutes, followed by 35 cycles of amplification (95°C, 10 seconds and 60°C, 30 seconds). 
 
4.2.5 Generation of the UHD construct. A 594 bp fragment upstream and a 581 bp fragment 
downstream of the thiosulfate sulfurtransferase encoding gene, MSMEG_5789 (NC_008596.1 
[5859664..5860497]) were amplified from M. smegmatis genomic DNA. A 1130 bp region 
containing the hygromycin resistance gene cassette (hygR) was amplified from plasmid 
pYUB28b. The resulting amplified fragments contained 10-20 bp sequence identity with the 
fragment to be fused. Fusion of the three PCR products (i.e. upstream fragment, hygR gene and 
downstream fragment) was carried out using Overlap PCR technique in two steps (Figure 1). In 
step 1, either the M. smegmatis upstream (U) region or downstream (D) was fused with hygR (H) 
gene cassette to generate a ‘UH’ or ‘HD’ fusion product using PCR. The above overlap PCR 
reactions included a total of 300 ng DNA template, which included U/D and H DNA in a 1:3 
ratio.  PCR amplifications were carried out as follows: initial denaturation at 95ºC (30 seconds), 
30 cycles of amplification, and final extension at 68ºC for 5 minutes. The first 15 cycles of 
amplification were carried out without any primers and annealing temperature (Ta) set at 68ºC. 
In these cycles, common region among genes to be fused served as a primer. After 15 cycles, 5’ 
and 3’ end primers were added, and amplification was performed with Ta set at 47ºC. In step 2, 
the UH and HD gene products were used as a template to generate UHD construct in similar 




The fused UHD gene product was reamplified using primers internal to the edges of the UHD 
product to generate 127 bp shorter iUHD product. The re-amplification was carried out using 
standard PCR amplification with annealing at 48ºC. Before their use in the next step, all 
amplified fragments were analyzed using agarose gel electrophoresis. The DNA fragments were 
then excised from agarose gels and purified using QIAquick gel extraction kit (Qiagen).  Purified 
DNA fragments were quantified using Qubit dsDNA BR Assay kit and Qubit 2.0 Fluorometer 
(Life Technologies). 
 
4.2.6 Preparation of electrocompetent cells and transformation. Electrocompetent M. 
smegmatis were prepared as described previously [34]. The bacterial culture was inoculated into 
500 ml of Middlebrook 7H9 media and grown to an OD600 of 0.6. The cells were incubated on 
ice for 1.5 hours and harvested by centrifugation at 10,000 rpm for 15 minutes at 4ºC. The cell 
pellet was resuspended in equal volume of ice-cold 10% glycerol. A total of three washes were 
performed in ice-cold 10% glycerol. The cell pellet was resuspended to a final volume of 1 ml in 
ice-cold 10% glycerol and 100 µl aliquots were prepared in 1.5 ml tubes. The tubes were frozen 
in dry ice/ethanol and stored at -80°C until use.  
 
Transformation was performed by gently mixing 200 µl electrocompetent M. smegmatis cells 
with 660 ng of purified pJV53 plasmid DNA. The mixture was incubated on ice for 10 minutes. 
Electroporation was carried out using Gene Pulser Xcell™ Electroporation System (Bio-Rad) 
and pre-chilled 0.2 cm electrode gap cuvette. The mixture was electroporated at 2.5 KV, 25 µF 
and 800 Ω. After electroporation cells were recovered in 2 ml Middlebrook 7H9 media at 37ºC 




minutes at 37°C. Cell pellet was resuspended in 200 µl Middlebrook 7H9 media and plated on 
Middlebrook 7H10 media supplemented with kanamycin (25 µg/ml). After 3 days of growth on 
plates, kanamycin resistant colonies were selected. The colonies were resuspended in 
Middlebrook 7H9 media containing kanamycin. These M. smegmatis cells containing pJV53 
cells were labelled as M53 cells. 
 
M53 cells were then induced using acetamide to express Che9c gp60 and gp61 recombinases 
from plasmid pJV53. Electrocompetent M53 cells expressing recombinases were prepared as 
described previously [30]. A saturated bacterial culture of M53 cells was inoculated into 100 ml 
of Middlebrook 7H9 media containing 0.2% succinate, 1mM calcium chloride and 25 µg/ml 
kanamycin at OD600 0.020. The cells were incubated at 37ºC and 150 rpm till an OD600 of 0.400 
was achieved. At this point, acetamide was added to a final concentration of 0.2% followed by 
incubation for 3 hours to allow induction of Che9c gp60 and gp61 recombinases. After 3 hours, 
cells were incubated on ice for 2 hours and harvested by centrifugation at 10,000 rpm for 15 
minutes at 4ºC. Electrocompetent cells were prepared as described above, but with total of 4 
washes with ice-cold 10% glycerol. The cells were resuspended to a final volume of 4 ml in ice-
cold 10% glycerol (1/25th of original volume) and 100 µl aliquots were prepared in 1.5 ml tubes. 
The tubes were frozen in dry ice/ethanol and stored at -80°C until use. These acetamide induced 
M53 cells was labelled as M53I. 
 
4.2.7. Deletion of the chromosomal MSMEG_5789 gene in M. smegmatis. Electrocompetent 
cells expressing mycobacteriophage Che9c gp60 and gp61 recombinase genes from pJV53 




carried out as described above. The mixture of 110 µl cells (M53I) and 1.5 µg iUHD DNA was 
incubated on ice for 10 minutes. Electroporation was carried out at 2.5 KV, 25 µF and 800 Ω. 
After electroporation cells were recovered in 4 ml Middlebrook 7H9 media at 37 ºC and 150 rpm 
for 4 hours. Cells were plated on Middlebrook 7H10 media supplemented with hygromycin (150 
µg/ml). After 3 days of growth on plates, hygromycin resistant colonies were selected. The 
colonies were resuspended in Middlebrook 7H9 media containing hygromycin. Overnight grown 
cultures were analyzed for replacement of MSMEG_5789 with hygR through colony PCR using 
quantitative real time-PCR (RT-PCR). Genomic DNA was isolated from MsmegΔTST as 
described earlier, and was verified for replacement of MSMEG_5789 with hygR using PCR. The 
genomic DNA from wild type M. smegmatis mc2155 was used as control. The PCR products 
obtained were further sequenced to confirm the replacement of MSMEG_5789 with hygR.  
 
4.2.8 Colony PCR. A 50 µl of culture was centrifuged at 15,000 rpm for 10 minutes. The 
supernatant was discarded, and cell pellet were kept at -80 ˚C for 5 minutes. The pellet was 
resuspended in 0.001% Triton-X and incubated in 100°C water bath for 15 minutes. This was 
followed by centrifugation at 15,000 rpm for 10 minutes to separate the supernatant from the cell 
debris. 5 µl supernatant was used as template for PCR analysis. 
 
4.2.9 Glycerol stocks of cultures. Glycerol stocks of all bacterial cultures used were prepared 
for their long-term storage. Typically, 500 µl overnight grown culture was mixed with 500 µl of 
40% sterile glycerol and transferred to 2 ml cryo-vial. The vial was snap chilled in liquid 





4.2.10 Disk diffusion assay. The sensitivity of wild type M. smegmatis and MsmegΔTST to 
various antimicrobial compounds was determined by disk diffusion assays [35]. Wild type M. 
smegmatis and MsmegΔTST were grown to an OD600 of 0.3 and plated on TSA plates using 
sterile cotton swabs. Sterile filter paper disks (8 mm) were saturated with 20 µl antimicrobial 
compound to be tested and allowed to air dry. The following compounds were tested for disk 
diffusion assay: sodium dodecyl sulfate (SDS) (10%), formaldehyde (10%), dithiothreitol (DTT) 
(2 M), hydrogen peroxide (H2O2) (1 M), chloramphenicol (32 mg/ml), phenolic acid mixture 
(equal proportions of hydroxybenzoic acid, vanillic acid, coumaric acid, syringic acid, ferulic 
acid) (0.5 M), 4-hydroxybenzoic acid (HA) (2 M), nalidixic acid (50 mg/ml), rifampicin (50 
mg/ml), 2-mercaptoethanol (2 M) and hygromycin (100 mg/ml). Air dried filter paper disks were 
placed on culture plates and incubated at 37°C for two to three days. The diameter of zone of 
inhibition (mm) was recorded for each compound.  
 
4.2.11 Spot assay. The effect of four different compounds on wild type M. smegmatis and 
MsmegΔTST was analyzed using spot assays. Wild type M. smegmatis or MsmegΔTST were 
grown in M9 media containing MgSO4 to an OD600 of 0.4. A total of 100 µl volume in each well 
of 96-well plates, contained 99 µl cell cultures and  0-1 µl of compound to be tested (final 
volume made to 100 µl using sterile water). The following compounds were tested: SDS (0.00, 
0.01, 0.02, 0.05, 0.10%), formaldehyde (0.00, 0.01, 0.02, 0.05, 0.10%), diamide (0, 20, 40, 60, 
80 mM), H2O2 (0.0, 2.5, 5.0, 7.5, 10.0 mM). The 96-well plates containing diamide were 
incubated in dark for 6 hours at 37°C. The 96-well plates containing H2O2, SDS and 
formaldehyde were incubated for 3 hours at 37°C. After incubation, ten-fold dilutions of each 




on TSA plates. The plates were incubated at 37°C for 1-2 days and growth was observed. 
 
4.2.12 Survival under aerobic and microaerophilic conditions. The role of TST during 
survival under oxygen limitation conditions was analyzed. Wild type M. smegmatis or 
MsmegΔTST were grown in M9 media containing MgSO4 to an OD600 of 0.3. Cultures were 
inoculated into fresh media at 1:1000 dilution. Three different types of media were used for 
growth analysis i.e. Middlebrook 7H9 media, M9 media containing MgSO4 (1 mM) as a sulfur 
source, M9 media containing cysteine (100 µM) as a sulfur source. After inoculations, 1 ml 
culture was used for measurement of OD600 at 0 hours. Oxygen limitation was induced as 
described previously with modifications [36]. A 10 ml culture was incubated in 15 ml screw-
capped tubes (head to space ratio of 0.5). The screw-caps were tightly secured and tubes were 
incubated for 24 days at 37˚C without agitation. After incubation, culture tubes were vortexed 
vigorously for 2 hours to allow for breakage of clumps. The OD600 was measured using 1 ml 
culture. For growth under aerobic conditions, 4 ml culture was incubated in 50 ml tubes and 
incubated at 37˚C with shaking at 150 rpm for 48 hours. The OD600 was measured using 1 ml 
culture. 
 
4.2.13 Growth in presence of different sulfur sources. Growth of MsmegΔTST in the presence 
of different sulfur sources was observed. Starter cultures of wild type M. smegmatis or 
MsmegΔTST were grown in Middlebrook 7H9 media without and with hygromycin respectively 
to an OD600 of 1.2. Cultures were pelleted by centrifugation at 21,000 g and supernatant was 
discarded. The pellets were resuspended in equal volume of 1x M9 salts containing 0.05% 




salts containing 0.05% Tween 80. Resuspended cultures were inoculated into 10 ml fresh media 
at 1:500 dilution. The media contained either MgSO4, Na2SO3, Na2S, Na2S2O3 or cysteine as the 
sole sulfur source. Cultures were grown in 50 ml tubes under aerobic conditions at 37ºC and 
shaking at 150 rpm. Growth was monitored for 72 hours at regular intervals by measuring OD600 
using 1 ml culture. To observe growth under microaerophilic conditions, cultures prepared in the 
same way were grown in glass vials secured with rubber caps and sealed with aluminum caps. A 
2 ml culture was added to each 3 ml glass vial, to maintain a head-to-space ratio of 0.5. The vials 
also contained sterile magnetic stir bars (8x1-1.2 mm) to allow for agitation to prevent cell 
clumping. Growth was monitored every day for a total of 6 days by measuring OD600 using 1 ml 
culture. The cultures were passed through 27 mm gauge needle 7 times to disperse cell clumps 
before measuring OD600. 
 
4.2.14 Murine macrophage mycobacterial infection. Macrophage infection with mycobacteria 
was carried out as described previously with modifications [37]. Single-cell suspension of 
murine mononuclear macrophage cell line were seeded at 105 cells /ml in RPMI (Roswell Park 
Memorial Institute) medium containing 10% FBS (fetal bovine serum) and 1X Antibiotic-
Antimycotic solution (Gibco). The cultures were maintained in 24-well plates at 500 µl/well. 
Cells were passaged at 1:10 dilution and maintained till 70-80% confluency was achieved. One 
day prior to culturing with mycobacteria, the macrophage cells were washed three times with 
PBS (phosphate buffered saline) and cultured in media without antibiotics. 
 
Wild type M. smegmatis and MsmegΔTST strains were grown overnight in Middlebrook 7H9 




prepared to determine colony forming units/ml (CFU/ml). Mycobacteria at 3*106 cells/ml were 
added to each well containing 3*105 cells/ml macrophages without antibiotic to achieve a 
multiplicity of infection (MOI) of 10:1 (bacteria per macrophage). The co-cultures were 
incubated at 37ºC in 0.5% CO2 for 6 hours to allow phagocytosis of mycobacteria by 
macrophages. After 6 hours, phagocytosis was stopped and extracellular bacteria were removed 
by washing two times in ice-cold PBS. The macrophages were further incubated in fresh media 
containing gentamicin (50 µg/ml) to inhibit the growth of extracellular bacteria. Macrophages 
were harvested at various time points (6, 24, 48 and 72 hours) and lysed with ice-cold water to 
determine the number of surviving mycobacteria in infected macrophages. Ten-fold serial 
dilutions of the lysates were prepared in TSB and 100 µl each dilution was plated on TSA plates. 
After 3 days of incubation, colonies were counted and CFU/ml were determined. 
 
4.3 Results 
4.3.1 UHD construct generation. All PCR amplified products that were obtained and further 
used for the generation of the UHD construct are shown in the agarose gel (Fig. 2). A 594 bp 
upstream (U) and 581 bp downstream (D) sequence of MSMEG_5789 were amplified using PCR 
and the M. smegmatis genomic DNA template. Gene cassette encoding for hygromycin 
resistance, hygR (H) was amplified from plasmid pYUB28b [29]. The U and D products were 
fused separately with the H product using overlap PCR to generate a 1690 bp UH and a 1686 bp 
HD constructs, respectively. The 2246 bp UHD construct was generated by fusing UH and HD 
products using PCR (Fig. 2). To generate more UHD DNA for downstream experiments, the 
UHD construct was further amplified using internal primers and the resulting linear DNA 




pJV53 [30].  
 
4.3.2 Deletion of the chromosomal MSMEG_5789 gene in M. smegmatis. The transformation 
of acetamide-induced pJV53 containing M. smegmatis cells (M53I) with iUHD construct yielded 
four colonies after 3 days of growth on plates containing 150 µg/ml hygromycin. The colonies 
were labelled as MsmegΔTST, MsmegΔTST2, MsmegΔTST3, MsmegΔTST4 and analyzed for 
presence of hygR and deletion of MSMEG_5789 using RT-PCR. The genomic DNA from 
MsmegΔTST and wild type M. smegmatis were analyzed using PCR for further verification of 
for replacement of MSMEG_5789 with hygR. PCR products obtained after amplification using 
different combination of primers (Table 3) confirmed the presence of hygR and absence of 
MSMEG_5789 in the genomic DNA of MsmegΔTST (Fig. 3). The same combination of primers 
confirmed the absence of hygR and presence of MSMEG_5789 in the genomic DNA of wild type 
M. smegmatis (Fig. 3). 
 
4.3.3 Disc diffusion assay. Disc diffusion assays were used to test the sensitivity of wild type M. 
smegmatis or MsmegΔTST to various antimicrobial compounds. The zone of inhibition was 
measured in mm. It was observed that MsmegΔTST was significantly more sensitive than its 
parent strain to formaldehyde, DTT, hydrogen peroxide and PA (Fig. 4). MsmegΔTST was 
slightly more sensitive to SDS and 2-mercaptoethanol. On the contrary, the wild type strain was 
more sensitive than MsmegΔTST to HA, however the difference was not significant. In addition, 
no significant difference between the sensitivities of the wild type strain and MsmegΔTST was 
observed upon exposure to antibiotics chloramphenicol, nalidixic acid and rifampicin (Fig. 4). 




highly sensitive to hygromycin, while the MsmegΔTST was resistant to hygromycin due to the 
presence of hygR gene inserted in place of the TST gene in the chromosome. 
 
4.3.4 Spot assay. Spot assays were employed to analyze the antimicrobial effect of four different 
compounds on MsmegΔTST compared to the wild type M. smegmatis. The four compounds 
tested included: SDS, formaldehyde, diamide and hydrogen peroxide. The size of the spot 
indicated qualitative differences in growth of the two strains in different treatments. In case of 
SDS, there was no difference in spot size among the two strains at 0.01%. However, the 
MsmegΔTST showed lesser growth compared to wild type when exposed to SDS at 0.02, 0.05 
and 0.1% concentration. The growth difference increased with increasing SDS concentrations 
(Fig. 5A). Similar effect was observed with formaldehyde. There was no significant difference in 
spot size among the two strains at 0.01 and 0.02% formaldehyde. However, the MsmegΔTST 
showed lesser growth compared to wild type at 0.05 and 0.1% formaldehyde concentration (Fig. 
5B). No decrease in growth in either wild type or MsmegΔTST strain was observed after 
exposure to diamide or H2O2 (Fig. 5C, 5D).  
 
4.3.5 Survival under aerobic and microaerophilic conditions. Under microaerophilic 
conditions, there was a significant decrease in growth of MsmegΔTST compared to wild type 
when MgSO4 was used as a sole sulfur source (Fig. 6). However, when cysteine was used as a 
sulfur source, MsmegΔTST grew equally well as the wild type strain. These data indicated that 
TST may play a role in the synthesis of cysteine from inorganic sulfate during microaerophilic 
conditions since the MsmegΔTST strains lacking the TST could not efficiently utilize MgSO4 as 




compared to wild type in Middlebrook 7H9 media under microaerophilic conditions. Under 
aerobic conditions, MsmegΔTST strain grew equally well as the wild type strain on M9 minimal 
media. The deletion of TST did not seem to have an effect on the organism’s ability to utilize 
MgSO4 or cysteine as a sole sulfur source under aerobic conditions (Fig. 7). There was slight 
increase in growth observed in MsmegΔTST compared to wild type in Middlebrook 7H9 media, 
however, the difference in the growth was not significant.  
 
4.3.6 Growth in presence of different sulfur sources. Growth of MsmegΔTST in M9 minimal 
media containing either MgSO4, Na2SO3, Na2S, Na2S2O3 or cysteine as the sole sulfur source 
was observed under aerobic condition. There was no significant difference observed in the 
growth pattern of MsmegΔTST compared to wild type in the presence of different sulfur sources 
(Fig. 8). The deletion of TST did not seem to have significant effect on the ability of the 
organism to utilize different sulfur sources for growth under aerobic conditions. We could not 
conclude results on the preference of sulfur sources under microaerophilic conditions, due to 
variations among replicates and tube to tube variations among different growth points. 
 
4.3.7 Murine macrophage mycobacterial infection. The number of surviving phagocytosed 
mycobacteria in macrophages was calculated at 24, 48 and 72 hours. Both wild type and 
MsmegΔTST survival decreased at 24 and 48 hours. At 72 hours, an increase in the number of 
phagocytosed mycobacteria was observed possibly due to macrophage cell death (Fig. 9A). The 
number of surviving wild type mycobacteria was 2-fold lesser than MsmegΔTST at 24 hours, 
however, there was no significant difference in CFU/ml of both strains at 48 hours (Fig. 9B). The 




(the mycobacteria were allowed to be phagocytosed by macrophages for first 6 hours of co-
culturing). There was no significant difference in percent survival among M. smegmatis or 
MsmegΔTST strain (Fig. 9C). 
 
4.4 Discussion 
TST gene deletion in M. smegmatis was carried out using a process called recombineering [30]. 
van Kessel and Hatfull (2007) reported the development of a gene replacement strategy in 
mycobacteria using a Rec-ET like enzyme system from mycobacteriophage Che9c [30]. 
Mycobacteriophage Che9c proteins gp60 and gp61 were reported to show exonuclease and DNA 
binding activity, respectively, that facilitated allelic exchange in both fast growing M. smegmatis 
and slow growing M. tuberculosis. The authors constructed pJV53 plasmid containing Che9c 
gp60 and gp61 fused to an inducible acetamidase promoter to allow for controlled expression of 
phage recombinases in the host. This plasmid was used in our study to facilitate the replacement 
of MSMEG_5789 (TST) with hygromycin resistance gene cassette (hygR) in M. smegmatis. The 
linear gene construct for replacement was constructed as described by Mao et al., (2016) with 
modifications [38]. In-frame deletion of TST was carried out by fusing homologous arms of the 
target gene to hygR. Electroporation of the resulting linear construct into M. smegmatis 
expressing the phage recombinases yielded hygromycin resistant colonies indicating allelic 
exchange of hygR for TST.  
 
The three gene fragments of interest i.e. upstream region of MSMEG_5789 (U), hygromycin 
resistance gene cassette (hygR) and downstream region of MSMEG_5789 (D) were fused using 




product. Firstly, the primers for PCR amplification were designed to have Tm around 55°C. The 
primers containing the overlapping extension from the neighboring gene, however, had higher 
Tm due to longer length and high G+C content of the sequences to be fused. Secondly, addition 
of DMSO (5%) and betaine (1M) to the reaction mixture increased PCR product yields. Thirdly, 
the first 15 cycles of amplification were carried out without any primers. The common region 
among two genes to be fused served as a primer. After 15 cycles, end primers were added and 
amplification of fused gene products was carried out. The addition of end primers to the reaction 
mix in the beginning of reaction yielded poor results. In addition, the three genes were fused in 
two steps: firstly, U or D were fused to H, yielding UH and HD; secondly, UH and HD were 
fused together to generate UHD where the entire hygR region served as an overlap template. 
Amplification reactions where all three genes were simultaneously added to the reaction mixture 
for fusion, resulted in poor yields in our case. It was also observed that for fusion, having the 
genes in 1:3, 1:5 or 1:7 ratio yielded more fusion product compared to 1:1 ratio. For all fusion 
PCRs, 1:3 ratio of genes was used as similar yields were obtained with 1:5 and 1:7 ratio.  
 
Disc diffusion assay was employed to analyze the phenotypic differences between wild type and 
MsmegΔTST. The sensitivity to multiple antimicrobial compounds was tested. We observed that 
the deletion of TST gene resulted in increased sensitivity of the organism to formaldehyde, DTT, 
hydrogen peroxide, 2-mercaptoethanol, SDS and PAs. Exposure to formaldehyde discs resulted 
in the most significant difference among sensitivity between wild type and MsmegΔTST. 
Formaldehyde, despite its simple structure, is highly toxic to microorganisms because of its 
electrophilic nature [39]. Most microorganisms, especially bacterial pathogens, employ a thiol-




detoxification system to render it into non-toxic formate or carbon dioxide [40-42]. It has 
previously been observed in M. smegmatis, that oxidation of formaldehyde results in the 
formation of formate and MSH and vice-versa [43]. Cellular cysteine pools are important for 
generation of mycothiol in mycobacteria. We hypothesize that the possible role of TST in 
cysteine generation, might be the reason for the inability of MsmegΔTST mutants to detoxify 
formaldehyde, resulting in increased sensitivity after exposure compared to wild type strain. 
Similar results were obtained with spot assays, wherein, formaldehyde exposure led to lesser 
growth of MsmegΔTST compared to wild type at concentrations as low as 0.05%. These results 
suggest a possible role of TSTs in maintaining cysteine and mycothiol pools in cells, that help in 
detoxification of toxic electrophilic compounds.  
 
Due to the presence of rhodanese domain, TSTs have been predicted to have a role in 
maintaining redox balance of cells. In Azotobacter vinelandii, a rhodanese domain containing 
protein, RhdA, was found to participate in redox reactions using its cysteine thiol to maintain 
cellular redox balance [26, 44]. The RhdA deletion mutants were found to have lower reduced 
glutathione levels compared to wild type strain. We tested the effect of few oxidizing and 
reducing agents on cells lacking TST. SDS, 2-mercaptoethanol and DTT are commonly used 
reducing agents used for the reduction of disulfide bonds and other disulfides. At higher 
concentrations these agents reduce the cysteine residues on proteins, prevent disulfide bond 
within or among different protein molecules, possibly hampering cellular functions. 
 
DTT exhibits low oxidation-reduction potential, that ensures quantitative reduction of disulfides 




resulting in the formation of a sulfide and oxidized DTT [46]. We observed that cells lacking 
TST were more sensitive to DTT as compared to the wild type strain. Another reducing agent 
tested, 2-mercaptoethanol, also has strong reducing properties, and is used when complete 
disulfide reduction is required [47]. This might be the reason for increased sensitivity of 
MsmegΔTST to 2-mercaptoethanol compared to DTT. The MsmegΔTST was also found to be 
slightly more sensitive to SDS compared to wild type. The sulfhydryl groups on TST enzyme are 
converted into disulfide during denaturation induced by SDS in a reversible reaction [48]. The 
engagement of SDS by these enzymes might be a mechanism to protect the other cellular 
proteins from denaturation.  
 
There are numerous reports of TST upregulation under oxidative stress conditions. Our previous 
studies indicated that TST aids in protection from stress, through its role in the generation of 
cysteine. In A. cellulolyticus, the addition of cysteine alleviated the upregulation of TST in 
response to stress induced by hydroxybenzoic acid (see Chapter 2). Cysteine is an important 
component of sulfur metabolism, which along with rhodanese has been proposed to serve as an 
anti-oxidative stress system [49]. Voss et al., (2011) observed that a mycobacterial 
molybdopterin biosynthesis protein, MoeZR, showed thiosulfate:sulfurtransferase activity and 
was involved in cysteine biosynthesis in a pathway involving a sulfur carrier protein, CysO and a 
cysteine synthase, CysM [19]. It has been previously observed that the expression of MoeZR is 
upregulated along with the expression of CysO and CysM under oxidative stress conditions [50]. 
We exposed MsmegΔTST to 1 M H2O2 in a disk diffusion assay. The deletion of TST in these 
cells resulted in increased sensitivity to hydrogen peroxide. This observation correlates with the 




paralog, MSMEG_1809 and the corresponding mutant in M. tuberculosis (Rv3283) were found to 
show increased sensitivity to oxidative stressors tert-butyl-hydroperoxide and cumene 
hydroperoxide [51]. In their study, TST was shown to form a membrane-associated 
oxidoreductase complex (MRC) along with superoxide-detoxifying enzyme (SodA) and an 
integral membrane protein (DoxX), and relieve oxidative stress by maintaining thiol homeostasis 
[51]. The authors, however, did not observe any toxicity of either the wild type or the mutants 
with hydrogen peroxide. The toxic effects in their study were analyzed at 1 mM H2O2 
concentration, which is 10 times lower than what we used for the disc assays. Similar to their 
observations, we also did not observe any toxicity when H2O2 was used at concentrations 2.5-10 
mM in spot assays. Possibly, the presence of multiple TST homologs compensates for the 
deletion of one TST homolog during H2O2 induced oxidative stress. The toxic effect increases at 
higher concentration, which might not be completely compensated by the other homologs, 
resulting in increased sensitivity. Since the predicted function TST in maintaining cellular redox 
balance is through thiol recycling, we looked at the effect of thiol-specific oxidant, diamide. The 
MsmegΔTST were exposed to 20-80 mM diamide for 6 hours. We did not observe any toxicity 
to diamide in either wild type or the deletion strain.  
 
Phenolic acids are small aromatic compounds that have been shown to trigger oxidative stress 
response in microorganisms at high concentrations [52]. Our disc diffusion assays showed that 
PA mixture was significantly more toxic to MsmegΔTST compared to wild type strain. These 
results are in agreement with the previous results, where E. coli cells overexpressing A. 
cellulolyticus TST were significantly less sensitive to PA mixture compared to wild type (see 




MsmegΔTST strain was less sensitive to HA, compared to wild type. HA derivatives have been 
predicted to play a different role in mycobacteria. These have been shown to be secreted by M. 
tuberculosis during infection and have the ability to suppress the pro-inflammatory response to 
infection [53, 54].  
 
We looked at the toxic effects of three commonly used antibiotics: chloramphenicol, nalidixic 
acid and rifampicin on MsmegΔTST. Chloramphenicol is an inhibitor of protein synthesis in M. 
tuberculosis [55]. We did not observe any significant differences on the toxicity of 
chloramphenicol to wild type or MsmegΔTST. Nalidixic acid is a selective inhibitor of DNA 
synthesis and is shown to result in decreased the DNA/protein ratio in M. smegmatis [56]. 
Rifampicin blocks the DNA-dependent RNA polymerase in M. smegmatis, blocking the 
initiation of RNA chain synthesis [57]. We observed that MsmegΔTST was slightly more 
sensitive compared to wild type strain, when exposed to either nalidixic acid or rifampicin, 
however, the difference in sensitivity was not significant. Analysis of global protein levels of a 
clinical isogenic pair of Beijing genotype M. tuberculosis revealed that TST (Rv3283) was less 
abundant in cells that acquired multi-drug resistance (MDR) to isoniazid and rifampicin [58]. 
However, it was previously shown that another TST homolog (Rv0815c) was present in both 
intracellular MDR and sensitive isolates and was proposed as potential drug target against drug-
resistant and sensitive M. tuberculosis [16]. We did not observe high sensitivity to rifampicin as 
expected. It is possible that the presence of its paralog MSMEG_1809 compensates for the 
deletion of MSMEG_5789 in these cells. Hygromycin B, was used as a control in our disc 
diffusion assay. Hygromycin is widely used in mycobacteria as a selectable marker and inhibits 




MSMEG_5789 with hygR in MsmegΔTST resulted in no zone inhibition with hygromycin, while 
the wild type strain was found to be highly sensitive to hygromycin. 
 
A study with M. avium subsp. paratuberculosis showed that TST was one of the 10 proteins 
whose expression was upregulated during infection [61]. TST has been predicted to be important 
in intracellular survival of drug resistant/sensitive M. tuberculosis [16]. The intracellular 
environment of granuloma is characterized by an acidic pH, the presence of toxic fatty acids, and 
the low availability of oxygen [62]. We investigated the involvement of TST during survival in 
low availability of oxygen. In addition, we tested whether TST aids in alleviating hypoxic stress 
through generation of cysteine under such conditions. We observed that when MgSO4 was used 
as the sole sulfur source, the growth was significantly decreased in MsmegΔTST compared to 
wild type under microaerophilic conditions. However, in the presence of cysteine, the growth of 
MsmegΔTST under microaerophilic conditions was comparable to that of wild type. Under 
aerobic conditions, there was no effect of deletion of MSMEG_5789 during growth in any of the 
growth medium.  
 
Florczyk et al., (2001) previously reported that the amount of the two putative TSTs, CysA2 and 
CysA3 (Rv0815c and Rv3117, respectively) were approximately six-fold greater in standing 
culture conditions than under shaking culture conditions [8]. Their data suggest that TST is 
important for survival under stress induced by low availability of oxygen [8]. The possible 
mechanism by which TST helps in alleviating such stress is by being either directly or indirectly 
involved in generation of cysteine, a precurser for antioxidant redox molecules such as 




Actinomycete Gordonia polyisoprenivorans VH2, wherein, the transcription level of TST was 
predicted to slightly decrease with increase in cysteine concentration [64]. It has been shown that 
there is a significant increase in reactive oxygen species along with a significant decrease in 
glutathione peroxidase, glutathione reductase and reduced glutathione levels in the neuronal 
hippocampal cells exposed to hypoxia [63]. N-acetyl cysteine, a precurser for the formation of 
glutathione, has been shown to have a protective effect on the such hypoxia-induced cytotoxicity 
[63].  
 
We hypothesized that TST might be involved in cysteine biosynthesis in a sulfur reduction [65]. 
We grew the MsmegΔTST in presence of different sulfur sources including sulfate, sulfite, 
sulfide, thiosulfate and cysteine. Under aerobic growth conditions, we did not observe any 
significant differences in the growth of MsmegΔTST compared to wild type on various sulfur 
sources (Fig. 8). These results were similar to our previous observations (Fig. 7). It was expected 
that a clear phenotypic difference based on the preference for sole sulfur source might be 
observed during growth under microaerophilic conditions. However, there were tube to tube 
variations among replicates and the results could not be concluded. This could be attributed to 
the possibility that consistent microaerophilic conditions were not maintained in these tubes due 
to the possible entry of oxygen through the puncture in the rubber stopper caused by needle used 
to add cultures to these tubes. Our studies with mycobacterial macrophage infections did not 
yield significant conclusions (Fig. 9). It is possible that an MOI of 10:1 used was high, resulting 
in increased survival for both strains. The high number of cells might have masked the 
significant differences in survival among the two strains. In order to avoid achieving high cell 




did not obtain any growth of bacteria at all. So the effect of deletion of TST on survival in 







Table 1. Percent (%) identity among different thiosulfate sulfurtransferase homologs based on 
blastx 
Locus tag 












Mtb  Rv0815c 88 49 26 74 28 29 - 
 Rv3117 88 49 26 74 28 29 - 
 Rv3283 50 84 - 52 33 28 - 
 Rv2291 26 27 63 28 39 33 27 
 
 
Table 2. List of primers used in the study. 




















Table 3. List of primer sets used in the study. 
Primer set Product description Product length (bp) 
U1/U2 Upstream region of MSMEG_5789 with 15 bp 
sequence identity to hygR at 3' end (U) 
594 
D1/D2 Downstream region of MSMEG_5789 with 11 bp 
sequence identity to hygR at 5' end (D)  
581 
H1/H2 hygR with 19 bp sequence identity to U at 5' end, 
and 14 bp sequence identity to D at 3' end (H) 
1130 
U1/UH2 Upstream region of MSMEG_5789 fused to hygR 
with 16 bp sequence identity to D at 3' end (UH) 
1690 
HD1/D2 hygR fused to downstream region of MSMEG_5789 
with 19 bp sequence identity to U at 5' end (HD) 
1686 
U1/D2 Upstream region of MSMEG_5789 fused to hygR 
and downstream region of MSMEG_5789 (UHD) 
2246 
(MsmegΔTST); 
1983 (wild type   M. 
smegmatis) 
iUHD1/iUHD2 Upstream region of MSMEG_5789 fused to hygR 
and downstream region of MSMEG_5789 amplified 




Region within MSMEG_5789 249 
qPCR_hygR_F/ 
qPCR_hygR_R 
Region within hygR 390 
UP_MSMEG_F/
qPCR_hygR_R 












4.6 Figures  
 
Figure 1. Schematic representation of MSMEG_5789 gene replacement with hygR. Arrows 





Figure 2. Agarose gel electrophoresis of PCR amplified products. 50 ng purified PCR products 
were analyzed on agarose gel. Lane M, 4 µl 1 kb DNA ladder (New England Biolabs); lane 1, 
PCR product of the upstream (U) region of MSMEG_5789 using primers U1/U2; lane 2, PCR 
product of the hygR (H) from pYUB28b using primers H1/H2; lane 3, PCR product of 
downstream (D) region of MSMEG_5789 using primers D1/D2; lane 4, PCR products of overlap 
PCR using U and H fragments as template (UH) using primers U1/UH2; lane 5, PCR products of 
overlap PCR using H and D fragments as template (HD) using primers HD1/D2; lane 6, PCR 
products of overlap PCR using UH and HD fragments as template (UHD) using primers U1/D2; 
lane 7, PCR products of reamplification of UHD (iUHD) using internal primers iUHD1/iUHD2. 






Figure 3. Agarose gel electrophoresis of PCR amplified products. 50 µl each PCR product was 
mixed with 10 µl 6X loading dye. 10 µl each sample was analyzed using agarose gel 
electrophoresis. lane M, 4 µl 1 kb DNA ladder (New England Biolabs); lane 1, PCR 
amplification product of MSMEG_5789 from MsmegΔTST genomic DNA using primers qPCR-
_TST_F/ qPCR_TST_R; lane 2, PCR amplification product of MSMEG_5789 from wild type M. 
smegmatis genomic DNA using primers qPCR_TST_F/ qPCR_TST_R; lane 3, PCR 
amplification product of hygR from MsmegΔTST genomic DNA using primers qPCR_hygR_F/ 
qPCR_hygR_R; lane 4, PCR amplification product of hygR from wild type M. smegmatis 
genomic DNA using primers qPCR_hygR_F/ qPCR_hygR_R; lane 5, PCR amplification product 
of region starting at 758 bp upstream of U (see Table 3) and ending within hygR from 
MsmegΔTST genomic DNA using primers UP_MSMEG_F/qPCR_hygR_R; lane 6, PCR 
product of region starting at 758 bp upstream of U and ending within hygR from wild type M. 
smegmatis genomic DNA using primers UP_MSMEG_F/qPCR_hygR_R; lane 7, PCR 
amplification product of region starting at 758 bp upstream of U and ending within 
MSMEG_5789 from MsmegΔTST genomic DNA using primers UP_MSMEG_F/qPCR_TST_R; 
lane 8, PCR amplification product of region starting at 758 bp upstream of U and ending within 
MSMEG_5789 from wild type M. smegmatis genomic DNA using primers 
UP_MSMEG_F/qPCR_TST_R; lane 9, PCR amplification product of 594 bp upstream to 581 bp 
downstream region of MSMEG_5789 from MsmegΔTST genomic DNA using primers U1/D2; 
lane 10, PCR amplification product of 594 bp upstream to 581 bp downstream region of 






Figure 4. Sensitivity to various antimicrobial compounds using disk diffusion assay. Zone of 
inhibition (mm) of wild type M. smegmatis (white bars) or MsmegΔTST (grey bars). Zone of 
inhibition were measured after growth on TSA plates containing filter paper disks saturated with 
the compound to be tested. Error bars represent standard error values from duplicates. The 
asterisk (*) indicates statistically significant (*** p£0.005, ** p£0.01, * p£0.05) difference 





































































Figure 5. Spot assay of wild type M. smegmatis and MsmegΔTST. Qualitative differences in 
growth in the presence of different antimicrobial compounds was analyzed by plating 3 µl spots 
of cultures after exposure (3 hours for SDS, formaldehyde and H2O2, 6 hours for diamide) in M9 
media to the various concentrations of the compounds. Ten-fold dilutions were prepared, and 






Figure 6. Growth under microaerophilic conditions. Wild type M. smegmatis (black bars) or 
MsmegΔTST (grey bars) were grown in either Middlebrook 7H9, M9-MgSO4 or M9-cysteine 
media for 24 days without agitation under oxygen limitation conditions (air tight screw cap 
vials). Growth was monitored using optical density at 600 nm. Error bars represent standard error 


























Figure 7. Growth under aerobic conditions. Wild type M. smegmatis (black bars) or 
MsmegΔTST (grey bars) were grown in either Middlebrook 7H9, M9-MgSO4 or M9-cysteine 
media aerobically for 48 hours at 37°C and shaken at 150 rpm for aeration. Growth was 


























Figure 8. Growth in presence of different sole sulfur sources. Wild type M. smegmatis (grey 
lines) or MsmegΔTST (black lines) were grown in M9 mineral salts media containing different 
sulfur sources aerobically for 72 hours at 37°C and 150 rpm. Panel A, indicates growth in the 
presence of MgSO4 (circles) as the sole sulfur source; panel B, indicates growth in the presence 
of Na2SO3 (squares) as the sole sulfur source;  panel C, indicates growth in the presence of Na2S 
(diamonds) as the sole sulfur source; panel D, indicates growth in the presence of Na2S2O3 
(triangles) as the sole sulfur source; panel E, indicates growth in the presence of cysteine (x) as 
the sole sulfur source. Growth was monitored using optical density at 600 nm. Error bars 






Figure 9. Murine macrophage mycobacterial infection. Murine mononuclear macrophage cell 
line infected with either M. smegmatis or MsmegΔTST was harvested at various time points i.e. 
6, 24, 48 and 72 hours and phagocytosed mycobacteria were isolated and plated on agar plates to 
calculate CFU/ml. Panel A, represents CFU/ml of M. smegmatis (white bars) or MsmegΔTST 
(grey bars) at 6, 24, 48 and 72 hours;  panel B, represents CFU/ml of M. smegmatis (white bars) 
or MsmegΔTST (grey bars) at 24 and 48 hours; panel C, represents percentage of surviving M. 











4.7 Supplementary figures 
 
Figure S1. Verification of presence of pJV53 plasmid in M. smegmatis M53 cells. lane 1, 50 ng 
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Graphene is an allotrope of carbon, made up of monolayer of carbon atoms arranged into a two-
dimensional (2D) honey-comb lattice [1]. It was originally observed under electron microscopes 
in 1962 and was named by Hanns-Peter Boehm and his coworkers describing it as single sheets 
of graphite [2, 3]. Graphene was later rediscovered and isolated through micromechanical 
exfoliation of graphite in 2004 by Andre Geim and Konstantin Novoselov at the University of 
Manchester [4]. In 2010, Geim and Novoselov were awarded the Nobel Prize in Physics for their 
experiments regarding graphene [5]. Graphene serves as a basic structural element for various 
allotropes of carbon. Graphene layers comprised in a planar structure, form graphite. Graphene 
oxide (GO) is a graphene sheet with carboxylic groups at its edges and phenol hydroxyl and 
epoxide groups on its basal plane [6]. Graphene is the thinnest and strongest material ever tested 
with high elasticity and flexibility [7, 8 ]. It exhibits exceptional thermal and electrical 
conductivity, impermeability to gases and other electronic and mechanical properties [9]. A 
recent study showed that the melting temperature of graphene is approximately 4510 K, that is 
around 250 K higher than that of graphite [10]. Graphene is highly stable since the carbon atoms 
are present in a sp2 orbital hybridization. The presence of p electrons in the outer orbital allows 






Graphene and its derivatives are gaining interest in applications such as nanoelectronics, super-
capacitors, optoelectronics, nanosensors, nanomedicine [12-15]. Apart from high elasticity and 
flexibility, graphene-based materials possess adaptability to flat or irregular surfaces making 
them suitable as support and adhesion materials used for tissue engineering [16]. The presence of 
delocalized p electrons, allows graphene to bind to various aromatic compounds via p-p stacking 
interactions, in addition to the hydrophobic interactions, ensuring a number of possible 
applications [17, 18]. GO nanocarriers covalently bound to folic acid molecules, were used in 
drug delivery to cells overexpressing the folic acid receptors [19]. The growing interest in 
graphene-family nanomaterials is driving the study of their biological activity [20]. 
Nanomaterials can penetrate skin, lungs and also pass the blood-tissue barriers after intravenous 
injections and accumulate in organs [21]. In order to implement the use graphene towards its 
various applications, potential hazards on human and environmental health need to be evaluated.  
 
There have been contradictory reports on the toxicity of graphene; some studies show no risks 
involved with graphene, while some studies suggest that graphene family materials might 
become health hazards [22]. The cytotoxicity of graphene and single-wall carbon nanotubes has 
been studied in neural phaeochromocytoma-derived PC12 and it was proposed that graphene 
may induce oxidative stress and mitochondrial injury in cells at 10 µg/ml [23]. A study on 
neurite maturation using a mouse hippocampal culture model, however, demonstrated that 
graphene had no negative influence on cell viability, and significantly enhanced the number of 
neurites and their length [24]. Graphene has been shown to specifically accelerate the 
differentiation of human mesenchymal stem cells into bone cells [16]. Akhavan and Ghaderi 




membrane stress induced by sharp edges of graphene nanosheets [25]. The studies on 
antibacterial activity of graphite, graphite oxide, graphene oxide and reduced graphene oxide in 
Escherichia coli showed that cytotoxicity was due to both membrane and oxidative stress [26]. It 
was shown that most of bacterial inactivation occurred in the first hour of incubation, and there 
was an increase in cell death with an increase in concentration [26]. However, another study by 
Zhang et al., (2011) showed that E. coli had the ability to accumulate on a graphene electrode 
surface without any growth inhibition [27]. GO at doses less than 20 µg/ml was found non-toxic, 
but induced cell apoptosis at higher than 50 µg/ml in human fibroblast cells [28].  
 
The contradictions in the toxicity reports of graphene could be attributed to the varying 
characteristics of the graphene material tested, including its size, solubility, concentration, shape, 
crystallinity and surface functionalization [18, 29]. The techniques employed at enhancing 
dispersion of otherwise hydrophobic graphene are gaining interest to cater to graphene’s end 
applications [30]. The solubility of graphene in aqueous solutions depends on the number and 
kind of functional groups attached. These determine the structure and surface properties of 
graphene, and hence are important factors in dictating the interaction of graphene with its 
environment. Functionalization of graphene family nanomaterials has been proposed to greatly 
change their cytotoxicity, by attenuating the hydrophobic interactions between graphene and 
cells [31]. The oxidized graphene tested in our study, also referred to as functionalized graphene, 
is pristine graphene that has been oxidized by treating with concentrated sulfuric acid and nitric 
acid for enhanced hydrophilicity [29]. This study focuses on how oxidation of pristine graphene 
affects its cytotoxicity on E. coli. The gene expression profiles after exposure to oxidized 




differential expression in the presence of OG. The potential role of these genes during survival in 
the presence of stress induced by OG is discussed. 
 
5.2 Materials and methods 
5.2.1 Bacterial growth conditions and chemicals. Escherichia coli DH5α was grown in Luria 
Bertani (LB) medium at 37°C with shaking at 250 rpm [32]. Bacterial growth was monitored 
using optical density at 600 nm. PG, OD, GO and single-walled carbon nanotubes (SWCNT) 
were obtained from McNabb’s lab. PG and OG stock solutions were prepared in sterile water at 
2 mg/ml concentration and stored at room temperature. GO (4.3 mg/ml) and SWCNT (3 mg/ml) 
stock solutions in water were stored at room temperature. The solutions were thoroughly 
vortexed before each use.  
 
5.2.2 Cytotoxicity assays. Cytotoxicity assays were carried out in 96-well plates. Overnight 
grown cells (≈ 5 x 108 cells/ml) were inoculated into 100 µl LB broth at 1:1000 dilution ratio. 
Media was supplemented with graphene at concentrations 0, 80, 160, 320, 640, and 1280 µg/ml. 
Plates were incubated for 6 hours at 37°C without shaking. After 6 hours, 10-1 to 10-7 dilutions 
were made for each treatment. From each dilution, 3 µl was used for plating spots on LB agar 
plate for spot test analysis. The spot plate was incubated for 24 hours at 37°C. In addition, 100 µl 
of each dilution was spread plated on LB agar plates to assess the number of cells surviving after 
graphene exposure. The plates were incubated at 37°C for 48 hours and the number of colonies 





5.2.3 RNA extraction and mRNA enrichment. PG or OG were added to LB Broth at 640 
µg/ml concentration. Media was inoculated with overnight grown cells at 1:1000 ratio and 
incubated at 37°C. After 6 hours of graphene exposure, RNA extraction was carried out using 
RNeasy Mini kit (Qiagen) as per manufacturer’s protocol. In order to avoid any genomic DNA 
contamination, one round of on-column treatment with RNase-Free DNase (Qiagen) was 
included in the isolation process. RNA obtained was quantified using Qubit RNA HS Assay Kit 
and Qubit 2.0 Fluorometer (Life Technologies). Quality of RNA was analyzed using 2100 
Bioanalyzer (Agilent) and Agilent RNA ScreenTape system (Agilent Technologies). A total of 5 
µg of each RNA sample was used for further processing. Firstly, ribosomal RNA was removed 
from total RNA isolated using Ribo-Zero Magnetic Kit for Bacteria (Epicenter, Illumina). The 
rRNA depleted samples were purified using Agencourt RNAClean XP system (Beckman 
Coulter). The rRNA depletion from total RNA was validated using 2100 Bioanalyzer (Agilent) 
and Agilent RNA ScreenTape system (Agilent Genomics). The samples were quantified using 
Qubit RNA HS Assay Kit and Qubit 2.0 Fluorometer (Life Technologies). The RNA was stored 
at -80°C until use. 
 
5.2.4 cDNA Library Preparation and MiSeq run. Double stranded cDNA libraries were 
prepared from mRNA enriched samples using the TruSeq Stranded mRNA LT Sample 
Preparation kit (Illumina) following the TruSeq Stranded mRNA Sample Preparation Guide 
(Illumina) as described earlier (Chapter 3). A 5 µl of mRNA enriched template was denatured, 
fragmented and primed using random hexamers (Illumina). The first strand cDNA was 
synthesized using SuperScript II Reverse Transcriptase (Thermo Fisher Scientific) and First 




DNA polymerase I and RNase H present in the Second Strand Master Mix (Illumina). The 
resulting double stranded cDNA obtained was purified using Agencourt AMPure XP beads 
(Beckman Coulter) and was adenylated at 3’ ends and ligated with indexing adapters. For OG 
sample Adapter index 6 (AR006; GCCAAT) was used, and for PG sample Adapter index 12 
(AR012; CTTGTA) was used.  
 
The adapter ligated cDNA was purified using AMPure XP beads and amplified using adapter 
specific primers in PCR Primer Cocktail (Illumina). The PCR products were purified using 
AMPure XP beads and quantified using Qubit dsDNA BR Assay Kit and Qubit 2.0 Fluorometer 
(Life Technologies). The quality and the average library size for each sample were analyzed 
using 2100 Bioanalyzer (Agilent) and Agilent High Sensitivity D1K ScreenTape system (Agilent 
Technologies). The average library size of PG and OG libraries were 258 bp and 269 bp, 
respectively. The libraries were then prepared for sequencing according to the Preparing 
Libraries for Sequencing on MiSeq Guide (Illumina) as described earlier (Chapter 3). A 4 nM 
each of PG and OG sample libraries were pooled together and denatured resulting in a final 
concentration of 20 pM DNA library in 1 mM NaOH. In order to balance for low diversity 
libraries, a PhiX control was used. The MiSeq Reagent Kit v2, 250 cycles (Illumina) was used 
and the libraries were sequenced on the MiSeq platform (Carbonero lab). 
 
5.2.5 Sequence assembly and analysis. The sequences obtained from the MiSeq Run were 
analyzed as explained earlier (Chapter 3). The sequencing results obtained from BaseSpace 
(Illumina) were used for analysis using DNAStar (Madison, WI, USA). The reads were mapped 




(DNAStar) platform. The GenBank file containing the complete sequence of E. coli genome 
(NC_000913.gbk) was obtained from NCBI FTP (ftp://ftp.ncbi.nlm.nih.gov/). The undetermined 
reads were not used for the analyses. Assembly was performed using Transcriptome/RNA-seq 
workflow by launching SeqMan NGen. The mapping of sequence reads onto the reference 
genome was then performed using the default settings for haploid genome with few changes 
(merSkipQuery:2; maxGap: 25; minDepth: 5; pNotRef: 75). The PG and OG reads were run as 
separate assemblies.   
 
The sequence assemblies generated were analyzed using ArrayStar (DNAStar). The PG and OG 
assemblies were combined into single project for analysis. The gene expression was quantified 
using QSeq and normalized by RPKM. Gene expression levels were obtained based on log2 fold 
change values. The heat map showing gene expression pattern was obtained using hierarchical 
clustering, Euclidean (distance metric) and centroid (fast) linkage method in ArrayStar. The 
scatter plots showing log2 expression profile of all genes of OG treatment compared to PG 
treatment were generated using ArrayStar. The genes whose expression was up or downregulated 
at ³ 2-fold change were curated and the genes of interest were selected. The up and 
downregulated gene information was collected using NCBI (https://www.ncbi.nlm.nih.gov/), 
KEGG (https://www.genome.jp/kegg/) and Uniprot (https://www.uniprot.org/proteomes/) 
databases. 
 
5.2.6 Real-time PCR. The list of genes of interest selected for analysis is provided in Table 1.  
The primers for detection of genes of interest using one-step real-time reverse transcriptase 




Fisher Scientific). Gene specific primers used in the study are listed in Table 2. Total RNA 
extracted from cells exposed to either PG or OG (640 µg/ml) for 6 hours were used as template. 
The relative gene expression level was quantified using QuantiFast SYBR Green RT-PCR kit 
(Qiagen) and BioRad CFX96 Real-Time System. The 25 µl reaction mix consisted of: 2x 
QuantiFast SYBR Green RT-PCR Master Mix (1x), QuantiFast RT Mix (0. 25 µl), forward and 
reverse primer (1 µM each), template RNA (10 ng) and double autoclaved RNase-free water. 
The reaction mix was incubated at 50°C for 10 minutes for reverse transcription, followed by 
PCR initial activation at 95°C for 5 minutes and 35 cycles of PCR (10 seconds at 95°C and 30 
seconds at 60°C). 
 
5.2.7 Knockout mutants of genes of interest. In-frame, single gene deletion mutants of genes 
of interest were obtained from E. coli Keio Knockouts (GE Dharmacon). Mutants had their open-
reading frame coding regions replaced with a kanamycin cassette in Parent E. coli K-12 
BW25113 [rrnB3 DElacZ4787 hsdR514 DE(araBAD)567 DE(rhaBAD)568 rph-1] [33]. 
Knockout mutant for b4593 (ymgI, uncharacterized protein) was not available, which indicates 
that it might be an essential gene required for survival in E. coli. Knockout mutant for gene 
b2763 was also chosen for analysis. The gene is present in an operon with the upregulated gene 
of interest b2764 and is also upregulated in the transcriptome of cells exposed to OG. Knockout 
mutant for gene b2699 (recA) was selected in order to account for difference between parent 
strain and DH5a, as the latter strain contains recA mutation. The Parent strain was revived from 
its glycerol stock by plating on LB agar. Knockout mutants were revived from their respective 




maintained by regular sub-culturing in LB broth with or without kanamycin and by incubation at 
37°C with shaking at 225 rpm. 
 
5.2.8 OG cytotoxicity on knockout deletion mutants. Cytotoxicity assays were carried out as 
described above. Media with/without kanamycin was supplemented with OG at 640 µg/ml. Each 
strain was inoculated at 1 x 106 cells/ml final concentration and plates were incubated for 6 hours 
at 37°C for graphene exposure. After 6 hours, 10-1 to 10-7 dilutions were made for each treatment. 
3 µl from each dilution was used for plating spots on LB agar plate for spot test analysis. 100 µl 




5.3.1 Graphene cytotoxicity. The effect of graphene on cell survival was first analyzed using 
spot test assays for a quick visible reference (Fig. 1). There was no significant difference in cell 
survival after exposure to PG at various concentrations (0-1280 µg/ml). The OG was found to be 
more inhibitory than PG. The spot test did not show significant reduction in growth upon OG 
exposure at 0-320 µg/ml. The OG was observed to be toxic to cells at 640 µg/ml and the toxicity 
was much higher at 1280 µg/ml (Fig. 1). For a more specific analysis of graphene exposure on 
cell survival, the dilution plates were analyzed and the colony forming units/ml (CFU/ml) were 
measured to assess the number of cells surviving after graphene exposure (Fig. 2). In case of PG, 
at lower concentrations (80 and 160 µg/ml) it stimulated growth with more growth at 160 µg/ml. 
With increase in concentration the number of surviving cells were lesser as compared to 160 




no graphene control at 0 µg/ml (Fig. 2). In case of OG, at 80 and 160 µg/ml the OG exposure 
seemed to have a positive effect on cell survival. However, OG exposure at 320 µg/ml drastically 
decreased the cell survival and the toxicity increased with increase in concentration of OG (Fig. 
2).  
 
GO and SWCNT both had inhibitory effect on the growth of bacteria when compared to no 
graphene control at 0 µg/ml (Fig. S1). At 80 µg/ml, both GO and SWCNT were more toxic than 
160 µg/ml. Generally, the toxicity was dose dependent with increased loss of cell viability with 
increase in concentration. However more trials would have been beneficial in making definite 
conclusions.  
 
5.3.2 Comparative cytotoxicity of graphene materials. Percent survial upon exposure to 
graphene was used to compare cytotoxicity of various graphene materials. Percent survival was 
calculated by comparing the CFU/ml obtained after 6 hour at 640 µg/ml (or 1240 µg/ml) with no 
graphene control (0 µg/ml) as a baseline. Overall, OG was the most toxic to E. coli cells, 
followed by GO and SWCNT (Fig. 3). PG did not inhibit the growth of E. coli. At 640 µg/ml, 
approximately 8%, 36% and 89% cells survived after exposure to OG, GO and SWCNT 
respectively (Fig. 3a). At 1280 µg/ml, approximately 1%, 47% and 71% cells survived after 
exposure to OG, GO and SWCNT respectively (Fig. 3b). PG was not toxic to growth and 
approximately 120% and 112% cells survived at 640 µg/ml and 1280 µg/ml, respectively. 
 
5.3.3 Whole transcriptome analysis. Total RNA extracted from E. coli exposed to PG or OG at 




The mRNA was used to generate transcript libraries. The sequencing of libraries on MiSeq 
generated 32,241,576 total reads including 26,671,848 passing filter (PF) reads with a coefficient 
of variation of 0.1951. The percentage reads identified (PF) were 96.18%, with 41.45% and 
54.72% reads (PF) each for PG and OG respectively. The scatter plot showing log2 expression 
levels of all genes upon exposure to PG and OG is shown in Fig. S3. The heat map showing gene 
expression obtained using hierarchical clustering is shown in Fig. S4.  
 
There were a total of 183 genes upregulated and 125 genes downregulated at ³ 2-fold change 
upon exposure to OG. The list of upregulated genes is provided in Table 3, and the list of 
downregulated genes is provided in Table 4. The genes that were upregulated in the presence of 
OG were grouped based on their predicted functions: sulfur metabolism (5 genes), stress 
resistance and response proteins (16 genes), iron-sulfur (Fe-S) cluster proteins (3 genes), formate 
dehydrogenases and other hydrogenases (19 genes), membrane proteins (9 genes), transporters 
and two-component system proteins (25 genes), regulators (6 genes), oxidoreductases (6 genes), 
other enzymes (9 genes), amino acid metabolism (6 genes), pyrimidine and purine metabolism (6 
genes), ribosomal RNA proteins (24 genes), tRNA (4 genes), miscellaneous (32 genes), 
uncharacterized (13 genes). The list of these groups and their respective genes involved is 
provided in Table 5.  
 
The differentially expressed genes selected to confirm RNA-seq analysis data using RT-qPCR 
included: b2158, UPF0324 family inner membrane protein (15.03 fold upregulated in OG); 
b2764, sulfite reductase alpha subunit flavoprotein (7.02 fold upregulated in OG); b4593, 




and stress induced protein (7.66 fold downregulated in OG). Two genes with similar expression 
in OG and PG were also selected: b1731, cell division modulator (1.07 fold upregulated in OG) 
and  b1322, UPF0283 family inner membrane protein (1.07 fold upregulated in OG). The 
membrane protein coding gene b1322 was selected as a control membrane protein in order to 
check that the upregulation of b2158 was specific to this particular protein and not to all 
membrane proteins.  
 
5.3.4 Real time PCR. The relative gene expression of differentially expressed genes correlated 
with expression data obtained from RNA-seq analysis. The relative fold expression of genes of 
interest is shown in Fig. 4. The genes coding for UPF0324 family inner membrane protein 
(b2158) and sulfite reductase alpha subunit flavoprotein (b2764) were 7.74 fold and 4.38 fold 
upregulated respectively in OG. These genes were consistently upregulated in OG in both RNA-
seq and RT-qPCR analysis. The genes coding for uncharacterized protein (b4593) and blue light, 
low temperature and stress induced protein (b1167) were 2.24 fold and 9.17 fold downregulated, 
respectively. These genes were consistently downregulated in OG in both RNA-seq and RT-
qPCR analysis. The cell division modulator (b1731) was 1.15 fold downregulated in OG. This 
gene was 1.07 fold upregulated in OG in the RNA-seq data. The UPF0283 family inner 
membrane protein (b1322) was 1.49 fold downregulated in OG. This gene was 1.07 fold 
upregulated in OG in the RNA-seq data. For both of these genes, the gene expression was neither 
significantly upor downregulated in OG and we concluded that not all the membrane protein 





5.3.5 OG cytotoxicity on knockout deletion mutants. The strains tested included: Parent strain 
BW25113 (WT); single gene deletion knockout strains of genes coding for inner membrane 
protein (b2158), sulfite reductase a subunit (b2764), sulfite reductase b subunit (b2763), low 
temperature stress induced protein (b1167), cell division modulator (b1731), inner membrane 
protein (b1322). Compared to the parent strain, all the knockout mutants were more sensitive to 
OG (Fig. 5). The knockout mutant for b1167 grew better than the other mutants. This correlates 
with the downregulation of this gene in the presence of OG. The gene knockout mutants of 
respective genes that were upregulated in OG (namely, b2158, b2764 and b2763) were more 
sensitive to OG toxicity compared to the rest of the genes.  
 
In some of the preliminary cytotoxicity tests that were conducted, E. coli DH5a was found to be 
much more sensitive to OG than the parent strain of knockout mutant (Fig. S5). The DH5a has 
recA (DNA recombination and repair protein) mutation. We suspected that this might be the 
reason for difference in behavior among the two strains upon graphene exposure. The respective 
knockout mutant with recA mutation (Db2699) in the BW25113 background was selected to 
investigated for this behavior. As expected, the knockout mutant of DNA recombination protein 
coding gene (b2699) was much more sensitive to the parent strain (Fig. S6).  
 
5.4 Discussion 
We tested the effect of graphene exposure on E. coli. Owing to its hydrophobic nature, graphene 
materials were not completely soluble in water. Therefore, all solutions were thoroughly and 
equally vortexed before each use to enhance its dispersion in solution. Sonication in water bath 




solution. In addition, sonication can break the graphene sheets, resulting in differences in size 
among molecules. Flake size affects graphene’s internalization in cells, as well as how long it 
stays in circulation [29]. Hence, vortexing was used for dispersion. We observed that at lower 
concentrations (80 and 160 µg/ml) both PG and OG stimulated the growth of E. coli when 
compared to no graphene control. However at higher concentrations (320-1280 µg/ml), OG was 
highly toxic to cells. The PG did not seem to have an inhibitory effect on cell survival in E. coli. 
OG was the most inhibitory out of all forms of graphene tested (Fig. 3). This could be due to the 
presence of reactive functional groups in OG. The oxidation process adds functional groups, 
such as hydroxyl, epoxide, carbonyl and carboxylic acid to graphene [29]. This results in a more 
negative surface charge; and some disruption to the internal sp2 lattice domains [29]. Various 
studies conducted on graphene show that the dose, functional groups attaches, hydrophobicity, 
size and number of layers determine its toxicity [34-36]. The presence of functional groups on 
OG and GO might be responsible for their higher toxicity possibly due to enhanced penetration 
and interaction with the bacterial cells. The SWCNTs were not as toxic OG and GO, but still led 
to growth inhibition with a 30% loss of cell viability. The SWCNTs are 1-D structures with their 
length often exceeding micrometers [37]. Ema et al., (2016) suggested that oxidative stress and 
inflammation might be the reason for their inhibitory properties [38].  
 
The toxicity of graphene is still debated, as some reports suggest that graphene acts as a growth 
enhancer, while others suggest that it is a growth inhibitor. Ruiz et al., (2011) had previously 
reported that GO acted as an enhancer for mammalian and bacterial growth [39]. The exposure 
of E. coli to GO (25 µg/mL) for 16 hours, resulted in bacteria growing faster and forming dense 




may be used in biomedical and drug delivery applications. Several reports have shown that GO 
paper promotes the adhesion and proliferation of osteoblasts and kidney cells [40, 41]. Another 
study conducted in the same year, however, reported contradictory results, wherein GO at 20 
µg/mL and 50 µg/mL lead to 20% and 50% loss in cell viability, respectively [42]. In case of 
human erythrocytes and skin fibroblasts, it was observed that graphene and GO materials were 
cytotoxic to these cell lines [43]. A study with E. coli and Staphylococcus aureus, showed that 
GO caused growth reductions by about 51 and 61% respectively [44].  
 
In order to understand how OG induces toxicity in cells, we looked at the relative gene 
expression of cells in the presence of OG using transcriptomic analysis. The mechanism of 
cytotoxicity of graphene in cells is not yet clearly understood. It has been proposed that in case 
of cultured kidney tubular epithelial cells, graphene induces oxidative injury and DNA 
fragmentation using endonucleases, leading to cell death [45]. GO and other carbon 
nanomaterials have been shown to cause chromosomal DNA damage and interference with DNA 
replication [46, 47]. We observed that some of the genes involved in DNA biosynthesis were 
downregulated in the presence of OG. A ribonucleoside diphosphate reductase operon dedicated 
towards biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides was found 
to be downregulated upon exposure to OG [48]. This operon included genes coding for a 
glutaredoxin-like hydrogen donor for nrdEF (b2673, 2.20-fold¯), an nrdEF cluster assembly 
flavodoxin (b2674, 2.54-fold¯), ribonucleoside-diphosphate reductase 2, alpha subunit nrdE 
(b2675, 2.48-fold¯) and ribonucleoside-diphosphate reductase 2, beta subunit nrdF (b2676, 2.16-
fold¯). In addition, some of the genes involved in nucleotide sugar metabolism were also 




at Ter, DNA-binding protein (b1610, 2.44-fold¯); alpha-D-ribose 1-methylphosphonate 5-
phosphate C-P lyase (b4098, 3.97-fold¯); ribose 1,5-bisphosphate phosphokinase (b4094, 2.38-
fold¯); phosphodeoxyribose mutase (b4383, 2.36-fold¯); pyridine nucleotide-dependent 
disulfide oxidoreductase, a stress response protein (b0304, 4.86-fold¯). This indicates that DNA 
synthesis is impacted in the presence of OG.  
 
GO treatments have previously been shown to alter gene expression patterns, and the 
differentially expressed genes were shown to mediate DNA-damage control [47]. We observed 
that among the upregulated genes, six genes were directly involved in pyrimidine and purine 
metabolism (Table 5). These included genes coding for anaerobic ribonucleotide reductase 
activating protein (b4237, 3.21-fold­) and anaerobic ribonucleoside-triphosphate reductase 
(b4238, 2.41-fold­), that are arranged in an operon. Ribonucleoside-triphosphate reductases are 
class III reductases containing [4Fe-4S]2+ center, that provide a balanced supply of DNA 
precursors to cell by reducing ribonucleotides into deoxyribonucleotides [49]. A DNA-packaging 
protein (b0560, 2.39-fold­) and a putative DNA repair protein (b2644, 2.73-fold­) were also 
upregulated. In addition, a DNA utilization protein HofO (b4238, 2.41-fold­), required for the 
use of extracellular DNA as a nutrient was upregulated [50]. The upregulation of these genes 
along with other pyrimidine/purine metabolism genes might be in response to the DNA damage 
caused by graphene.  
 
Graphene materials produce reactive oxygen species (ROS), that in turn lead to oxidative stress 
and damage to membranes, proteins and DNA [51-53]. Sulfur metabolism plays an important 




assimilation and its integration into cysteine and methionine are crucial steps for the formation of 
sulfur containing defense compounds such as glutathione [54]. In Pseudomonas aeruginosa, 
multiwall carbon nanotubes and graphene were shown to induce the expression of sulfur 
metabolism genes [55]. We were interested in looking at the effect of OG on the expression of 
genes involved in sulfur metabolism. Table 5 shows the five genes involved in sulfur metabolism 
that were upregulated. Of these, three genes present in an operon dedicated towards the 
formation of sulfide from 3'-Phosphoadenosine-5'-phosphosulfate (PAPS) via sulfite, were of 
interest. These genes included: PAPS reductase, cysH (b2762, 6.76-fold­); sulfite reductase b-
subunit, cysI (b2763, 6.37-fold­); sulfite reductase a-subunit, cysJ (b2764, 7.02-fold­). The 
sulfide generated serves as a S-source for incorporation into cysteine. Cysteine is used to transfer 
sulfur to various redox molecules, iron-sulfur clusters (Fe-S) and vice-versa in oxidative stress 
response. A tauC (b0367, 2.10-fold­) was also upregulated. In E. coli tauABCD gene cluster 
was shown to be involved in the utilization of taurine as sulfur source, and was found to be 
expressed only under conditions of sulfate or cysteine starvation [56]. 
 
The sulfite reductase a-subunit (b2764) was selected as a candidate gene for RT-qPCR analysis. 
It was observed that the relative gene expression was 4.38 fold more in OG than in PG (Fig. 4). 
Furthermore, the knockout mutants of sulfite reductase b-subunit (b2763) and sulfite reductase 
a-subunit (b2764) were used to test for cytotoxicity of OG. The mutants Db2763 and Db2764 
were much more sensitive to OG as compared to the wild type strain (Fig. 5) indicating the 
importance of sulfur assimilation under graphene toxicity. A few genes coding for Fe-S cluster 
proteins were also upregulated (Fig. 5). However, we did not observe any significant change in 




(b2688, 1.03-fold¯); glutathione synthetase, gshB (b2947, 1.01-fold­), glutathione reductase, 
gor (b3500, 1.00-fold). Genes coding for oxidoreducates and formate dehydrogenses were 
upregulated in the presence of OG (Table 5). The formate dehydrogenase-H selenopolypeptide 
subunit (b4079, 3.56-fold­), formate dehydrogenase-H, [4Fe-4S] ferredoxin subunit (b2713, 
3.18-fold­) and other related proteins were upregulated. The formate dehydrogenases due to 
their electron transfer element have been shown to help in oxidative stress tolerance and survival 
in E. coli [57]. These have been shown to act as stress response proteins with their amount 
increasing more than ten-fold under stress [58].  
 
In a study conducted by Efremova et al., (2015), graphene shells (GS), GO and graphene oxide 
paper (GO-P) were evaluated with luminescent E.coli for toxicity and bioactivity mechanisms. 
While GS and GO-P were non-toxic, GO expressed bioactivity in aqueous suspension [20]. The 
authors suggested, direct membrane interaction and membrane stress to be a possible mechanism 
of toxicity [20]. Our study showed that nine genes coding for membrane proteins were 
upregulated in the presence of OG (Table 5). Among those, one of the genes showed the highest 
expression in the presence of OG: UPF0324 family inner membrane protein (b2158, 15.03-
fold­). The upregulation was confirmed using RT-qPCR analysis showing the relative gene 
expression was 7.74 fold more in OG than in PG (Fig. 4). The knockout mutant of this gene was 
most sensitive out of all the mutants tested for toxicity of PG (Fig. 5). Another gene coding for 
membrane protein, UPF0283 family inner membrane protein (b1322, 1.07-fold­) was selected to 
serve as a control. The knockout mutant of this gene was not as sensitive to OG (Fig. 5) 





Genes coding for a number of regulators, stress resistance and response proteins including 
membrane stress resistance protein (b4682, 19.18-fold­), DUF2527 family heat-induced protein 
(b1824, 3.73-fold­) and multiple acid-resistance proteins were also upregulated in response to 
OG (Table 5). However, not all the stress response proteins were upregulated. A gene coding for 
blue light, low temperature and stress induced protein (b1167, 7.66-fold¯) was downregulated in 
the presence of OG as confirmed by both RNA-seq and RT-qPCR analysis. This protein, also 
known as Uncharacterized protein ymgC, is induced at 16°C with blue light irradiation in E. coli 
[59]. The genes involved in the operon along with b1167 were also significantly downregulated 
in the presence of OG. These genes code for: RcsB connector protein for regulation of biofilm 
and acid-resistance, ycgZ (b1164, 5.28-fold¯); RcsB connector protein for regulation of biofilm, 
ymgA (b1165, 4.96-fold¯); RcsB connector protein for regulation of biofilm and acid-resistance, 
ymgB (b1166, 6.27-fold¯); blue light, low temperature and stress induced protein, ymgC (b1167, 
7.66-fold¯); putative membrane-anchored cyclic-di-GMP phosphodiesterase, ycgG (b1168, 
4.07-fold¯).  
 
The ymgABC gene cluster has been shown to play an important role in biofilm formation and 
acid resistance in E. coli [60, 61]. Brominated furanones, that are disrupters of quorum sensing, 
have been shown to repress ymgAB [62]. The expression of ymgABC has also been shown to be 
downregulated upon addition of indole, a stationary phase signal shown to have an impact on 
biofilm formation [63]. In a study conducted on E. coli MG1655 and Bacillus subtilis 168, it was 
observed that the biofilm formation was inhibited at high concentration of GO, due to the loss of 
enough number of cells to trigger biofilm formation [64]. Recently, a number of studies have 




The downregulation of the ymgABC operon genes indicates that OG targets the biofilm 
formation genes in E. coli. The knockout mutant Db1167 grew better than the knockout mutants 
of other genes tested (Fig. 5). However, more studies on how these genes are affected by OG are 
needed to understand the mechanism of toxicity. 
 
A gene coding for uncharacterized protein, ymgI (b4593, 9.53-fold¯) was highly downregulated 
in the presence of OG in both RNA-seq and RT-qPCR analysis. The ymgI gene was seen to be 
downregulated in the presence of butanol [68]. The knockout mutant for this gene was not 
available in the knockout mutant library, suggesting the importance of this gene in cell survival. 
The other two genes present in an operon with ymgI: ymgD (b1171, 1.61-fold¯) and ymgG 
(b1172, 1.42-fold¯) did not show >2-fold change in presence of OG. The results of the RNA-seq 
analysis are shown from one trial conducted. It was observed that the second set of data varied 
and did not show significant results. We observed that the OG samples lost toxicity over time. 
The discrepancies in results could originate from loss of oxidation over time due to long term 
storage, storage temperatures, exposure to light or differences in the method of preparation. 
 
Our study indicates that cytotoxicity of OG to E. coli could therefore be due to oxidative stress, 
membrane stress, DNA damage and possible inhibition of biofilm formation. Liu et al., (2011) 
proposed that graphene-based materials use a three-step antimicrobial mechanism: initial cell 
deposition on graphene-based materials, membrane stress caused by direct contact with sharp 
nanosheets, and superoxide anion-independent oxidation [26]. At low concentrations, graphene 
based materials have been shown to be biocompatible with mammalian cells by promoting cell 




functionalization first, in order to correlate the toxicity of graphene materials to bacteria and 
other organisms. The structure and functionalization could be tailored to reduce the human and 








Table 1. The list of genes of interest selected from transcriptome analysis. The genes were either 
highly upregulated (b2158, b2764) or downregulated (b1167, b4593) in the presence of OG. The 
genes with similar expression (b1322, b1761) in both OG and PG were selected to serve as a 
reference. 





b1167 7.66¯ ymgC Blue light, low temperature and stress induced 
protein 
b1322 1.07­ ycjF UPF0283 family inner membrane protein 
b1731 1.07­ cedA cell division modulator 
b2158 15.03­ yeiH UPF0324 family inner membrane protein 
b2764 7.02­ cysJ sulfite reductase, alpha subunit, flavoprotein 
b4593 9.53¯ ymgI uncharacterized protein 
 
 
Table 2. List of primers used in RT-qPCR studies. 
Locus tag Forward and reverse primer sequence Product length 
b1167 1. CTCGAGAGGGAGGTGTTCA 
2. GCACGGATTCCCTGTCAT 
187 bp 
b1322 1. GACGAAGCGCAGGAAGAA 
2. GCCAGGCATTCATTGTCC 
157 bp 
b1731 1. CAGCAAAACCGCCAGATT 
2. ACGTTGGGCAGATTCAGG 
183 bp 
b2158 1. TGTCGGTATCAGTGGGATCA 
2. TACTGGCTTCCGCTTTCACT 
188 bp 
b2764 1. ATCGCCAGCGAAAAACTG 
2. CTGGCAGCAGCCTGGTAT 
269 bp 










Table 3. List of genes upregulated upon exposure to OG compared to PG. 
Locus tag Up 
Fold 
change 
Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b4677 163.86 Uncharacterized protein YobI 21 
 
b4010 112.65 5S ribosomal RNA of rrnE operon 
 
Ribosome 
b2849 101.55 Uncharacterized protein YqeK 141 
 
b4674 81.93 Uncharacterized protein YnbG 21 
 




b1575 57.22 Division inhibition protein DicB 62 
 
b2588 45.06 5S ribosomal RNA of rrnG operon 
 
Ribosome 
b3272 22.53 5S ribosomal RNA of rrnD operon 
 
Ribosome 
b3274 22.53 5S ribosomal RNA of rrnD operon 
 
Ribosome 
b4682 19.18 Uncharacterized protein YqcG 46 
 
b2158 15.03 UPF0324 inner membrane protein YeiH 349 
 
b3342 12.95 30S ribosomal protein S12 (Small ribosomal subunit protein uS12) 124 Ribosome 
b0317 10.86 Uncharacterized protein YahC 165 
 
b2764 7.02 Sulfite reductase [NADPH] flavoprotein alpha-component (SiR-FP) (EC 1.8.1.2) 599 Sulfur metabolism 
b0617 6.99 Citrate lyase acyl carrier protein (Citrate lyase gamma chain) 98 Two-component system 
b2762 6.76 Phosphoadenosine phosphosulfate reductase (EC 1.8.4.8) (3'-phosphoadenylylsulfate reductase) 
(PAPS reductase, thioredoxin dependent) (PAPS sulfotransferase) (PAdoPS reductase) 
244 Sulfur metabolism 
b1155 6.71 Uncharacterized protein YmfS 137 
 
b2763 6.37 Sulfite reductase [NADPH] hemoprotein beta-component (SiR-HP) (SiRHP) (EC 1.8.1.2) 570 Sulfur metabolism 
b2851 5.87 Uncharacterized protein YgeG 163 
 
b1492 5.32 Probable glutamate/gamma-aminobutyrate antiporter (Extreme acid sensitivity protein) 511 Quorum sensing 
b2725 5.13 Formate hydrogenlyase regulatory protein HycA 153 
 
b2166 4.83 Pseudouridine kinase (EC 2.7.1.83) 313 Pyrimidine metabolism 
b4705 4.71 Small protein MntS 42 
 





Table 3 (con’t) 
Locus tag Up 
Fold 
change 
Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b1493 4.39 Glutamate decarboxylase beta (GAD-beta) (EC 4.1.1.15) 466 Alanine, aspartate and 
glutamate metabolism 
b0336 4.29 Cytosine permease 419 
 
b2724 4.24 Formate hydrogenlyase subunit 2 (FHL subunit 2) (Hydrogenase-3 component B) 203 
 
b0337 4.21 Cytosine deaminase (CD) (CDA) (CDase) (EC 3.5.4.1) (Cytosine aminohydrolase) (Isoguanine 
deaminase) (EC 3.5.4.-) 
427 Pyrimidine metabolism 
b4684 4.20 Uncharacterized protein YqfG 41 
 
b0485 4.17 Glutaminase 1 (EC 3.5.1.2) 310 Arginine biosynthesis 
b0484 4.11 Copper-exporting P-type ATPase (EC 3.6.3.54) (Copper-exporting P-type ATPase A) (Cu(+)-
exporting ATPase) (Soluble copper chaperone CopA(Z)) 
834 
 
b2723 3.95 Formate hydrogenlyase subunit 3 (FHL subunit 3) (Hydrogenase-3 component C) 608 
 
b2721 3.90 Formate hydrogenlyase subunit 5 (FHL subunit 5) (Hydrogenase-3 component E) 569 
 
b1258 3.88 Protein YciF 166 
 
b1824 3.73 Protein YobF 47 
 
b0334 3.72 2-methylcitrate dehydratase (2-MC dehydratase) (EC 4.2.1.79) ((2S,3S)-2-methylcitrate 
dehydratase) (Aconitate hydratase) (ACN) (Aconitase) (EC 4.2.1.3) 
483 Propanoate metabolism 
b3756 3.60 16S ribosomal RNA of rrnC operon 
 
Ribosome 
b2591 3.58 16S ribosomal RNA of rrnG operon 
 
Ribosome 
b2094 3.58 PTS system galactitol-specific EIIA component (EIIB-Gat) (Galactitol-specific 
phosphotransferase enzyme IIA component) 
150 Galactose metabolism 
b4079 3.56 Formate dehydrogenase H (EC 1.17.1.9) (EC 1.17.99.7) (Formate dehydrogenase-H subunit 
alpha) (FDH-H) (Formate-hydrogen-lyase-linked, selenocysteine-containing polypeptide) 
715 
 
b0201 3.56 16S ribosomal RNA of rrnH operon 
 
Ribosome 
b2243 3.53 Anaerobic glycerol-3-phosphate dehydrogenase subunit C (G-3-P dehydrogenase) 396 Glycerophospholipid 
metabolism 
b3851 3.50 16S ribosomal RNA of rrnA operon 
 
Ribosome 
b4007 3.48 16S ribosomal RNA of rrnE operon 
 
Ribosome 
b0901 3.46 Uncharacterized NAD(P)H oxidoreductase YcaK (EC 1.6.99.-) 196 
 





Table 3 (con’t) 
Locus tag Up 
Fold 
change 
Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b0486 3.40 Inner membrane transport protein YbaT 430 
 
b2718 3.38 Formate hydrogenlyase maturation protein HycH 136 
 
b0733 3.36 Cytochrome bd-I ubiquinol oxidase subunit 1 (EC 1.10.3.14) (Cytochrome bd-I oxidase subunit 
I) (Cytochrome d ubiquinol oxidase subunit I) 
522 Oxidative phosphorylation 
b0734 3.36 Cytochrome bd-I ubiquinol oxidase subunit 2 (EC 1.10.3.14) (Cytochrome bd-I oxidase subunit 
II) (Cytochrome d ubiquinol oxidase subunit II) 
379 Oxidative phosphorylation 
b1409 3.36 Uncharacterized protein YnbB 298 Glycerophospholipid 
metabolism 
b2110 3.36 Probable fimbrial chaperone YehC 239 
 
b3577 3.36 2,3-diketo-L-gulonate TRAP transporter small permease protein YiaM 157 
 
b4299 3.36 Uncharacterized HTH-type transcriptional regulator YjhI 262 
 
b3278 3.33 16S ribosomal RNA of rrnD operon 
 
Ribosome 
b3968 3.32 16S ribosomal RNA of rrnB operon 
 
Ribosome 
b3517 3.24 Glutamate decarboxylase alpha (GAD-alpha) (EC 4.1.1.15) 466 Alanine, aspartate and 
glutamate metabolism 
b2095 3.21 D-tagatose-1,6-bisphosphate aldolase subunit GatZ 420 Galactose metabolism 
b4237 3.21 Anaerobic ribonucleoside-triphosphate reductase-activating protein (EC 1.97.1.-) (Class III 
anaerobic ribonucleotide reductase small component) 
154 
 
b0735 3.21 Uncharacterized protein YbgE 97 
 
b2713 3.18 Electron transport protein HydN 175 
 
b2093 3.13 PTS system galactitol-specific EIIB component (EIIB-Gat) (Galactitol-specific 
phosphotransferase enzyme IIB component) (EC 2.7.1.200) 
94 Galactose metabolism 
b3508 3.05 Putative magnesium transporter YhiD 215 
 
b1312 3.04 Inner membrane ABC transporter permease protein YcjP 280 
 
b1729 3.03 L-cystine transporter YdjN 463 
 
b2483 3.02 Hydrogenase-4 component C (EC 1.-.-.-) 315 
 
b1443 3.01 Inner membrane ABC transporter permease protein YdcV 264 Quorum sensing 





Table 3 (con’t) 
Locus tag Up 
Fold 
change 
Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b3315 2.95 50S ribosomal protein L22 (Large ribosomal subunit protein uL22) 110 Ribosome 
b1011 2.94 Peroxyureidoacrylate/ureidoacrylate amidohydrolase RutB (EC 3.5.1.110) (Ureidoacrylate 
amidohydrolase) 
230 Pyrimidine metabolism 
b1408 2.94 Inner membrane protein YnbA 201 
 
b1576 2.94 Uncharacterized protein YdfD 63 
 
b2054 2.94 Putative colanic acid biosynthesis acetyltransferase WcaF (EC 2.3.1.-) 182 
 
b0123 2.91 Blue copper oxidase CueO (Copper efflux oxidase) 516 
 
b0836 2.90 Biofilm regulator BssR 127 
 
b1905 2.90 Bacterial non-heme ferritin (EC 1.16.3.2) (Ferritin-1) 165 
 
b2720 2.88 Formate hydrogenlyase subunit 6 (FHL subunit 6) (Hydrogenase-3 component F) 180 
 
b3512 2.86 Transcriptional regulator GadE 175 
 
b0977 2.86 Hydrogenase-1 operon protein HyaF 285 
 
b3985 2.85 50S ribosomal protein L10 (50S ribosomal protein L8) (Large ribosomal subunit protein uL10) 165 Ribosome 
b2589 2.85 23S ribosomal RNA of rrnG operon 
 
Ribosome 
b2719 2.84 Formate hydrogenlyase subunit 7 (FHL subunit 7) (Hydrogenase-3 component G) 255 
 
b3854 2.81 23S ribosomal RNA of rrnA operon 
 
Ribosome 
b0573 2.80 Cation efflux system protein CusF 110 Two-component system 
b3970 2.78 23S ribosomal RNA of rrnB operon 
 
Ribosome 
b1957 2.77 Uncharacterized protein YodC 60 
 
b0204 2.76 23S ribosomal RNA of rrnH operon 
 
Ribosome 
b2644 2.73 UPF0758 protein YfjY 160 
 
b4075 2.69 Formate-dependent nitrite reductase complex subunit NrfF 127 
 
b3748 2.66 D-ribose pyranase (EC 5.4.99.62) 139 ABC transporters 
b1304 2.65 Phage shock protein A 222 
 







Table 3 (con’t) 
Locus tag Up 
Fold 
change 
Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b4009 2.64 23S ribosomal RNA of rrnE operon 
 
Ribosome 
b0953 2.63 Ribosome modulation factor (RMF) (Hibernation factor RMF) (Protein E) 55 
 
b2096 2.62 D-tagatose-1,6-bisphosphate aldolase subunit GatY (TBPA) (TagBP aldolase) (EC 4.1.2.40) 
(D-tagatose-bisphosphate aldolase class II) (Tagatose-bisphosphate aldolase) 
284 Galactose metabolism 
b3275 2.59 23S ribosomal RNA of rrnD operon 
 
Ribosome 
b3513 2.58 Multidrug resistance protein MdtE 385 
 
b3311 2.57 30S ribosomal protein S17 (Small ribosomal subunit protein uS17) 84 Ribosome 
b3922 2.56 UPF0381 protein YiiS 99 
 
b3507 2.56 HTH-type transcriptional regulator DctR 176 
 




b2425 2.55 Thiosulfate-binding protein 338 Sulfur metabolism 




b2726 2.53 Hydrogenase maturation factor HypA 116 
 
b1156 2.52 Prophage tail fiber assembly protein homolog TfaE (Tail fiber assembly protein homolog from 
lambdoid prophage e14) 
200 
 
b1549 2.52 Uncharacterized protein YdfO 136 
 
b3511 2.51 Protein HdeD 190 
 
b2847 2.50 Uncharacterized protein YqeI 269 
 
b0284 2.46 Putative xanthine dehydrogenase YagR molybdenum-binding subunit (EC 1.17.1.4) 732 Purine metabolism 
b1141 2.46 Prophage excisionase-like protein (Excisionase-like protein from lambdoid prophage 14) 81 
 
b4035 2.44 Maltose/maltodextrin import ATP-binding protein MalK (EC 3.6.3.19) 371 ABC transporters 
b0904 2.43 Probable formate transporter 1 (Formate channel 1) 285 
 
b3314 2.42 30S ribosomal protein S3 (Small ribosomal subunit protein uS3) 233 Ribosome 
b4238 2.42 Anaerobic ribonucleoside-triphosphate reductase (EC 1.1.98.6) (Class III ribonucleoside-
triphosphate reductase) 
712 Purine metabolism 





Table 3 (con’t) 
Locus tag Up 
Fold 
change 
Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b4126 2.40 Uncharacterized protein YjdI 76 
 
b2242 2.40 Anaerobic glycerol-3-phosphate dehydrogenase subunit B (Anaerobic G-3-P dehydrogenase 
subunit B) (Anaerobic G3Pdhase B) (EC 1.1.5.3) 
419 Glycerophospholipid 
metabolism 
b0560 2.39 DNA-packaging protein NU1 homolog 181 
 
b4535 2.37 Uncharacterized protein YniD 35 
 




b2013 2.34 UPF0394 inner membrane protein YeeE 352 
 




b4201 2.33 Primosomal replication protein N 104 Homologous recombination 
b2392 2.33 Divalent metal cation transporter MntH 412 
 
b1800 2.32 D-malate dehydrogenase [decarboxylating] (EC 1.1.1.83) (D-malate degradation protein A) (D-
malate oxidase) 
361 Glyoxylate and 
dicarboxylate metabolism 
b1388 2.31 1,2-phenylacetyl-CoA epoxidase, subunit A (EC 1.14.13.149) (1,2-phenylacetyl-CoA 
epoxidase, catalytic subunit alpha) (1,2-phenylacetyl-CoA monooxygenase, subunit A) 
309 Phenylalanine metabolism 
b1481 2.31 Protein bdm (Biofilm-dependent modulation protein) 71 
 




b0974 2.29 Probable Ni/Fe-hydrogenase 1 B-type cytochrome subunit 235 Two-component system 
b3506 2.29 Outer membrane protein slp 188 
 
b1672 2.28 Uncharacterized protein YdhW 215 
 
b3001 2.28 L-glyceraldehyde 3-phosphate reductase (GAP reductase) (EC 1.1.1.-) 346 
 
b2148 2.28 Galactoside transport system permease protein MglC 336 ABC transporters 
b0973 2.27 Hydrogenase-1 large chain (HYD1) (EC 1.12.99.6) (Membrane-bound hydrogenase 1 large 
subunit) (NiFe hydrogenase) 
597 Nitrotoluene degradation 
b4152 2.27 Fumarate reductase subunit C (Fumarate reductase 15 kDa hydrophobic protein) 131 Citrate cycle (TCA cycle) 






Table 3 (con’t) 
Locus tag Up 
Fold 
change 
Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b1593 2.26 ATP-dependent dethiobiotin synthetase BioD 2 (EC 6.3.3.3) (DTB synthetase 2) (DTBS 2) 
(Dethiobiotin synthase 2) 
231 Biotin metabolism 
b4153 2.25 Fumarate reductase iron-sulfur subunit (EC 1.3.5.1) 244 Citrate cycle (TCA cycle) 
b4239 2.24 Trehalose-6-phosphate hydrolase (EC 3.2.1.93) (Alpha,alpha-phosphotrehalase) 551 Starch and sucrose 
metabolism 
b3117 2.24 L-threonine dehydratase catabolic TdcB (EC 4.3.1.19) (L-serine dehydratase) (EC 4.3.1.17) 
(Threonine deaminase) 
329 Glycine, serine and 
threonine metabolism 
b2097 2.23 Fructose-bisphosphate aldolase class 1 (EC 4.1.2.13) (Fructose-bisphosphate aldolase class I) 
(FBP aldolase) 
350 Glycolysis / 
Gluconeogenesis 
b1256 2.22 Outer membrane protein W 212 
 
b2126 2.20 Sensor histidine kinase BtsS (EC 2.7.13.3) 561 
 
b3113 2.20 Putative reactive intermediate deaminase TdcF (EC 3.5.4.-) 129 
 
b3410 2.20 Probable [Fe-S]-dependent transcriptional repressor FeoC (Fe(2+) iron transport protein C) 78 
 
b1730 2.18 Uncharacterized protein YdjO 267 
 
b0994 2.18 Periplasmic protein TorT 342 
 
b1444 2.16 Gamma-aminobutyraldehyde dehydrogenase (EC 1.2.1.19) (1-pyrroline dehydrogenase) (4-
aminobutanal dehydrogenase) (ABALDH) 
474 Arginine and proline 
metabolism 
b1244 2.16 Oligopeptide transport system permease protein OppB 306 beta-Lactam resistance 
b0564 2.14 HTH-type transcriptional regulator AppY (M5 polypeptide) 249 Two-component system 
b0513 2.13 Putative purine permease YbbY 433 
 
b1992 2.13 Adenosylcobinamide-GDP ribazoletransferase (EC 2.7.8.26) (Cobalamin synthase) 
(Cobalamin-5'-phosphate synthase) 
247 Porphyrin and chlorophyll 
metabolism 
b4199 2.13 Uncharacterized protein YjfY 91 
 
b4119 2.12 Alpha-galactosidase (EC 3.2.1.22) (Melibiase) 451 Galactose metabolism 
b2367 2.12 Probable multidrug resistance protein EmrY 512 Two-component system 
b3491 2.11 Inner membrane protein YhiM 350 
 






Table 3 (con’t) 
Locus tag Up 
Fold 
change 
Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b3114 2.10 PFL-like enzyme TdcE (Keto-acid formate acetyltransferase) (Keto-acid formate-lyase) 
(Ketobutyrate formate-lyase) (KFL) (EC 2.3.1.-) (Pyruvate formate-lyase) (PFL) (EC 2.3.1.54) 
764 Pyruvate metabolism 
b0367 2.10 Taurine transport system permease protein TauC 275 Sulfur metabolism 
b1148 2.10 Uncharacterized protein YmfM 112 
 
b1441 2.10 Uncharacterized ABC transporter ATP-binding protein YdcT 337 Quorum sensing 
b4085 2.10 D-allulose-6-phosphate 3-epimerase (EC 5.1.3.-) 231 Fructose and mannose 
metabolism 
b3751 2.09 Ribose import binding protein RbsB 296 ABC transporters 
b3408 2.09 Fe(2+) transport protein A (Ferrous iron transport protein A) 75 
 
b1732 2.09 Catalase HPII (EC 1.11.1.6) (Hydroxyperoxidase II) 753 Tryptophan metabolism 
b0613 2.08 2-(5''-triphosphoribosyl)-3'-dephosphocoenzyme-A synthase (2-(5''-triphosphoribosyl)-3'-
dephospho-CoA synthase) (EC 2.4.2.52) 
292 Two-component system 
b2403 2.08 tRNA-Val NA Aminoacyl-tRNA 
biosynthesis 
b1257 2.08 Protein YciE 168 
 
b3393 2.08 DNA utilization protein HofO 146 
 
b4316 2.08 Chaperone protein FimC 241 
 
b2204 2.07 Ferredoxin-type protein NapH (Ubiquinol--[NapC cytochrome c] reductase NapH subunit) 287 
 
b2809 2.07 Uncharacterized lipoprotein YgdI 75 
 
b1003 2.05 Uncharacterized protein YccJ 75 
 
b1581 2.04 Starvation-sensing protein RspA 404 Pentose and glucuronate 
interconversions 
b2717 2.04 Hydrogenase 3 maturation protease (EC 3.4.23.51) (HycI protease) 156 
 
b1838 2.03 Serine/threonine-protein phosphatase 1 (EC 3.1.3.16) 218 
 
b1101 2.03 PTS system glucose-specific EIICB component (EIICB-Glc) (EII-Glc) [Includes: Glucose 
permease IIC component (PTS system glucose-specific EIIC component); Glucose-specific 
phosphotransferase enzyme IIB component (EC 2.7.1.199) (PTS system glucose-specific EIIB 
component)] 
477 Glycolysis / 
Gluconeogenesis 





Table 3 (con’t) 
Locus tag Up 
Fold 
change 
Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b3509 2.02 Acid stress chaperone HdeB (10K-L protein) 108 
 
b2057 2.02 Putative colanic acid biosynthesis glycosyl transferase WcaC 405 
 
b1311 2.01 Inner membrane ABC transporter permease protein YcjO 293 
 
























Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b1717 73.11 50S ribosomal protein L35 (Large ribosomal subunit protein bL35) (Ribosomal protein A) 65 Ribosome 
b0205 53.70 5S ribosomal RNA of rrnH operon 
 
Ribosome 
b4341 39.05 Uncharacterized protein YjiS 54 
 
b1041 28.26 Minor curlin subunit 151 Biofilm formation 
b4047 25.27 Uncharacterized protein YjbL 84 
 
b3307 13.69 30S ribosomal protein S14 (Small ribosomal subunit protein uS14) 101 Ribosome 
b4202 11.52 30S ribosomal protein S18 (Small ribosomal subunit protein bS18) 75 Ribosome 
b4593 9.53 Uncharacterized protein YmgI 57 
 
b0272 8.49 Uncharacterized HTH-type transcriptional regulator YagI 252 
 
b1167 7.66 Blue light, low temperature and stress induced protein, YmgC 82 
 
b0273 6.41 Ornithine carbamoyltransferase subunit F (OTCase-2) (EC 2.1.3.3) 334 Arginine biosynthesis 
b2609 6.29 30S ribosomal protein S16 (Small ribosomal subunit protein bS16) 82 Ribosome 
b1166 6.27 RcsB connector protein for regulation of biofilm and acid-resistance, YmgB AriR 88 
 
b4513 5.96 Potassium-transporting ATPase KdpF subunit (ATP phosphohydrolase [potassium-
transporting] F chain) (Potassium-binding and translocating subunit F) (Potassium-translocating 
ATPase F chain) 
29 Two-component system 
b3301 5.85 50S ribosomal protein L15 (Large ribosomal subunit protein uL15) 144 Ribosome 
b1301 5.59 Gamma-glutamylputrescine oxidoreductase (Gamma-Glu-Put oxidase) (Gamma-
glutamylputrescine oxidase) (EC 1.4.3.-) 
426 Arginine and proline 
metabolism 
b1300 5.57 NADP/NAD-dependent aldehyde dehydrogenase PuuC (ALDH) (EC 1.2.1.5) (3-
hydroxypropionaldehyde dehydrogenase) (Gamma-glutamyl-gamma-aminobutyraldehyde 
dehydrogenase) (Gamma-Glu-gamma-aminobutyraldehyde dehydrogenase) 
495 Arginine and proline 
metabolism 
b1020 5.50 Protein PhoH (Phosphate starvation-inducible protein PsiH) 354 
 
b1611 5.47 Fumarate hydratase class II (Fumarase C) (EC 4.2.1.2) (Aerobic fumarase) (Iron-independent 
fumarase) 
467 Citrate cycle (TCA cycle) 
b1164 5.28 RcsB connector protein for regulation of biofilm and acid-resistance, YcgZ 78 
 












Gene description Uniprot 
protein 
length 
KEGG pathway annotation 




b0328 4.79 Uncharacterized membrane protein YahN 223 
 
b1302 4.78 4-aminobutyrate aminotransferase PuuE (EC 2.6.1.19) (GABA aminotransferase) (GABA-AT) 
(Gamma-amino-N-butyrate transaminase) (GABA transaminase) (Glutamate:succinic 
semialdehyde transaminase) 
421 Alanine, aspartate and 
glutamate metabolism 
b4511 4.21 Enterobactin biosynthesis protein YbdZ 72 
 
b1168 4.07 Putative membrane-anchored cyclic-di-GMP phosphodiesterase, YcgG 507 
 
b0330 4.06 Propionate catabolism operon regulatory protein 528 
 




b4098 3.97 Alpha-D-ribose 1-methylphosphonate 5-phosphate C-P lyase (PRPn C-P lyase) (EC 4.7.1.1) 281 Phosphonate and 
phosphinate metabolism 
b1746 3.88 N-succinylglutamate 5-semialdehyde dehydrogenase (EC 1.2.1.71) (Succinylglutamic 
semialdehyde dehydrogenase) (SGSD) 
492 Arginine and proline 
metabolism 
b1747 3.79 Arginine N-succinyltransferase (AST) (EC 2.3.1.109) (AOST) 344 Arginine and proline 
metabolism 
b1297 3.74 Gamma-glutamylputrescine synthetase PuuA (Gamma-Glu-Put synthetase) (EC 6.3.1.11) 
(Glutamate--putrescine ligase) 
472 Arginine and proline 
metabolism 
b1058 3.58 Uncharacterized protein YceO 46 
 
b4533 3.58 Uncharacterized protein YnfO (Uncharacterized protein YnfO from Qin prophage) 77 
 
b1748 3.56 Succinylornithine transaminase (SOAT) (EC 2.6.1.81) (Carbon starvation protein C) 
(Succinylornithine aminotransferase) 
406 Arginine and proline 
metabolism 
b0585 3.50 Enterochelin esterase (Ferric enterobactin esterase) 400 
 
b0590 3.46 Ferric enterobactin transport system permease protein FepD 334 ABC transporters 
b3924 3.36 Flavodoxin/ferredoxin--NADP reductase (EC 1.18.1.2) (EC 1.19.1.1) (Ferredoxin 
(flavodoxin):NADP(+) oxidoreductase) (Ferredoxin--NADP reductase) (FNR) (Flavodoxin--
NADP reductase) (FLDR) (Methyl viologen resistance protein A) (dA1) 
248 
 
b0589 3.26 Ferric enterobactin transport system permease protein FepG 330 ABC transporters 













Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b3320 3.15 50S ribosomal protein L3 (Large ribosomal subunit protein uL3) 209 Ribosome 
b4062 3.15 Regulatory protein SoxS 107 
 
b1229 3.13 Protamine-like protein 29 
 
b1296 3.03 Putrescine importer PuuP 461 
 
b0044 2.98 Ferredoxin-like protein FixX 95 
 
b1032 2.98 tRNA-Ser NA Aminoacyl-tRNA 
biosynthesis 
b0346 2.89 DNA-binding transcriptional activator MhpR (mhp operon transcriptional activator) 277 
 
b1351 2.83 Protein RacC 91 
 
b0138 2.82 Uncharacterized fimbrial-like protein YadM 189 
 
b4203 2.80 50S ribosomal protein L9 (Large ribosomal subunit protein bL9) 149 Ribosome 
b4100 2.78 Alpha-D-ribose 1-methylphosphonate 5-triphosphate synthase subunit PhnH (RPnTP synthase 
subunit PhnH) (EC 2.7.8.37) 
194 Phosphonate and 
phosphinate metabolism 
b2417 2.78 PTS system glucose-specific EIIA component (EIIA-Glc) (EIII-Glc) (Glucose-specific 
phosphotransferase enzyme IIA component) 
169 Glycolysis / 
Gluconeogenesis 
b3637 2.78 50S ribosomal protein L28 (Large ribosomal subunit protein bL28) 78 Ribosome 
b0333 2.75 2-methylcitrate synthase (2-MCS) (MCS) (EC 2.3.3.5) ((2S,3S)-2-methylcitrate synthase) 
(Citrate synthase) (EC 2.3.3.16) 
389 Propanoate metabolism 
b3321 2.73 30S ribosomal protein S10 (Small ribosomal subunit protein uS10) 103 Ribosome 
b4291 2.71 Fe(3+) dicitrate transport protein FecA (Iron(III) dicitrate transport protein FecA) 774 
 
b1660 2.68 Inner membrane transport protein YdhC 403 
 
b1745 2.66 N-succinylarginine dihydrolase (EC 3.5.3.23) 447 Arginine and proline 
metabolism 
b2210 2.63 Malate:quinone oxidoreductase (EC 1.1.5.4) (MQO) (Malate dehydrogenase [quinone]) 548 Citrate cycle (TCA cycle) 
b2458 2.59 Ethanolamine utilization protein EutD 338 Pyruvate metabolism 
b0804 2.58 PKHD-type hydroxylase YbiX (EC 1.14.11.-) 225 
 
b2674 2.54 Protein NrdI 136 
 










Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b0347 2.51 3-(3-hydroxy-phenyl)propionate/3-hydroxycinnamic acid hydroxylase (3-HCI hydroxylase) (3-
HPP hydroxylase) (EC 1.14.13.127) 
554 Phenylalanine metabolism 
b0591 2.51 Enterobactin exporter EntS (Protein p43) 416 
 
b0586 2.50 Enterobactin synthase component F (EC 2.7.7.-) (Enterochelin synthase F) (Serine-activating 
enzyme) (Seryl-AMP ligase) 
1293 Biosynthesis of siderophore 
group nonribosomal 
peptides 
b2675 2.48 Ribonucleoside-diphosphate reductase 2 subunit alpha (EC 1.17.4.1) (R1E protein) 
(Ribonucleotide reductase 2) 
714 Purine metabolism 
b1378 2.47 Probable pyruvate-flavodoxin oxidoreductase (EC 1.2.7.-) 1174 Glycolysis / 
Gluconeogenesis 
b2634 2.44 Uncharacterized HTH-type transcriptional regulator YfjR 233 
 
b1610 2.44 DNA replication terminus site-binding protein (Ter-binding protein) 309 
 
b2155 2.42 Colicin I receptor 663 
 
b3452 2.42 sn-glycerol-3-phosphate transport system permease protein UgpA 295 ABC transporters 
b0723 2.41 Succinate dehydrogenase flavoprotein subunit (EC 1.3.5.1) 588 Citrate cycle (TCA cycle) 
b1161 2.40 Uncharacterized protein YcgX 134 
 
b1495 2.39 Uncharacterized protein YddB (CDS103) 790 
 
b4672 2.38 Putative protein YmiB 34 
 
b1347 2.38 Double-strand break reduction protein 69 
 
b4526 2.38 Uncharacterized protein YdaE 56 
 
b1744 2.38 Succinylglutamate desuccinylase (EC 3.5.1.96) 322 Arginine and proline 
metabolism 
b4541 2.38 Uncharacterized protein YehK 105 
 
b2387 2.38 PTS system fructose-like EIIB component 1 (EC 2.7.1.202) (Fructose-like phosphotransferase 
enzyme IIB component 1) 
108 
 
b3759 2.38 5S ribosomal RNA of rrnC operon NA Ribosome 
b4094 2.38 Ribose 1,5-bisphosphate phosphokinase PhnN (EC 2.7.4.23) (Ribose 1,5-bisphosphokinase) 185 Pentose phosphate pathway 
b4101 2.38 Alpha-D-ribose 1-methylphosphonate 5-triphosphate synthase subunit PhnG (RPnTP synthase 
subunit PhnG) (EC 2.7.8.37) 











Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b4105 2.38 Phosphonates-binding periplasmic protein 338 ABC transporters 
b4383 2.36 Phosphopentomutase (EC 5.4.2.7) (Phosphodeoxyribomutase) 407 Pentose phosphate pathway 
b4367 2.36 Ferric iron reductase protein FhuF 262 
 
b3605 2.35 L-lactate dehydrogenase (EC 1.1.-.-) 396 Pyruvate metabolism 
b3047 2.35 Uncharacterized fimbrial chaperone YqiH 249 
 
b0849 2.35 Glutaredoxin 1 (Grx1) 85 
 
b4366 2.32 Transcriptional activator protein BglJ 225 
 




b2459 2.24 Ethanolamine utilization cobalamin adenosyltransferase (EC 2.5.1.17) 267 Porphyrin and chlorophyll 
metabolism 
b1496 2.22 Inner membrane ABC transporter ATP-binding protein YddA (CDS102) 561 ABC transporters 
b2673 2.20 Glutaredoxin-like protein NrdH 81 
 
b4407 2.20 Sulfur carrier protein ThiS (Thiamine biosynthesis protein ThiS) 66 Sulfur relay system 
b3069 2.19 tRNA-Ile NA Aminoacyl-tRNA 
biosynthesis 
b2462 2.18 Ethanolamine utilization protein EutS 111 
 
b4292 2.18 Protein FecR 317 
 
b4290 2.17 Fe(3+) dicitrate-binding periplasmic protein (Iron(III) dicitrate-binding periplasmic protein) 300 ABC transporters 
b2676 2.16 Ribonucleoside-diphosphate reductase 2 subunit beta (EC 1.17.4.1) (R2F protein) 
(Ribonucleotide reductase 2) 
319 Purine metabolism 
b0150 2.15 Ferrichrome outer membrane transporter/phage receptor (Ferric hydroxamate receptor) (Ferric 
hydroxamate uptake) (Ferrichrome-iron receptor) 
747 
 
b2407 2.15 Purine nucleoside phosphorylase 2 (EC 2.4.2.1) (Inosine-guanosine phosphorylase) (Purine 
nucleoside phosphorylase II) (PNP II) (Xanthosine phosphorylase) 
277 Purine metabolism 
b0593 2.13 Isochorismate synthase EntC (EC 5.4.4.2) (Isochorismate mutase) 391 Ubiquinone and other 
terpenoid 












Gene description Uniprot 
protein 
length 
KEGG pathway annotation 
b0618 2.09 [Citrate [pro-3S]-lyase] ligase (EC 6.2.1.22) (Acetate:SH-citrate lyase ligase) (Citrate lyase 
synthetase) 
352 Two-component system 
b1396 2.09 Acyl-coenzyme A thioesterase PaaI (EC 3.1.2.-) (Phenylacetic acid degradation protein PaaI) 140 Phenylalanine metabolism 
b2003 2.09 Uncharacterized protein YeeT 73 
 
b0592 2.09 Ferrienterobactin-binding periplasmic protein 318 ABC transporters 
b0724 2.08 Succinate dehydrogenase iron-sulfur subunit (EC 1.3.5.1) 238 Citrate cycle (TCA cycle) 
b2505 2.07 Uncharacterized lipoprotein YfgH 172 
 
b3143 2.05 Probable fimbrial chaperone YraI 231 
 
b4289 2.05 Fe(3+) dicitrate transport system permease protein FecC (Iron(III) dicitrate transport system 
permease protein FecC) 
332 ABC transporters 
b0587 2.05 Ferric enterobactin transport protein FepE 377 
 
b0349 2.04 2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase (EC 3.7.1.14) 
(2-hydroxy-6-ketonona-2,4-diene-1,9-dioic acid 5,6-hydrolase) (2-hydroxy-6-oxonona-2,4,7-
triene-1,9-dioic acid 5,6-hydrolase) (2-hydroxy-6-oxonona-2,4-diene-1,9-dioic acid 5,6-
hydrolase) 
288 Phenylalanine metabolism 
b3820 2.03 Uncharacterized protein YigI 155 
 
b3299 2.03 50S ribosomal protein L36 (Large ribosomal subunit protein bL36-A) (Ribosomal protein B) 38 Ribosome 
b4477 2.03 2-dehydro-3-deoxy-6-phosphogalactonate aldolase (EC 4.1.2.21) (2-oxo-3-deoxygalactonate 
6-phosphate aldolase) (6-phospho-2-dehydro-3-deoxygalactonate aldolase) (6-phospho-2-keto-
3-deoxygalactonate aldolase) (KDPGal) 
205 Galactose metabolism 
b4061 2.02 Probable cyclic di-GMP phosphodiesterase PdeC (EC 3.1.4.52) 528 
 
b4106 2.02 Phosphonates import ATP-binding protein PhnC (EC 3.6.3.28) 262 ABC transporters 
b3070 2.02 NADPH-dependent ferric-chelate reductase (EC 1.16.1.9) (Ferric siderophore reductase) 254 
 
b3604 2.01 Putative L-lactate dehydrogenase operon regulatory protein 258 
 
b0588 2.01 Ferric enterobactin transport ATP-binding protein FepC 271 ABC transporters 
b2163 2.00 Regulatory protein YeiL 219 
 
b0271 2.00 Putative beta-xylosidase (EC 3.2.1.37) (1,4-beta-D-xylan xylohydrolase) (Xylan 1,4-beta-
xylosidase) 





Table 5. The list of genes upregulated upon exposure to OG (compared to PG), grouped into 
respective metabolic categories.  
Sulfur metabolism 
 
Locus tag Fold change KEGG, NCBI Description 
b2764 7.02 sulfite reductase, alpha subunit, flavoprotein 
b2762 6.76 phosphoadenosine phosphosulfate reductase; PAPS reductase, thioredoxin 
dependent 
b2763 6.37 sulfite reductase, beta subunit, NAD(P)-binding, heme-binding 
b2425 2.55 cysP, thiosulfate-binding protein, sulfate transport system substrate-binding 
protein 
b0367 2.10 taurine transport system permease protein 
 
Stress Resistance and Response proteins 
Locus tag Fold change KEGG, NCBI Description 
b4682 19.18 membrane stress resistance protein 
b2851 5.87 SycD-like chaperone family TPR-repeat-containing protein 
b1492 5.32 glutamate:gamma-aminobutyric acid antiporter 
b4705 4.71 Mn(2)-response protein, MntR-repressed 
b1824 3.73 DUF2527 family heat-induced protein 
b3508 3.05 putative Mg(2+) transport ATPase, inner membrane protein 
b0836 2.90 repressor of biofilm formation by indole transport regulation 
b3512 2.86 gad regulon transcriptional activator 
b2644 2.73 CP4-57 prophage; putative DNA repair protein 
b3513 2.58 anaerobic multidrug efflux transporter, ArcA-regulated 
b3507 2.56 Putative LuxR family repressor for dicarboxylate transport 
b3511 2.51 acid-resistance membrane protein 
b3491 2.11 acid resistance protein, inner membrane 
b1257 2.08 putative rubrerythrin/ferritin-like metal-binding protein 
b1582 2.03 UPF0060 family inner membrane protein 
b3509 2.02 acid-resistance protein 
 
Fe-S Cluster proteins 
 
Locus tag Fold change KEGG, NCBI Description 
b4126 2.40 putative 4Fe-4S mono-cluster protein 
b1802 2.36 putative YeaWX dioxygenase alpha subunit; 2Fe-2S cluster 
b2204 2.07 ferredoxin-type protein essential for electron transfer from ubiquinol to 
periplasmic nitrate reductase (NapAB) 
 
Hydrogenases and Formate 
dehydrogenase 
 
Locus tag Fold change KEGG, NCBI Description 
b2724 4.24 hydrogenase 3, Fe-S subunit 
b2723 3.95 hydrogenase 3, membrane subunit 
b2721 3.90 hydrogenase 3, large subunit 
 
 209 
Table 5 (con’t) 
Locus tag Fold change KEGG, NCBI Description 
b4079 3.56 formate dehydrogenase-H, selenopolypeptide subunit 
b2722 3.42 hydrogenase 3, membrane subunit 
b2718 3.38 hydrogenase 3 maturation protein 
b2713 3.18 formate dehydrogenase-H, [4Fe-4S] ferredoxin subunit 
b2483 3.02 hydrogenase 4, membrane subunit 
b2720 2.88 formate hydrogenlyase complex iron-sulfur protein 
b0977 2.86 hydrogenase-1 protein nickel incorporation factor 
b2719 2.84 hydrogenase 3 and formate hydrogenase complex, HycG subunit  
b4075 2.69 formate-dependent nitrite reductase complex subunit NrfF 
b2728 2.55 hydrogenase maturation protein, hydrogenase expression/formation protein 
HypC 
b2726 2.53 hydrogenase nickel incorporation protein HypA/HybF 
b0904 2.43 formate transporter 
b0974 2.29 hyaC, hydrogenase 1, b-type cytochrome subunit 
b0973 2.27 hyaB, hydrogenase 1, large subunit 
b2717 2.04 protease involved in processing C-terminal end of HycE  




Locus tag Fold change KEGG, NCBI Description 
b2158 15.03 UPF0324 family inner membrane protein 
b0317 10.86 putative inner membrane protein 
b0735 3.21 putative inner membrane protein in cydABX-ybgE operon 
b1408 2.94 inner membrane protein 
b2013 2.34 UPF0394 family inner membrane protein 
b3506 2.29 outer membrane lipoprotein 
b4317 2.26 fimbrial usher outer membrane porin protein; FimCD chaperone-usher 
b1256 2.22 outer membrane protein W 
b1311 2.01 inner membrane putative ABC superfamily sugar transporter permease 
 
Transporters and Two-component system 
Locus tag Fold change KEGG, NCBI Description 
b0617 6.99 citrate lyase, acyl carrier (gamma) subunit 
b0336 4.29 cytosine transporter 
b0484 4.11 copper transporter 
b1258 3.88 putative rubrerythrin/ferritin-like metal-binding protein 
b0486 3.40 putative amino acid transporter 
b3577 3.36 2,3-diketo-L-gulonate TRAP transporter small permease protein 
b1312 3.04 putative sugar ABC transporter permease 
b1729 3.03 putative transporter 
b1443 3.01 putative spermidine/putrescine transporter subunit 
 
 210 
Table 5 (con’t) 
Locus tag Fold change KEGG, NCBI Description 
b0573 2.80 Cu(I)/Ag(I) efflux system periplasmic protein CusF 
b3748 2.66 D-ribose pyranase 
b4035 2.44 fused maltose transport subunit, ATP-binding component of ABC 
superfamily/regulatory protein 
b2392 2.33 manganese/divalent cation transporter 
b2148 2.28 methyl-galactoside transporter subunit 
b4152 2.27 fumarate reductase subunit C, membrane anchor subunit 
b4153 2.25 fumarate reductase (anaerobic), Fe-S subunit 
b2126 2.20 inner membrane putative sensory kinase in two-component system with YehT 
b0994 2.18 periplasmic sensory protein associated with the TorRS two-component 
regulatory system 
b1244 2.16 oligopeptide ABC transporter permease 
b0513 2.13 putative uracil/xanthine transporter 
b2367 2.12 MFS transporter, DHA2 family, multidrug resistance protein 
b1441 2.10 putative spermidine/putrescine transport system ATP-binding protein 
b3751 2.09 D-ribose transporter subunit 
b3408 2.09 ferrous iron transporter, protein A 




Locus tag Fold change KEGG, NCBI Description 
b2725 5.13 regulator of the transcriptional regulator FhlA 
b4299 3.36 putative DNA-binding transcriptional regulator 
b1304 2.65 regulatory protein for phage-shock-protein operon 
b2847 2.50 putative transcriptional regulator 
b3410 2.20 putative DNA-binding transcriptional regulator, ferrous iron transport 
protein C 




Locus tag Fold change KEGG, NCBI Description 
b0901 3.46 putative NAD(P)H-dependent oxidoreductase 
b0123 2.91 multicopper oxidase (laccase) 
b1905 2.90 ferritin iron storage protein (cytoplasmic) 
b1672 2.28 FNR, Nar, NarP-regulated protein; putative subunit of YdhYVWXUT 
oxidoreductase complex 
b3001 2.28 L-glyceraldehyde 3-phosphate reductase 




Locus tag Fold change KEGG, NCBI Description 
b0334 3.72 2-methylcitrate dehydratase 
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Table 5 (con’t) 
Locus tag Fold change KEGG, NCBI Description 
b0733 3.36 cytochrome d terminal oxidase, subunit I 
b0734 3.36 cytochrome d terminal oxidase, subunit II 
b1409 3.36 putative CDP-diglyceride synthase 
b2054 2.94 putative acyl transferase 
b1141 2.46 e14 prophage; putative excisionase 
b3113 2.20 putative reactive intermediate deaminase 
b1838 2.03 serine/threonine-specific protein phosphatase 1 
b2057 2.02 putative colanic acid biosynthesis glycosyltransferase  
 
Amino acid metabolism 
 
Locus tag Fold change KEGG, NCBI Description 
b1493 4.39 glutamate decarboxylase B, PLP-dependent 
b0485 4.17 glutaminase 1 
b3517 3.24 glutamate decarboxylase A, PLP-dependent 
b3117 2.24 L-threonine dehydratase, catabolic 
b1444 2.16 gamma-aminobutyraldehyde dehydrogenase 
b1732 2.09 catalase HPII, heme d-containing 
 
Pyrimidine and Purine metabolism 
Locus tag Fold change KEGG, NCBI Description 
b2166 4.83 pseudouridine kinase 
b0337 4.21 cytosine/isoguanine deaminase 
b4237 3.21 anaerobic ribonucleotide reductase activating protein 
b1011 2.94 ureidoacrylate amidohydrolase 
b0284 2.46 PaoABC aldehyde oxidoreductase, Moco-containing subunit, xanthine 
dehydrogenase YagR molybdenum-binding subunit  
b4238 2.42 anaerobic ribonucleoside-triphosphate reductase 
 
Ribosomal RNA proteins 
 
Locus tag Fold change KEGG, NCBI Description 
b4010 112.65 5S ribosomal RNA of rrnE operon 
b2588 45.06 5S ribosomal RNA of rrnG operon 
b3272 22.53 5S ribosomal RNA of rrnD operon 
b3274 22.53 5S ribosomal RNA of rrnD operon 
b3342 12.95 30S ribosomal subunit protein S12 
b3756 3.60 16S ribosomal RNA of rrnC operon 
b2591 3.58 16S ribosomal RNA of rrnG operon 
b0201 3.56 16S ribosomal RNA of rrnH operon 
b3851 3.50 16S ribosomal RNA of rrnA operon 
b4007 3.48 16S ribosomal RNA of rrnE operon 
b3278 3.33 16S ribosomal RNA of rrnD operon 
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Table 5 (con’t) 
Locus tag Fold change KEGG, NCBI Description 
b3968 3.32 16S ribosomal RNA of rrnB operon 
b3315 2.95 50S ribosomal subunit protein L22 
b3985 2.85 50S ribosomal subunit protein L10 
b2589 2.85 23S ribosomal RNA of rrnG operon 
b3854 2.81 23S ribosomal RNA of rrnA operon 
b3970 2.78 23S ribosomal RNA of rrnB operon 
b0204 2.76 23S ribosomal RNA of rrnH operon 
b3758 2.65 23S ribosomal RNA of rrnC operon 
b4009 2.64 23S ribosomal RNA of rrnE operon 
b0953 2.63 ribosome modulation factor 
b3275 2.59 23S ribosomal RNA of rrnD operon 
b3311 2.57 30S ribosomal subunit protein S17 




Locus tag Fold change KEGG, NCBI Description 
b3273 71.15 tRNA-Thr 
b2402 2.34 tRNA-Val 
b1984 2.29 tRNA-Asn 




Locus tag Fold change KEGG, NCBI Description 
b1575 57.22 Qin prophage; cell division inhibition protein 
b0560 2.39 DLP12 prophage; DNA packaging protein 
b4201 2.33 primosomal protein N 
b1481 2.31 biofilm-dependent modulation protein 
b0699 4.62 DUF2517 family protein 
b2343 3.01 UPF0381 family protein 
b3922 2.56 UPF0381 family protein 
b4199 2.13 YhcN family protein, periplasmic 
b2094 3.58 galactitol-specific enzyme IIA component of PTS 
b2243 3.53 anaerobic sn-glycerol-3-phosphate dehydrogenase, C subunit, 4Fe-4S iron-
sulfur cluster 
b2242 2.40 sn-glycerol-3-phosphate dehydrogenase (anaerobic), membrane anchor 
subunit 
b2110 3.36 putative periplasmic pilin chaperone 
b1156 2.52 e14 prophage; putative tail fiber assembly protein 
b2095 3.21 D-tagatose 1,6-bisphosphate aldolase 2, subunit 
b2093 3.13 galactitol-specific enzyme IIB component of PTS 
b2096 2.62 D-tagatose 1,6-bisphosphate aldolase 2, catalytic subunit  
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Table 5 (con’t) 
Locus tag Fold change KEGG, NCBI Description 
b4119 2.12 alpha-galactosidase, NAD(P)-binding 
b4379 2.54 putative pyruvate formate lyase activating enzyme 
b1800 2.32 D-malate oxidase, NAD-dependent; putative tartrate dehydrogenase 
b1388 2.31 ring-1,2-phenylacetyl-CoA epoxidase subunit PaaA  
b1593 2.26 putative dethiobiotin synthetase 
b4239 2.24 trehalose-6-P hydrolase 
b1992 2.13 cobalamin synthase 
b2097 2.23 fructose-bisphosphate aldolase class I 
b1101 2.03 fused glucose-specific PTS enzymes: IIB component/IIC component 
b3588 2.10 aldehyde dehydrogenase B 
b3114 2.10 pyruvate formate-lyase 4/2-ketobutyrate formate-lyase  
b4085 2.10 allulose-6-phosphate 3-epimerase 
b3393 2.08 DNA catabolic protein 
b4316 2.08 periplasmic chaperone 
b2809 2.07 DUF903 family verified lipoprotein 
b1581 2.04 bifunctional D-altronate/D-mannonate dehydratase 
 
Uncharacterized 
    
Locus tag Fold change Locus tag Fold change Locus tag Fold change 
b4677 163.86 b1576 2.94 b4535 2.37 
b2849 101.55 b1957 2.77 b1730 2.18 
b4674 81.93 b1549 2.52 b1148 2.10 
b1155 6.71 b4527 2.41 b1003 2.05 
b4684 4.20 












Figure 1. Spot test assay for graphene toxicity. 3 µl spots of E. coli exposed to either PG or OG 
at the indicated concentrations for 6 hours were plated on LB agar plates. Plates were incubated 
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Figure 2. Survival of E. coli DH5a upon exposure to PG and OG. Graph shows the number 
colony forming units per ml (CFU/ml) obtained after 6 hours of exposure to 0, 80, 160, 320, 640, 
and 1280 µg/ml of PG (diamond) or OG (square). The x-axis represents concentration (µg/ml); 




































Figure 3. Percent survival of E. coli DH5a upon exposure to graphene. The graphs show 
percentage of cells surviving after 6 hours of exposure to graphene vs no graphene control. The 
x-axes represent the type of graphene tested: PG (gray bars), OG (black bars), GO (bars with 
diagonal lines), SWCNT (bars with dotted fill). The y-axes represent percentage of surviving 
cells. Panel (a) shows percent survival after exposure to 640 µg/ml graphene; panel (b) shows 




Figure 4. Effect of PG and OG on the expression of genes of interest. Total RNA was isolated 
from bacteria exposed to graphene for 6 hours. Relative transcript abundance was quantified 
using qRT-PCR. Fold expression of the genes in the presence of OG (gray bars) relative to their 


































Figure 5. Survival of knockout mutants of genes of interest upon exposure to OG. Cytotoxicity 
assays were performed wherein 1 x 106 cells/ml of each culture was exposed to 640 µg/ml of OG 
for 6 hours. Graph shows the number of surviving cells after exposure for different cell types 
tested. The x-axis represents cell type: Parent strain BW25113 WT (white bar); knockout 
mutants of upregulated genes (gray bars): inner membrane protein (Db2158), sulfite reductase a 
subunit (Db2764), sulfite reductase b subunit (Db2763); knockout mutants of downregulated 
gene (black bars): low temperature stress induced protein (Db1167); knockout mutants of genes 
with similar expression in OG and PG (bars with diagonal lines): cell division modulator 
(Db1731), inner membrane protein (Db1322). The y-axis represents colony forming units per ml 
































5.7 Supplementary figures 
 
Figure S1. Survival of E. coli DH5a upon exposure to GO and SWCNT. Graph shows the 
number colony forming units per ml (CFU/ml) obtained after 6 hours of exposure to 0, 80, 160, 
320, 640, and 1280 µg/ml of GO (diamonds) or SWCNT (squares). The x-axis represents 








Figure S2. mRNA enrichment from total RNA. The gel image and graphs represent snapshots of 
RNA quality analyses before and after rRNA depletion. The x-axis on graph represent size (nt); 
the y-axis represent sample intensity [FU]. (a) total RNA from PG; (b) total RNA from OG; (c) 
rRNA depleted RNA from PG; (d) rRNA depleted RNA from OG. The images show one 





Figure S3. Scatter plot of gene expression levels. Each gene (4,313 total genes) is represented as 
an individual data point and is plotted on a log2 scale based on its expression in PG and OG. The 
x-axis represents control, PG; the y-axis represents treatment, OG. The middle blue line is the 
identity line showing genes expressed at the same level in both control and treatment. The outer 
two green lines show genes with at least 2-fold change in expression value in either control (blue 
data points) or treatment (red data points). The increase in color intensity of a data point 
represent increase in expression level. The dashed purple line is the linear regression line that 









Figure S4. Heat map displaying the expression levels of all E. coli genes across PG and OG 
treatments. Each row corresponds to one gene (4,313 rows) and each column represents a 
treatment. The color displays expression levels of genes across treatments. Red indicates positive 





Figure S5. Survival of E. coli upon exposure to oxidized graphene. Cytotoxicity assays were 
performed wherein 1 x 106 cells/ml of each culture was exposed to 640 µg/ml of OG for 6 hours. 
Graph shows the number of surviving cells after exposure for different cell types tested. The x-
axis represents cell type: parent strains (white bars): E. coli DH5a, Parent strain BW25113; 
knockout mutants of upregulated genes (gray bars): inner membrane protein (Db2158), sulfite 
reductase a subunit (Db2764), sulfite reductase b subunit (Db2763); knockout mutants of 
downregulated gene (black bar): low temperature stress induced protein (Db1167); knockout 
mutants of genes with similar expression in OG and PG (bars with diagonal lines): cell division 
modulator (Db1731), inner membrane protein (Db1322). The y-axis represents colony forming 



































Figure S6. Survival of E. coli upon exposure to oxidized graphene. Cytotoxicity assays were 
performed wherein 1 x 106 cells/ml of each culture was exposed to 640 µg/ml of OG for 6 hours. 
Graph shows the number of surviving cells after exposure for different cell types tested. The x-
axis represents cell type: knockout mutant of recA gene, DNA recombination and repair protein 
(Db2699) similar to E. coli DH5a (white bar); parent strain (white bar): Parent strain BW25113; 
knockout mutants of upregulated genes (gray bars): inner membrane protein (Db2158), sulfite 
reductase a subunit (Db2764), sulfite reductase b subunit (Db2763); knockout mutants of 
downregulated gene (black bar): low temperature stress induced protein (Db1167); knockout 
mutants of genes with similar expression in OG and PG (bars with diagonal lines): cell division 
modulator (Db1731), inner membrane protein (Db1322). The y-axis represents colony forming 
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The studies described in Chapters 2-5 were aimed at gaining a molecular understating of the 
shared and unique molecular and cellular aspects of how different bacteria deal with hostile 
environmental conditions. The genetic changes occurring in three bacteria exposed to different 
stress conditions were studied and analyzed. A short summary of major findings and conclusions 
from each study are presented below. 
 
In Chapter 2, we looked at the effect of lignocellulose derived phenolic acids on the growth of 
the Acidothermus cellulolyticus. Phenolic acids have been shown to have inhibitory effects on 
the growth and survival of bacteria [1, 2]. The five phenolic compounds tested, namely, 
hydroxybenzoic acid (HA), vanillic acid (VA), coumaric acid (CA), syringic acid (SA) and 
ferulic acid (FA), tested were inhibitory to the growth of A. cellulolyticus. The cellular targets 
and underlying mechanism of toxicity of phenolic acids is yet to be fully understood [3]. Our 
studies of total protein profiles of A. cellulolyticus showed that the expression of a particular 
protein was upregulated specifically in the presence of phenolic acids. Mass spectrometry 
revealed the protein to be Acel_0059, a predicted thiosulfate sulfurtransferase (TST). We 
predicted that Acel_0059 played a role in sulfur metabolism. Expression of the Acel_0059 gene 
and the genes involved in sulfur assimilation (cysN, cysD, cysC, cysH, and cysM) was 
upregulated in the presence of phenolic acids. The data suggested that phenolic acids upregulated 
the expression of genes involved in assimilation of sulfate to cysteine. Reciprocally, the 
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supplementation of cysteine relieved the inhibition by HA and the upregulation of Acel_0059. 
The Acel_0059 gene was cloned and expressed in heterologous host Escherichia coli. Partially 
purified protein showed thiosulfate sulfurtransferase activity in vitro, with low specific activity. 
The heterologous expression of Acel_0059 in Escherichia coli increased its survival upon 
exposure to HA and PA (equimolar mixture of HA, VA, CA, SA and FA). We conclude that 
Acel_0059 is important in A. cellulolyticus survival in the presence of phenolic acids and 
possibly has a role in cysteine biosynthesis. 
 
To further expand our understanding of Acel_0059, in Chapter 3, we analyzed the genome-wide 
gene expression profiles of A. cellulolyticus in the presence of HA, PA and lignin, using RNA-
seq technology. The gene expression profiles of the organism in response to a particular stress 
aid in understanding the mechanism of toxicity and the factors involved in an adaptive response 
to that stress [4]. The transcriptome expression patterns in the presence of HA and PA were more 
similar, while the expression profile in the presence of lignin was more similar to that of control. 
Our preliminary growth studies had showed that HA and PA were more toxic to A. cellulolyticus 
cultures, compared to lignin. It has been reported that the inhibition mechanism of lignin could 
be different from phenolic acids, due to the low molecular weight, dispersity and multiple 
binding sites present in phenolic acids, as compared to the insoluble lignin [5, 6]. The number of 
significantly differentially expressed genes (HA: 470 genes; PA: 521 genes; lignin: 559 genes) 
correlated with the structural complexity of the compounds. Exposure to these inhibitory 
compounds induced the expression of a number of genes coding for membrane proteins, 
membrane related efflux proteins, multi-drug resistance ABC transporters, oxidative stress 
response proteins, redox-sensors, MarR (multiple antibiotic resistance regulator) family 
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transcriptional regulators, TST and sulfur assimilation pathway genes. Membrane proteins and 
transporters act as a protective barrier to prevent membrane disruption and influx of inhibitory 
compounds. Membrane permeabilization and inactivation of ABC transports have been proposed 
to contribute to toxicity of phenolic compounds [7, 8]. Lignin and its related phenolic acids have 
been shown to increase the generation of reactive oxygen species [9]. The enhanced expression 
of redox-sensors, oxidative stress response factors and sulfur metabolism genes could be 
attributed to the oxidative stress induced by the compounds tested. We conclude that lignin and 
its related phenolic acids act by inducing oxidative stress and membrane damage in A. 
cellulolyticus. The Acel_0059 gene and the genes involved in sulfate assimilation into cysteine 
might play an important role in A. cellulyticus during survival in the presence of phenolic acids. 
 
To further investigate the biological role of Acel_0059 using a genetic approach, in Chapter 4, 
we used the surrogate organism Mycobacterium smegmatis mc2 155. Using this surrogate 
organism, we studied whether the role of TST in survival under stress and cysteine synthesis was 
specific to A. cellulolyticus or shared among bacteria. The closest sequence homolog of A. 
cellulolyticus TST (Acel_0059) was identified as MSMEG_5789 of Mycobacterium smegmatis 
mc2 155, using the Uniprot/Swissprot database in NCBI blastp search (Chapter 1, Table S2). M. 
smegmatis mc2 155 (basonym for Mycolicibacterium smegmatis mc2 155) shares similarity with 
A. cellulolyticus in being a rod shaped, high G+C, Gram-positive Actinobacteria belonging to the 
order Actinomycetales. The knockout mutant of MSMEG_5789 was created using a process 
called recombineering [10]. The MsmegΔTST knockout mutant strain was found to be 
significantly more sensitive than the parent strain to a variety of stressors including 
formaldehyde, hydrogen peroxide, dithiothreitol, 2-mercaptoethanol, sodium dodecyl sulfate and 
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PA. TSTs have been shown to be induced under oxidative stress conditions and play a role in 
maintaining cellular redox balance [11]. We hypothesized possible role of TST in cysteine 
biosynthesis (Chapter 1), which is an important component of anti-oxidative stress system [12]. 
TST has been shown to be important in intracellular survival of mycobacteria in host 
macrophages, where it faces low oxygen, oxidative and nitrosative environments [13]. We 
investigated the ability of MsmegΔTST to use inorganic sulfate or cysteine as sole sulfur sources 
during survival in low oxygen environment. Under microaerophilic conditions, the growth of 
MsmegΔTST was significantly decreased when inorganic sulfate was used as the sole sulfur 
source. However, when cysteine was used as a sulfur source, the knockout mutant grew equally 
well as the parent strain. The transcriptional level of TST has been predicted to decrease with 
increase in cysteine concentration suggesting cysteine dependent regulation of the protein [14]. 
Our studies showed that supplementation of cysteine had inverse effect on the upregulation of 
TST by HA in A. cellulolyticus (Chapter 1). Thus TST might be directly or indirectly involved in 
the generation of cysteine. We conclude that the deletion of MSMEG_5789 affects the cysteine 
biosynthesis from sulfate under microaerophilic conditions, and increases the sensitivity of M. 
smegmatis to a variety of stressors.  
 
In a related but independent project, in Chapter 5, we studied the toxic effects of oxidized 
graphene nanomaterial, the basic structural element of various allotropes of carbon, on 
Escherichia coli. Growing interest in graphene-family nanomaterials in applications such as 
nanomedicine, nanosensors etc. demands the study of their biological activity [15]. E. coli is one 
of the most widely used model organism in understanding bacterial physiology and adaptation 
mechanisms under stress. We studied the effect of pristine graphene (PG) and oxidized graphene 
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(OG) on the growth of E. coli. At low concentrations, both were stimulatory to growth. However, 
at higher concentrations, OG drastically decreased cell survival, and the toxicity increased with 
increase in concentration. Other carbon nanomaterials, graphene oxide and single-walled carbon 
nanotubes, also had inhibitory effect on the growth of this bacteria. Gene expression profiles 
from E. coli exposed to PG and OG were compared. A total of 183 genes were induced and 125 
genes were repressed upon exposure to OG. Graphene is known to induce oxidative stress, DNA 
damage and membrane injury [16, 17]. Genes involved in DNA biosynthesis were repressed in 
the presence of OG and consequently DNA repair genes were induced in response to OG. Genes 
involved in sulfur metabolism and multiple formate dehydrogenases were upregulated to aid in 
oxidative stress tolerance. Genes involved in the formation of sulfide, which serves as a sulfur 
source for cysteine, were upregulated. A number of membrane proteins, stress resistance and 
response proteins were also induced in response to OG. The genes of interest were selected for 
further analysis. These included genes coding for: UPF0324 family inner membrane protein (up); 
sulfite reductase alpha subunit flavoprotein (up); sulfite reductase beta subunit flavoprotein (up); 
uncharacterized protein (down); blue light, low temperature and stress induced protein (down). 
Cytotoxicity assays of the knockout mutants of genes of interest followed the trend of the gene 
expression data. The cytotoxicity of OG to E. coli could therefore be attributed to oxidative 
stress, membrane stress and DNA damage. Integration of sulfur into cysteine seems crucial for 
cell survival under harmful environmental conditions. 
 
In summary, our studies revealed that a thiosulfate sulfurtransferase (TST) is important for 
survival during phenolic acid stress in A. cellulolyticus. The deletion of TST in M. smegmatis 
increased its sensitivity to various stressors. Cysteine biosynthesis from inorganic sulfate under 
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microaerophilic conditions was affected by the deletion of TST in M. smegmatis. We propose 
that TST might play a role in the generation of cysteine under stress conditions. Sulfur 
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